<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Chloral hydrate as a sedating agent for neurodiagnostic procedures in children - Fong, CY - 2021 | Cochrane Library</title> <meta content="Chloral hydrate as a sedating agent for neurodiagnostic procedures in children - Fong, CY - 2021 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011786.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Chloral hydrate as a sedating agent for neurodiagnostic procedures in children - Fong, CY - 2021 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011786.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD011786.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Chloral hydrate as a sedating agent for neurodiagnostic procedures in children" name="citation_title"/> <meta content="Choong Yi Fong" name="citation_author"/> <meta content="Faculty of Medicine, University of Malaya" name="citation_author_institution"/> <meta content="cyfong@ummc.edu.my" name="citation_author_email"/> <meta content="Wei Kang Lim" name="citation_author"/> <meta content="Faculty of Medicine, University of Malaya" name="citation_author_institution"/> <meta content="Limin Li" name="citation_author"/> <meta content="Faculty of Medicine, University of Malaya" name="citation_author_institution"/> <meta content="Nai Ming Lai" name="citation_author"/> <meta content="Taylor's University" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="8" name="citation_issue"/> <meta content="10.1002/14651858.CD011786.pub3" name="citation_doi"/> <meta content="2021" name="citation_date"/> <meta content="2021/08/16" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011786.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011786.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011786.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Chloral Hydrate [*administration &amp; dosage, adverse effects]; *Diagnostic Techniques, Neurological; Hydroxyzine [administration &amp; dosage]; Hypnotics and Sedatives [*administration &amp; dosage, adverse effects]; Midazolam [administration &amp; dosage, adverse effects]; Pentobarbital [administration &amp; dosage]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011786.pub3&amp;doi=10.1002/14651858.CD011786.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011786.pub3&amp;doi=10.1002/14651858.CD011786.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011786.pub3&amp;doi=10.1002/14651858.CD011786.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011786.pub3&amp;doi=10.1002/14651858.CD011786.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011786.pub3&amp;doi=10.1002/14651858.CD011786.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011786.pub3&amp;doi=10.1002/14651858.CD011786.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011786.pub3&amp;doi=10.1002/14651858.CD011786.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011786.pub3&amp;doi=10.1002/14651858.CD011786.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011786.pub3&amp;doi=10.1002/14651858.CD011786.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011786.pub3&amp;doi=10.1002/14651858.CD011786.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011786.pub3&amp;doi=10.1002/14651858.CD011786.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011786.pub3&amp;doi=10.1002/14651858.CD011786.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011786.pub3&amp;doi=10.1002/14651858.CD011786.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011786.pub3&amp;doi=10.1002/14651858.CD011786.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011786.pub3&amp;doi=10.1002/14651858.CD011786.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011786.pub3&amp;doi=10.1002/14651858.CD011786.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011786.pub3&amp;doi=10.1002/14651858.CD011786.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011786.pub3&amp;doi=10.1002/14651858.CD011786.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011786.pub3&amp;doi=10.1002/14651858.CD011786.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011786.pub3&amp;doi=10.1002/14651858.CD011786.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011786.pub3&amp;doi=10.1002/14651858.CD011786.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011786.pub3&amp;doi=10.1002/14651858.CD011786.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011786.pub3&amp;doi=10.1002/14651858.CD011786.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="jxlIh5Me";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011786\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011786\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011786\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011786\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","ru","ko","th","ms","fa","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD011786.pub3",title:"Chloral hydrate as a sedating agent for neurodiagnostic procedures in children",firstPublishedDate:"Aug 16, 2021 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Epilepsy Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jxlIh5Me&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011786.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011786.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD011786.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD011786.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011786.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD011786.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011786.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD011786.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD011786.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011786.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3726 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD011786.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011786.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011786.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011786.pub3/full#CD011786-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011786.pub3/full#CD011786-sec-0190"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011786.pub3/full#CD011786-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011786.pub3/full#CD011786-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011786.pub3/full#CD011786-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011786.pub3/full#CD011786-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011786.pub3/full#CD011786-sec-0041"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011786.pub3/full#CD011786-sec-0184"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011786.pub3/appendices#CD011786-sec-0195"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/table_n/CD011786StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/table_n/CD011786StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011786.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011786.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011786.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011786.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011786.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011786.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2021 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Chloral hydrate as a sedating agent for neurodiagnostic procedures in children</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011786.pub3/information#CD011786-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Choong Yi Fong</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011786.pub3/information#CD011786-cr-0005">Wei Kang Lim</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011786.pub3/information#CD011786-cr-0006">Limin Li</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011786.pub3/information#CD011786-cr-0007">Nai Ming Lai</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/information/en#CD011786-sec-0202">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 16 August 2021 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD011786.pub3">https://doi.org/10.1002/14651858.CD011786.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD011786-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011786-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011786-abs-0015">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011786-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011786-abs-0013">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD011786-abs-0006">한국어</a> </li> <li class="section-language"> <a class="" href="full/th#CD011786-abs-0008">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011786-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD011786-abs-0001" lang="en"> <section id="CD011786-sec-0001"> <h3 class="title" id="CD011786-sec-0001">Background</h3> <p>This is an updated version of a Cochrane Review published in 2017.</p> <p>Paediatric neurodiagnostic investigations, including brain neuroimaging and electroencephalography (EEG), play an important role in the assessment of neurodevelopmental disorders. The use of an appropriate sedative agent is important to ensure the successful completion of the neurodiagnostic procedures, particularly in children, who are usually unable to remain still throughout the procedure. </p> </section> <section id="CD011786-sec-0002"> <h3 class="title" id="CD011786-sec-0002">Objectives</h3> <p>To assess the effectiveness and adverse effects of chloral hydrate as a sedative agent for non‐invasive neurodiagnostic procedures in children. </p> </section> <section id="CD011786-sec-0003"> <h3 class="title" id="CD011786-sec-0003">Search methods</h3> <p>We searched the following databases on 14 May 2020, with no language restrictions: the Cochrane Register of Studies (CRS Web) and MEDLINE (Ovid, 1946 to 12 May 2020). CRS Web includes randomised or quasi‐randomised controlled trials from PubMed, Embase, ClinicalTrials.gov, the World Health Organization International Clinical Trials Registry Platform, the Cochrane Central Register of Controlled Trials (CENTRAL), and the specialised registers of Cochrane Review Groups including Cochrane Epilepsy. </p> </section> <section id="CD011786-sec-0004"> <h3 class="title" id="CD011786-sec-0004">Selection criteria</h3> <p>Randomised controlled trials that assessed chloral hydrate agent against other sedative agent(s), non‐drug agent(s), or placebo. </p> </section> <section id="CD011786-sec-0005"> <h3 class="title" id="CD011786-sec-0005">Data collection and analysis</h3> <p>Two review authors independently evaluated studies identified by the search for their eligibility, extracted data, and assessed risk of bias. Results were expressed in terms of risk ratio (RR) for dichotomous data and mean difference (MD) for continuous data, with 95% confidence intervals (CIs). </p> </section> <section id="CD011786-sec-0006"> <h3 class="title" id="CD011786-sec-0006">Main results</h3> <p>We included 16 studies with a total of 2922 children. The methodological quality of the included studies was mixed. Blinding of the participants and personnel was not achieved in most of the included studies, and three of the 16 studies were at high risk of bias for selective reporting. Evaluation of the efficacy of the sedative agents was also underpowered, with all the comparisons performed in small studies. </p> <p>Fewer children who received oral chloral hydrate had sedation failure compared with oral promethazine (RR 0.11, 95% CI 0.01 to 0.82; 1 study; moderate‐certainty evidence). More children who received oral chloral hydrate had sedation failure after one dose compared to intravenous pentobarbital (RR 4.33, 95% CI 1.35 to 13.89; 1 study; low‐certainty evidence), but there was no clear difference after two doses (RR 3.00, 95% CI 0.33 to 27.46; 1 study; very low‐certainty evidence). Children with oral chloral hydrate had more sedation failure compared with rectal sodium thiopental (RR 1.33, 95% CI 0.60 to 2.96; 1 study; moderate‐certainty evidence) and music therapy (RR 17.00, 95% CI 2.37 to 122.14; 1 study; very low‐certainty evidence). Sedation failure rates were similar between groups for comparisons with oral dexmedetomidine, oral hydroxyzine hydrochloride, oral midazolam and oral clonidine. </p> <p>Children who received oral chloral hydrate had a shorter time to adequate sedation compared with those who received oral dexmedetomidine (MD −3.86, 95% CI −5.12 to −2.6; 1 study), oral hydroxyzine hydrochloride (MD −7.5, 95% CI −7.85 to −7.15; 1 study), oral promethazine (MD −12.11, 95% CI −18.48 to −5.74; 1 study) (moderate‐certainty evidence for three aforementioned outcomes), rectal midazolam (MD −95.70, 95% CI −114.51 to −76.89; 1 study), and oral clonidine (MD −37.48, 95% CI −55.97 to −18.99; 1 study) (low‐certainty evidence for two aforementioned outcomes). However, children with oral chloral hydrate took longer to achieve adequate sedation when compared with intravenous pentobarbital (MD 19, 95% CI 16.61 to 21.39; 1 study; low‐certainty evidence), intranasal midazolam (MD 12.83, 95% CI 7.22 to 18.44; 1 study; moderate‐certainty evidence), and intranasal dexmedetomidine (MD 2.80, 95% CI 0.77 to 4.83; 1 study, moderate‐certainty evidence). </p> <p>Children who received oral chloral hydrate appeared significantly less likely to complete neurodiagnostic procedure with child awakening when compared with rectal sodium thiopental (RR 0.95, 95% CI 0.83 to 1.09; 1 study; moderate‐certainty evidence). </p> <p>Chloral hydrate was associated with a higher risk of the following adverse events: desaturation versus rectal sodium thiopental (RR 5.00, 95% 0.24 to 102.30; 1 study), unsteadiness versus intranasal dexmedetomidine (MD 10.21, 95% CI 0.58 to 178.52; 1 study), vomiting versus intranasal dexmedetomidine (MD 10.59, 95% CI 0.61 to 185.45; 1 study) (low‐certainty evidence for aforementioned three outcomes), and crying during administration of sedation versus intranasal dexmedetomidine (MD 1.39, 95% CI 1.08 to 1.80; 1 study, moderate‐certainty evidence). Chloral hydrate was associated with a lower risk of the following: diarrhoea compared with rectal sodium thiopental (RR 0.04, 95% CI 0.00 to 0.72; 1 study), lower mean diastolic blood pressure compared with sodium thiopental (MD 7.40, 95% CI 5.11 to 9.69; 1 study), drowsiness compared with oral clonidine (RR 0.44, 95% CI 0.30 to 0.64; 1 study), vertigo compared with oral clonidine (RR 0.15, 95% CI 0.01 to 2.79; 1 study) (moderate‐certainty evidence for aforementioned four outcomes), and bradycardia compared with intranasal dexmedetomidine (MD 0.17, 95% CI 0.05 to 0.59; 1 study; high‐certainty evidence). No other adverse events were significantly associated with chloral hydrate, although there was an increased risk of combined adverse events overall (RR 7.66, 95% CI 1.78 to 32.91; 1 study; low‐certainty evidence). </p> </section> <section id="CD011786-sec-0007"> <h3 class="title" id="CD011786-sec-0007">Authors' conclusions</h3> <p>The certainty of evidence for the comparisons of oral chloral hydrate against several other methods of sedation was variable. Oral chloral hydrate appears to have a lower sedation failure rate when compared with oral promethazine. Sedation failure was similar between groups for other comparisons such as oral dexmedetomidine, oral hydroxyzine hydrochloride, and oral midazolam. Oral chloral hydrate had a higher sedation failure rate when compared with intravenous pentobarbital, rectal sodium thiopental, and music therapy. Chloral hydrate appeared to be associated with higher rates of adverse events than intranasal dexmedetomidine. However, the evidence for the outcomes for oral chloral hydrate versus intravenous pentobarbital, rectal sodium thiopental, intranasal dexmedetomidine, and music therapy was mostly of low certainty, therefore the findings should be interpreted with caution. </p> <p>Further research should determine the effects of oral chloral hydrate on major clinical outcomes such as successful completion of procedures, requirements for an additional sedative agent, and degree of sedation measured using validated scales, which were rarely assessed in the studies included in this review. The safety profile of chloral hydrate should be studied further, especially for major adverse effects such as oxygen desaturation. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD011786-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011786-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011786-abs-0016">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011786-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011786-abs-0014">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD011786-abs-0007">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD011786-abs-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD011786-abs-0005">Русский</a> </li> <li class="section-language"> <a class="" href="full/th#CD011786-abs-0009">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011786-abs-0004">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD011786-abs-0002" lang="en"> <h3>The effectiveness of chloral hydrate as a sedative agent for children undergoing neurodiagnostic procedures </h3> <p><b>Review question</b> </p> <p>In children undergoing non‐invasive neurodiagnostic procedures, is chloral hydrate more effective at producing adequate sedation (slowing of brain activity) and safer than other ways of achieving sedation? </p> <p><b>Background</b> </p> <p>Neurodiagnostic procedures are non‐invasive neurological investigations important for children with suspected neurological disorders. These investigations include brain imaging and brain electrical activity testing. For these tests to be successfully performed, the child needs to remain still for at least 30 to 45 minutes during the investigation period. Sedative agents are required for children, who are usually unable to remain still for this period of time. </p> <p><b>Search date</b> </p> <p>The evidence is current to May 2020.</p> <p><b>Study characteristics</b> </p> <p>We included 16 studies involving a total of 2922 children (age up to 18 years old) in the review. All of the included studies were performed in hospitals that provided neurodiagnostic services. Most studies assessed the following three main outcomes: proportion of children who were unsuccessfully sedated for the neurodiagnostic procedure; length of time taken for adequate sedation; and side effects associated with the sedative agent. The quality of the evidence was mixed, ranging from very low to high. The main reason for lowering the quality of the evidence was that those closely involved in the trials, such as the doctors giving the sedation or the parents of the child, were not masked to the sedative agent used in the child, which could have affected their recording or interpretation of the results. </p> <p><b>Key results</b> </p> <p>We summarised the evidence of effectiveness and harms of oral chloral hydrate sedation when compared with other sedative agents. Our review suggests that oral chloral hydrate is just as effective a sedative agent with similar sedation failure rate when compared with oral dexmedetomidine, oral hydroxyzine hydrochloride, oral midazolam, and oral clonidine; and probably a more effective sedative agent with a lower sedation failure rate when compared with oral promethazine. Whilst most of the included studies showed that chloral hydrate was safe with no increase in side effects when compared to other sedative agents, one study reported an increased risk of side effects with oral chloral hydrate when compared with intranasal dexmedetomidine. </p> <p><b>Quality of the evidence</b> </p> <p>The quality of most of the evidence was poor due to flaws in study methods and the small sample size of each study, therefore our confidence in the results of the studies is reduced. </p> <p><b>Conclusions</b> </p> <p>Apart from intravenous pentobarbital, rectal sodium thiopental, and music therapy, oral chloral hydrate is either just as effective or more effective as a sedating agent when compared to other sedating agents for children undergoing non‐invasive neurodiagnostic procedures. Given the poor quality of the evidence, we could draw no clear conclusions on the effectiveness or safety of any of the paediatric sedative agents studied in the review. Further study is needed to look at the side effects of oral chloral hydrate when compared to other sedatives. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD011786-sec-0190" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD011786-sec-0190"></div> <h3 class="title" id="CD011786-sec-0191">Implications for practice</h3> <section id="CD011786-sec-0191"> <p>For children undergoing neurodiagnostic procedures, very low‐ to moderate‐certainty evidence suggests that oral chloral hydrate is either just as effective a sedative agent with similar sedation failure rate when compared with oral dexmedetomidine, oral hydroxyzine hydrochloride, or oral midazolam; and probably a more effective sedative agent with lower sedation failure rate when compared with oral promethazine or intranasal midazolam. Based on the limited evidence gathered in our review, the most effective oral chloral hydrate doses appear to be 100 mg/kg and 70 mg/kg. However, there was a report of increased risk of total adverse effects with oral chloral hydrate when compared to dexmedetomidine; given the low certainty of evidence associated with this outcome, caution should be exercised in the use of oral chloral hydrate until further evidence on its safety profile is available. </p> </section> <h3 class="title" id="CD011786-sec-0192">Implications for research</h3> <section id="CD011786-sec-0192"> <p>With the increasing need for neurodiagnostic procedures amongst children, further trials evaluating the efficacy of sedative agents in children undergoing such procedures is warranted. This review highlights the paucity of research performed in this area. Future trials should include major clinical outcomes as stipulated as the primary outcomes of our review, such as successful completion of procedure, requirements for additional sedative agent, degree of sedation measured using validated scales, and major adverse effects, especially bradycardia, hypotension, and oxygen desaturation. Further trials should ensure that blinding of participants and personnel is achieved with measures in place to reduce selection bias, and include clear documentation of trial methodologies. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD011786-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD011786-sec-0008"></div> <div class="table" id="CD011786-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Chloral hydrate oral (50 mg/kg or 100 mg/kg) compared to dexmedetomidine oral (2 µg/kg or 3 µg/kg) as sedating agents for neurodiagnostic procedures in children</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Chloral hydrate oral (50 mg/kg or 100 mg/kg) compared to dexmedetomidine oral (2 µg/kg or 3 µg/kg) as sedating agents for neurodiagnostic procedures in children</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children undergoing neurodiagnostic procedures<br/><b>Setting:</b> paediatric hospital or outpatient<br/><b>Intervention:</b> chloral hydrate oral (50 mg/kg or 100 mg/kg)<br/><b>Comparison:</b> dexmedetomidine oral (2 µg/kg or 3 µg/kg) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with dexmedetomidine</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with chloral hydrate</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children who successfully completed neurodiagnostic procedure without interruption by the child awakening </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study in this comparison assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children who required a further dose of either the same sedative agent or the addition of a different sedative agent </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study in this comparison assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean EEG time onset for adequate sedation (minutes) was 35.2.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean EEG time onset for adequate sedation (minutes) in the intervention group was 3.86 minutes shorter (5.12 shorter to 2.6 shorter). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>160<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Proportion of children who had sedation failure or inadequate level of sedation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.14<br/>(0.51 to 2.53) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>160<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>119 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>136 per 1000<br/>(61 to 301) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sedation duration (minutes)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of sedation/sleep was 112.1 minutes.<sup>3</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean EEG sedation/sleep duration in the intervention group was 16.47 minutes longer (9.21 to 23.72 minutes longer). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>160<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of children with clinical adverse events (any)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 7.66<br/>(1.78 to 32.91) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>160<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>24 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>182 per 1000<br/>(42 to 784) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>EEG:</b> electroencephalogram; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>The 95% CI for this estimate ranges from 2.6 to 5.1 minutes of difference, which in terms of length of sedation is wide. Certainty of evidence downgraded one level due to risk of bias.<br/><sup>2</sup>The 95% CI for this estimate ranges from substantial benefits favouring chloral hydrate to substantial benefits favouring dexmedetomidine. Certainty of evidence downgraded one level due to imprecision.<br/><sup>3</sup>The mean was derived by averaging the mean values of the two subgroups of children receiving two different doses of oral dexmedetomidine (2 mg/kg and 3 mg/kg), each of which consisted of 40 children.<br/><sup>4</sup>The 95% CI for this estimate ranges from about 9 more minutes to 23 more minutes of sleep duration, which is too wide in the context of sedation for neurodiagnostic procedures. Certainty of evidence downgraded one level due to imprecision.<br/><sup>5</sup>The 95% CI for this estimate is very wide. Certainty of evidence downgraded two levels due to imprecision. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD011786-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Chloral hydrate oral (75 mg/kg) compared to pentobarbital intravenous (5 mg/kg) as sedating agents for neurodiagnostic procedures in children</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Chloral hydrate oral (75 mg/kg) compared to pentobarbital intravenous (5 mg/kg) as sedating agents for neurodiagnostic procedures in children</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children undergoing neurodiagnostic procedures<br/><b>Setting:</b> paediatric hospital or outpatient<br/><b>Intervention:</b> chloral hydrate oral (75 mg/kg)<br/><b>Comparison:</b> pentobarbital intravenous (5 mg/kg) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p>Risk with <b>pentobarbital</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with chloral hydrate</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children who successfully completed neurodiagnostic procedure without interruption by the child awakening </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study in this comparison assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children who required a further dose of either the same sedative agent or the addition of a different sedative agent </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study in this comparison assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean time to adequate sedation was 9 minutes.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean time to adequate sedation in the intervention group was 19 minutes longer (16.61 to 21.39 minutes longer). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Proportion of children who had sedation failure after 1 dose of sedative agent</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 4.33<br/>(1.35 to 13.89) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>70<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>86 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>371 per 1000<br/>(116 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Proportion of children who had sedation failure after 2 doses of sedative agent (same or different) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 3.00<br/>(0.33 to 27.46) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>70<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>29 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>86 per 1000<br/>(9 to 785) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Non‐interpretable neuroimaging finding</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.23<br/>(0.03 to 1.94) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>54<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>154 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>35 per 1000<br/>(5 to 298) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of children with clinical adverse event: oxygen desaturation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.67<br/>(0.21 to 2.16) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>70<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>171 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>115 per 1000<br/>(36 to 370) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>The single included study had unclear risk of bias for allocation concealment and blinding of outcome assessor and high risk of bias for blinding of participants and personnel. Certainty of evidence downgraded one level due to risk of bias.<br/><sup>2</sup>Although both ends of the 95% CI clearly indicate a longer onset of adequate sedation for the chloral hydrate group, the range of 95% CI for this estimate was too wide to permit a confident estimate on the time difference. Certainty of evidence downgraded one level due to imprecision.<br/><sup>3</sup>The 95% CI for this estimate ranges from slightly higher risk of sedation failure for chloral hydrate group to substantially higher risk of sedation failure for chloral hydrate group. Certainty of evidence downgraded two levels due to imprecision.<br/><sup>4</sup>The 95% CI for this estimate ranges from substantially favouring chloral hydrate group to substantially favouring pentobarbital group. Certainty of evidence downgraded two levels due to imprecision.<br/><sup>5</sup>The 95% CI for this estimate ranges from substantially lower risk of sedation failure for chloral hydrate group to substantially higher risk of sedation failure for chloral hydrate group. Certainty of evidence downgraded two levels due to imprecision. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD011786-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Chloral hydrate oral (100 mg/kg or 75 mg/kg) compared to midazolam (intranasal 0.2 mg/kg or oral 0.5 mg/kg) as sedating agents for neurodiagnostic procedures in children</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Chloral hydrate oral (100 mg/kg or 75 mg/kg) compared to midazolam (intranasal 0.2 mg/kg or oral 0.5 mg/kg) as sedating agents for neurodiagnostic procedures in children</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children undergoing neurodiagnostic procedures<br/><b>Setting:</b> paediatric hospital or outpatient<br/><b>Intervention:</b> chloral hydrate oral (100 mg/kg or 75 mg/kg)<br/><b>Comparison:</b> midazolam (intranasal 0.2 mg/kg or oral 0.5 mg/kg) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with midazolam</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with chloral hydrate</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children who successfully completed neurodiagnostic procedure without interruption by the child awakening </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study in this comparison assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children who required a further dose of either the same sedative agent or the addition of a different sedative agent </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study in this comparison assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean time to adequate sedation was 10.92 minutes (intranasal midazolam).</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean time to adequate sedation in the intervention group was 12.83 minutes longer (7.22 to 18.44 minutes longer). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Proportion of children with inadequate level of sedation (Ramsay score below 4)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.11<br/>(0.03 to 0.44) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>60<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>600 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>66 per 1000<br/>(18 to 264) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Proportion of children who had sedation failure after 1 dose of sedative agent</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.17<br/>(0.02 to 1.12) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>33<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>545 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>93 per 1000<br/>(11 to 611) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sedation duration (minutes)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of sedation or sleep was 76 minutes (oral midazolam).</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of sedation or sleep in the intervention group was 19 minutes longer (3.4 minutes shorter to 41.4 minutes longer). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>EEG sedative‐induced artefact</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.58<br/>(0.44 to 0.76) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>198<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/>HIGH </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>700 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>406 per 1000</p> <p>(308 to 532)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of children with clinical adverse events (any)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.20<br/>(0.01 to 4.20) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>198<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>20 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4 per 1000<br/>(0 to 84) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>EEG:</b> electroencephalogram; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>The 95% CI for this estimate is wide, although both ends are on the same direction of effect. Certainty of evidence downgraded one level due to imprecision.<br/><sup>2</sup>The 95% CI for this estimate ranges from substantially lower risk to higher risk for chloral hydrate group. Certainty of evidence downgraded two levels due to imprecision.<br/><sup>3</sup>The 95% CI for this estimate ranges from slightly shorter to substantially higher for chloral hydrate group. Certainty of evidence downgraded two levels due to imprecision. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD011786-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Chloral hydrate oral (50 mg/kg) compared to melatonin oral as sedating agents for neurodiagnostic procedures in children</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Chloral hydrate oral (50 mg/kg) compared to melatonin oral as sedating agents for neurodiagnostic procedures in children</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children undergoing neurodiagnostic procedures<br/><b>Setting:</b> paediatric hospital or outpatient<br/><b>Intervention:</b> chloral hydrate oral (50 mg/kg)<br/><b>Comparison:</b> melatonin oral </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with melatonin</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with chloral hydrate</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children who successfully completed neurodiagnostic procedure without interruption by the child awakening </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study in this comparison assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children who required a further dose of either the same sedative agent or the addition of a different sedative agent </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study in this comparison assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study in this comparison assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children who had sedation failure or inadequate level of sedation</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study in this comparison assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>EEG sedative‐induced artefact</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.33<br/>(0.14 to 0.82) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>348<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>103 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>34 per 1000<br/>(14 to 85) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of children with clinical adverse events (any)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.00<br/>(0.25 to 3.93) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>348<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>23 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>23 per 1000<br/>(6 to 90) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>EEG:</b> electroencephalogram; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>The single included study was at unclear risk of bias for random sequence generation, allocation concealment, and blinding of outcome assessors, and high risk of bias for blinding of participants and personnel. Certainty of evidence downgraded one level due to risk of bias.<br/><sup>2</sup>The 95% CIs were too wide to permit a confident estimate of the effect sizes. Certainty of evidence downgraded one level due to imprecision. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD011786-tbl-0005"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Chloral hydrate oral (50 mg/kg + 50 mg/kg) compared to hydroxyzine hydrochloride oral (1 mg/kg + 1 mg/kg) as sedating agents for neurodiagnostic procedures in children</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Chloral hydrate oral (50 mg/kg + 50 mg/kg) compared to hydroxyzine hydrochloride oral (1 mg/kg + 1 mg/kg) as sedating agents for neurodiagnostic procedures in children</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children undergoing neurodiagnostic procedures<br/><b>Setting:</b> paediatric hospital or outpatient<br/><b>Intervention:</b> chloral hydrate oral (50 mg/kg + 50 mg/kg)<br/><b>Comparison:</b> hydroxyzine hydrochloride oral (1 mg/kg + 1 mg/kg) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with hydroxyzine hydrochloride</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with chloral hydrate</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children who successfully completed neurodiagnostic procedure without interruption by the child awakening </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study in this comparison assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children who required a further dose of either the same sedative agent or the addition of a different sedative agent </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study in this comparison assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TIme to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The time onset to adequate sedation was 23.7 minutes.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean time to adequate sedation in the intervention group was 7.5 minutes shorter (7.85 to 7.15 minutes shorter). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>282<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Proportion of children who had sedation failure or inadequate level of sedation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.33<br/>(0.11 to 1.01) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>282<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>85 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>28 per 1000<br/>(9 to 86) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sedation duration (minutes)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of sedation or sleep was 85.1 minutes.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of sedation or sleep in the intervention group was 3.1 minutes longer (2.23 to 3.97 minutes longer). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>282<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of children with clinical adverse event: behavioural change</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.17<br/>(0.40 to 3.38) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>282<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>43 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>50 per 1000<br/>(17 to 144) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of children with clinical adverse event: nausea or vomiting</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.25<br/>(0.34 to 4.56) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>282<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>28 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>35 per 1000<br/>(10 to 129) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>The single included study was at unclear risk of bias for random sequence generation, allocation concealment, blinding of participants and personnel, and blinding of outcome assessors. Certainty of evidence downgraded one level due to risk of bias.<br/><sup>2</sup>The 95% CI for this estimate ranges from substantially lower risk to marginally to moderately higher risk of sedation failure for the chloral hydrate group. Certainty of evidence downgraded one level due to imprecision. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD011786-tbl-0006"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Chloral hydrate oral (70 mg/kg) compared to promethazine oral (1 mg/kg) as sedating agents for neurodiagnostic procedures in children</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Chloral hydrate oral (70 mg/kg) compared to promethazine oral (1 mg/kg) as sedating agents for neurodiagnostic procedures in children</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children undergoing neurodiagnostic procedures<br/><b>Setting:</b> paediatric hospital or outpatient<br/><b>Intervention:</b> chloral hydrate oral (70 mg/kg)<br/><b>Comparison:</b> promethazine oral (1 mg/kg) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with promethazine</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with chloral hydrate</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children who successfully completed neurodiagnostic procedure without interruption by the child awakening </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study in this comparison assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children who required a further dose of either the same sedative agent or the addition of a different sedative agent </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study in this comparison assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean time to adequate sedation was 33.84 minutes.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean time to adequate sedation in the intervention group was 12.11 minutes shorter (18.48 to 5.74 minutes shorter). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Proportion of children with inadequate level of sedation (Ramsay score below 4)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.03<br/>(0.00 to 0.45) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>60<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>567 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>17 per 1000<br/>(0 to 255) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Proportion of children who had sedation failure or inadequate level of sedation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.11<br/>(0.01 to 0.82) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>60<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>300 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>33 per 1000<br/>(3 to 246) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of children with clinical adverse event: behavioural change</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.20<br/>(0.01 to 4.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>60<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>67 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>13 per 1000<br/>(1 to 267) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of children with clinical adverse event: vomiting or nausea</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 13.00<br/>(0.76 to 220.96) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>60<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/>(0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>The 95% CI for this estimate is wide but falls on the same direction of effect. Certainty of evidence downgraded one level due to imprecision.<br/><sup>2</sup>The 95% CI for this estimate is very wide, especially if the data are inverted. Certainty of evidence downgraded two levels due to serious imprecision.<br/><sup>3</sup>The 95% CI for this estimate is very wide. Certainty of evidence downgraded two levels due to imprecision. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD011786-tbl-0007"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Chloral hydrate oral (60 mg/kg) compared to music therapy as sedating agents for neurodiagnostic procedures in children</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Chloral hydrate oral (60 mg/kg) compared to music therapy as sedating agents for neurodiagnostic procedures in children</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children undergoing neurodiagnostic procedures<br/><b>Setting:</b> paediatric inpatient or outpatient<br/><b>Intervention:</b> chloral hydrate oral (60 mg/kg)<br/><b>Comparison:</b> music therapy </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with music therapy</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with chloral hydrate</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children who successfully completed neurodiagnostic procedure without interruption by the child awakening </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study in this comparison assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children who required a further dose of either the same sedative agent or the addition of a different sedative agent </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study in this comparison assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean EEG time onset for adequate sedation was 23 minutes.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean EEG time onset for adequate sedation in the intervention group was 9 minutes more (2.15 fewer to 20.15 more). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Proportion of children who had sedation failure or inadequate level of sedation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 17.00<br/>(2.37 to 122.14) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>58<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>29 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>500 per 1000<br/>(70 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sedation duration (minutes)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean EEG sedation/sleep duration was 66 minutes.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean EEG sedation/sleep duration in the intervention group was 160 minutes more (121.07 more to 198.93 more). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of children with clinical adverse events (any)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study in this comparison assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>EEG:</b> electroencephalogram; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Very serious concerns regarding the trial methodology led to a judgement of high risk of selection bias (using alternation rather than true randomisation), performance and detection biases (non‐blinding of participants and care personnel as well as outcome assessors), and reporting bias. Certainty of evidence downgraded two levels due to risk of bias.<br/><sup>2</sup>The 95% CI was wide. Certainty of evidence downgraded one level due to imprecision.<br/><sup>3</sup>The 95% CI was very wide. Certainty of evidence downgraded two levels due to imprecision. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD011786-tbl-0008"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Chloral hydrate oral (50 mg/kg) compared to sodium thiopental rectal (25 mg/kg) for neurodiagnostic procedures in children</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Chloral hydrate oral (50 mg/kg) compared to sodium thiopental rectal (25 mg/kg) for neurodiagnostic procedures in children</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> neurodiagnostic procedures in children<br/><b>Setting:</b> paediatric hospital or outpatient<br/><b>Intervention:</b> chloral hydrate (50 mg/kg) oral<br/><b>Comparison:</b> sodium thiopental rectal (25 mg/kg) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with sodium thiopental</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with chloral hydrate</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Proportion of children who successfully completed neurodiagnostic procedure without interruption by the child awakening </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.95<br/>(0.83 to 1.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>140<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>1</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>871 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>828 per 1000<br/>(723 to 950) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean onset sedation (minutes) was 28.7 minutes.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 4.2 minutes lower<br/>(6.08 lower to 2.32 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>140<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Proportion of children who had sedation failure or inadequate level of sedation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.33<br/>(0.60 to 2.96) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>140<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>129 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>171 per 1000<br/>(77 to 381) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sedation duration (minutes</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean sedation duration (minutes) was 13.7 minutes.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.8 minutes lower<br/>(1.7 lower to 0.1 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>140<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>4</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of children with clinical adverse event: desaturation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 5.00<br/>(0.24 to 102.30) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>140<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>5</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/>(0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of children with clinical adverse event: diarrhoea</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.04<br/>(0.00 to 0.72) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>140<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>6</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>157 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>6 per 1000<br/>(0 to 113) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean diastolic blood pressure during procedure (mmHg)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean diastolic blood pressure during procedure (mmHg) was 53 mmHg.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 7.4 mmHg higher<br/>(5.11 higher to 9.69 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>140<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>7</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>The 95% confidence interval ranges from a moderate reduction to a slight increase in risk in a single‐study analysis with a small sample.<br/><sup>2</sup>The 95% confidence interval ranges from a marked decrease to a modest decrease in a single‐study analysis with a small sample.<br/><sup>3</sup>The 95% confidence interval ranges from a marked decrease to a marked increase in risk in a single‐study analysis with a small sample.<br/><sup>4</sup>The 95% confidence interval ranges from a marked reduction to a slight increase in a single‐study analysis with a small sample.<br/><sup>5</sup>The small number of events in the single‐study analysis resulted in very wide 95% confidence interval; certainty of evidence downgraded two levels.<br/><sup>6</sup>The 95% confidence interval ranges from a marked reduction to a moderate reduction in the risk of diarrhoea in a single study with a small sample.<br/><sup>7</sup>Whilst the mean diastolic blood pressure was reported as representing the possible adverse effect of hypotension, the reported measure here does not provide a direct indication of the risk of hypotension, which is usually reported as the number of participants with hypotension. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD011786-tbl-0009"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 9.</span> <span class="table-title">Chloral hydrate oral (50 mg/kg) compared to clonidine oral (4 μg/kg) for neurodiagnostic procedures in children</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Chloral hydrate oral (50 mg/kg) compared to clonidine oral (4 μg/kg) for neurodiagnostic procedures in children</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> neurodiagnostic procedures in children<br/><b>Setting:</b> hospital or outpatient<br/><b>Intervention:</b> chloral hydrate oral (50 mg/kg)<br/><b>Comparison:</b> clonidine oral (4 μg/kg) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with clonidine</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with chloral hydrate</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) (minutes) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean onset sedation (minutes) was 86.28 minutes.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 37.48 minutes lower<br/>(55.97 lower to 18.99 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>198<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sedation duration (minutes)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean sedation duration (minutes) was 74.2 minutes.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 6.07 minutes lower<br/>(15.32 lower to 3.18 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>198<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of children with clinical adverse event: drowsiness</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.44<br/>(0.30 to 0.64) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>198<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>1</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>580 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>255 per 1000<br/>(174 to 371) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of children with clinical adverse event: vertigo</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.15<br/>(0.01 to 2.79) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>198<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>1</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>30 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5 per 1000<br/>(0 to 84) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>EEG:</b> electroencephalogram; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>The single included study had a high risk of selection bias.<br/><sup>2</sup>Wide 95% confidence interval that ranges from a major reduction to a modest reduction in the time taken for onset of sedation.<br/><sup>3</sup>Wide 95% confidence interval that ranges from a moderate reduction to a slight increase in sleep duration. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD011786-tbl-0010"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 10.</span> <span class="table-title">Chloral hydrate oral (50 mg/kg) compared to dexmedetomidine intranasal (3 μg/kg) for neurodiagnostic procedures in children</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Chloral hydrate oral (50 mg/kg) compared to dexmedetomidine intranasal (3 μg/kg) for neurodiagnostic procedures in children</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> neurodiagnostic procedures in children<br/><b>Setting:</b> hospital or outpatient<br/><b>Intervention:</b> chloral hydrate oral (50 mg/kg)<br/><b>Comparison:</b> dexmedetomidine intranasal (3 μg/kg) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with dexmedetomidine</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with chloral hydrate</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) (minutes) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean sedation onset (minutes) was 19.6 minutes.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 2.8 minutes higher<br/>(0.77 higher to 4.83 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>194<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>1</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of children with clinical adverse event: bradycardia</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.17<br/>(0.05 to 0.59) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>194<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/>HIGH </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>161 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>27 per 1000<br/>(8 to 95) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of children with clinical adverse event: unsteadiness within 24 h after discharge</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 10.21<br/>(0.58 to 178.52) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>173<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/>(0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of children with clinical adverse event: crying during administration of sedation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.39<br/>(1.08 to 1.80) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>194<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>483 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>671 per 1000<br/>(521 to 869) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of children with clinical adverse event: vomiting</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 10.59<br/>(0.61 to 185.45) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>194<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/>(0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>The 95% confidence interval ranges from a slight increase to a moderate increase in duration of sedation in a single included study.<br/><sup>2</sup>Low event rate in a single included study resulted in a very wide 95% confidence interval.<br/><sup>3</sup>95% confidence interval ranges from 8% to 80% increase in the risk of crying during administration of medication. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD011786-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD011786-sec-0009"></div> <p>This is an updated version of a Cochrane Review published in 2017 (<a href="./references#CD011786-bbs2-0103" title="FongCY , TayCG , OngLC , LaiNM . Chloral hydrate as a sedating agent for neurodiagnostic procedures in children. Cochrane Database of Systematic Reviews2017, Issue 11. Art. No: CD011786. [DOI: 10.1002/14651858.CD011786.pub2]">Fong 2017</a>). </p> <section id="CD011786-sec-0010"> <h3 class="title" id="CD011786-sec-0010">Description of the condition</h3> <p>Paediatric neurodevelopmental disorders are collectively a common problem that affect between 5% and 10% of all children (<a href="./references#CD011786-bbs2-0084" title="HorridgeKA . Assessment and investigation of the child with disordered development. Archives of Disease in Childhood. Education and Practice Edition2011;96(1):9-20. [PMID: 20926624]">Horridge 2011</a>; <a href="./references#CD011786-bbs2-0097" title="ShevellM , AshwalS , DonleyD , FlintJ , GingoldM , HirtzD , et al. Practice parameter: evaluation of the child with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society. Neurology2003;60(3):367-80. [PMID: 12578916]">Shevell 2003</a>; <a href="./references#CD011786-bbs2-0098" title="ShevellM . Global developmental delay and mental retardation or intellectual disability: conceptualization, evaluation, and etiology. Pediatric Clinics of North America2008;55(5):1071-84, xi. [PMID: 18929052]">Shevell 2008</a>). A structured clinical evaluation together with targeted neurodiagnostic investigations of children with possible neurodevelopmental disorders is important to establish the aetiology of the disorder, predict the prognosis, and develop management strategies (<a href="./references#CD011786-bbs2-0084" title="HorridgeKA . Assessment and investigation of the child with disordered development. Archives of Disease in Childhood. Education and Practice Edition2011;96(1):9-20. [PMID: 20926624]">Horridge 2011</a>; <a href="./references#CD011786-bbs2-0097" title="ShevellM , AshwalS , DonleyD , FlintJ , GingoldM , HirtzD , et al. Practice parameter: evaluation of the child with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society. Neurology2003;60(3):367-80. [PMID: 12578916]">Shevell 2003</a>; <a href="./references#CD011786-bbs2-0098" title="ShevellM . Global developmental delay and mental retardation or intellectual disability: conceptualization, evaluation, and etiology. Pediatric Clinics of North America2008;55(5):1071-84, xi. [PMID: 18929052]">Shevell 2008</a>; <a href="./references#CD011786-bbs2-0099" title="SiloveN , CollinsF , EllawayC . Update on the investigation of children with delayed development. Journal of Paediatrics and Child Health2013;49(7):519-25. [PMID: 23600797]">Silove 2013</a>). </p> <p>Paediatric neurodiagnostic (non‐interventional) investigations used in the assessment of children with possible neurodevelopmental disorders include brain neuroimaging and electroencephalography (EEG). Successful completion of neurodiagnostic procedures is challenging in the paediatric age group, as the child is required to be immobile during the procedure. In addition, routine paediatric EEG recording requires recording of a period of sleep. Sleep state EEG recording is important as it increases the yield in detecting interictal epileptiform abnormalities. Achieving spontaneous sleep is not possible in some children despite behavioural intervention (prior sleep deprivation). The use of an appropriate sedative agent in children who are unable to be immobile or do not naturally sleep (for EEG recording), or both, thus plays a pivotal role in ensuring successful completion of the procedure. </p> <p>Selection of the most appropriate pharmacological and non‐pharmacological agents is an important factor for the success and safety of the neurodiagnostic procedure. Moreover, there are other pharmacological considerations when choosing a sedative agent for paediatric EEG because some sedative agents can suppress abnormal EEG activity or background activity (e.g. anaesthesia), and others can induce background activity changes that may obscure abnormalities (e.g. benzodiazepines and barbiturates). </p> <p>Children with neurodevelopmental disorders can present with a variety of symptoms including epilepsy, developmental impairment, developmental regression, social communication deficits, and behavioural difficulties. These children will require a structured clinical evaluation with targeted investigations to enable an accurate diagnosis, provide appropriate intervention, and assist in predicting long‐term prognosis. </p> <p>Neurodiagnostic investigations include EEG and brain neuroimaging. The duration of a standard awake and sleep paediatric EEG recording is approximately 30 to 60 minutes; a routine paediatric brain magnetic resonance imaging (MRI) scan takes approximately 45 to 60 minutes. Routine EEG is an important investigation tool in evaluating children with a clinical history suggestive of epilepsy (<a href="./references#CD011786-bbs2-0091" title="National Institute for Health and Care Excellence. The epilepsies: diagnosis and management. National Institute for Health and Care Excellence Clinical Guideline (CG 137) 11 January 2012 (last updated 12 May 2021). [https://www.nice.org.uk/guidance/cg137]">NICE 2012</a>). The EEG will assist in defining the specific epilepsy syndrome (<a href="./references#CD011786-bbs2-0092" title="PillaiJ , SperlingMR . Interictal EEG and the diagnosis of epilepsy. Epilepsia2006;47(Suppl 1):14-22. [PMID: 17044820]">Pillai 2006</a>). Neuroimaging investigations (particularly brain MRI) are useful in detecting major or minor structural brain abnormalities that may assist in establishing the cause of the child's neurodevelopmental disorder (<a href="./references#CD011786-bbs2-0075" title="BattagliaA . Neuroimaging studies in the evaluation of developmental delay/mental retardation. American Journal of Medical Genetics Part C: Seminars in Medical Genetics2003;117C(1):25-30. [PMID: 12561055]">Battaglia 2003</a>; <a href="./references#CD011786-bbs2-0094" title="RodriguezDP , PoussaintTY . Neuroimaging of the child with developmental delay. Topics in Magnetic Resonance Imaging2007;18(1):75-92. [PMID: 17607144]">Rodriguez 2007</a>). Current guidelines advocate that neuroimaging investigations should be considered in those children with an abnormal antenatal or perinatal history, an abnormal neurological examination, a history of focal epilepsy, and in all epilepsies in children under two years of age (<a href="./references#CD011786-bbs2-0075" title="BattagliaA . Neuroimaging studies in the evaluation of developmental delay/mental retardation. American Journal of Medical Genetics Part C: Seminars in Medical Genetics2003;117C(1):25-30. [PMID: 12561055]">Battaglia 2003</a>; <a href="./references#CD011786-bbs2-0091" title="National Institute for Health and Care Excellence. The epilepsies: diagnosis and management. National Institute for Health and Care Excellence Clinical Guideline (CG 137) 11 January 2012 (last updated 12 May 2021). [https://www.nice.org.uk/guidance/cg137]">NICE 2012</a>; <a href="./references#CD011786-bbs2-0094" title="RodriguezDP , PoussaintTY . Neuroimaging of the child with developmental delay. Topics in Magnetic Resonance Imaging2007;18(1):75-92. [PMID: 17607144]">Rodriguez 2007</a>). </p> </section> <section id="CD011786-sec-0011"> <h3 class="title" id="CD011786-sec-0011">Description of the intervention</h3> <p>Sedation is defined as a drug‐induced depression of consciousness, which is a continuum from wakefulness to anaesthesia (<a href="./references#CD011786-bbs2-0100" title="StarkeyE , SammonsHM . Sedation for radiological imaging. Archives of Disease in Childhood. Education and Practice Edition2011;96(3):101-6. [PMID: 20675522]">Starkey 2011</a>). It assists in reducing anxiety, providing pain control, and minimising movement of the patient when undergoing a procedure. There are different levels of sedation, as defined by the American Society of Anesthesiologists. These include minimal sedation, moderation sedation, and deep sedation (<a href="./references#CD011786-bbs2-0074" title="American Society of Anesthesiologists. Continuum of Depth of Sedation: Definition of General Anesthesia and Levels of Sedation / Analgesia. ASA Standards, Guidelines and Statements 23 October 2019. [https://www.asahq.org/standards-and-guidelines/continuum-of-depth-of-sedation-definition-of-general-anesthesia-and-levels-of-sedationanalgesia]">ASA 2007</a>). Moderate sedation involves the technique of administering sedatives to induce a state of depressed level of consciousness whilst allowing the patient to maintain independent control of their airway and oxygenation by preserving their protective airway reflexes (<a href="./references#CD011786-bbs2-0090" title="National Institute for Health and Care Excellence. Sedation in under 19s: using sedation for diagnostic and therapeutic procedures. National Institute for Health and Care Excellence Clinical Guideline (CG 112) 15 December 2010. [https://www.nice.org.uk/guidance/cg112]">NICE 2010</a>). Current guidelines recommend moderate sedation over deep sedation and general anaesthesia for painless paediatric procedures (<a href="./references#CD011786-bbs2-0090" title="National Institute for Health and Care Excellence. Sedation in under 19s: using sedation for diagnostic and therapeutic procedures. National Institute for Health and Care Excellence Clinical Guideline (CG 112) 15 December 2010. [https://www.nice.org.uk/guidance/cg112]">NICE 2010</a>). </p> <p>The ideal sedative agent to achieve moderate sedation should have rapid onset, a moderate duration of action, minimal or no adverse effects, and low cost. There is no ideal or first‐line sedative agent at present. The agents currently available for painless procedures include the following. </p> <p> <ul id="CD011786-list-0001"> <li> <p>Chloral hydrate, a non‐opiate and non‐benzodiazepine sedative hypnotic drug.</p> </li> <li> <p>Benzodiazepines, which act via the γ‐aminobutyric acid A receptors.</p> </li> <li> <p>Hydroxyzine, a long‐acting first‐generation H<sub>1</sub> antagonist with central nervous system depressant activity and minimal circulatory and depressant activity. </p> </li> <li> <p>Melatonin, a pineal hormone and natural sleep agent that can modulate the circadian rhythm of sleep through action on the suprachiasmatic nucleus in the hypothalamus. </p> </li> <li> <p>Promethazine, an antiemetic and antisialagogue with sedative properties.</p> </li> <li> <p>Dexmedetomidine, a selective alpha<sub>2</sub>‐adrenoceptor agonist with sedative properties. </p> </li> <li> <p>Clonidine, an alpha<sub>2</sub>‐ adrenoceptor agonist with sedative properties. </p> </li> <li> <p>Sodium thiopental, a short‐acting barbiturate with sedative properties.</p> </li> </ul> </p> <p>In addition, non‐pharmacological approaches such as music therapy have been shown to be beneficial in providing sedation during procedures in adult patients (<a href="./references#CD011786-bbs2-0076" title="BechtoldML , PuliSR , OthmanMO , BartalosCR , MarshallJB , RoyPK . Effect of music on patients undergoing colonoscopy: a meta-analysis of randomized controlled trials. Digestive Diseases and Sciences2009;54(1):19-24. [PMID: 18483858]">Bechtold 2009</a>), whilst there is some evidence that breastfeeding or breast milk helps infants tolerate painful or uncomfortable procedures better by reducing crying and improving infants' physiological responses during the procedures (<a href="./references#CD011786-bbs2-0096" title="ShahPS , HerbozoC , AliwalasLL , ShahVS . Breastfeeding or breast milk for procedural pain in neonates. Cochrane Database of Systematic Reviews2012, Issue 12. Art. No: CD004950. [DOI: 10.1002/14651858.CD004950.pub3] [PMID: 23235618]">Shah 2012</a>). </p> </section> <section id="CD011786-sec-0012"> <h3 class="title" id="CD011786-sec-0012">How the intervention might work</h3> <p>Chloral hydrate is a central nervous system depressant and is one of the oldest sedatives (discovered in 1832). It is well absorbed orally as well as rectally and is rapidly metabolised into the active metabolite trichloroethanol, which is responsible for its hypnotic and sedative effects. It is one of the most frequently used conscious sedative agents for children undergoing neurodiagnostic procedures including neuroimaging and EEG recording, as it has a good safety profile when used at sedative doses, with little effect on EEG background activity (<a href="./references#CD011786-bbs2-0088" title="MalviyaS , Voepel-LewisT , TaitAR . Adverse events and risk factors associated with the sedation of children by nonanesthesiologists. Anesthesia and Analgesia1997;85(6):1207-13. [PMID: 9390581]">Malviya 1997</a>). Doses vary from 55 to 100 mg/kg in neonates and children younger than 12 years old, with a maximum dose of 2 g (<a href="./references#CD011786-bbs2-0100" title="StarkeyE , SammonsHM . Sedation for radiological imaging. Archives of Disease in Childhood. Education and Practice Edition2011;96(3):101-6. [PMID: 20675522]">Starkey 2011</a>). Chloral hydrate is absorbed from the gastrointestinal tract and starts to exert its effect within 60 minutes. Adverse reactions occur in 1.7% to 20% of children, with gastrointestinal side effects, particularly vomiting, being the most common (<a href="./references#CD011786-bbs2-0100" title="StarkeyE , SammonsHM . Sedation for radiological imaging. Archives of Disease in Childhood. Education and Practice Edition2011;96(3):101-6. [PMID: 20675522]">Starkey 2011</a>). There have also been some concerns with regard to respiratory depression, long duration of action, and potential carcinogenicity (<a href="./references#CD011786-bbs2-0081" title="HaselkornT , WhittemoreAS , UdaltsovaN , FriedmanGD . Short-term chloral hydrate administration and cancer in humans. Drug Safety2006;29(1):67-77. [PMID: 16454535]">Haselkorn 2006</a>; <a href="./references#CD011786-bbs2-0085" title="KaoSC , AdamsonSD , TatmanLH , BerbaumKS . A survey of post-discharge side effects of conscious sedation using chloral hydrate in pediatric CT and MR imaging. Pediatric Radiology1999;29(4):287-90. [PMID: 10199909]">Kao 1999</a>). </p> </section> <section id="CD011786-sec-0013"> <h3 class="title" id="CD011786-sec-0013">Why it is important to do this review</h3> <p>Neurodiagnostic procedures (particularly neuroimaging) in children are important investigative tools and have been increasingly used over the last decade to assess and manage children with neurodevelopmental disorders. However, a significant proportion of children may be unable to complete the procedure due to sedation failure. Sedation failure is a great inconvenience to the child and their family and requires rescheduling of another hospital admission to complete the procedure, often under general anaesthesia (which carries additional associated risks). </p> <p>Both the National Institute for Health and Care Excellence (NICE) 2010 guideline and the American College of Emergency Physicians 2008 guideline recommend chloral hydrate for moderate sedation during painless procedures in the paediatric population (<a href="./references#CD011786-bbs2-0087" title="MaceSE , BrownLA , FrancisL , GodwinSA , HahnSA , HowardPK , et al, EMSC Panel (Writing Committee) on Critical Issues in the Sedation of Pediatric Patients in the Emergency. Clinical policy: critical issues in the sedation of pediatric patients in the emergency department. Annals of Emergency Medicine2008;51(4):378-99. [PMID: 18359378]">Mace 2008</a>; <a href="./references#CD011786-bbs2-0090" title="National Institute for Health and Care Excellence. Sedation in under 19s: using sedation for diagnostic and therapeutic procedures. National Institute for Health and Care Excellence Clinical Guideline (CG 112) 15 December 2010. [https://www.nice.org.uk/guidance/cg112]">NICE 2010</a>). However, neither guideline has suggested the superiority of chloral hydrate over other agents. Some studies have shown that chloral hydrate is unsuccessful in a significant proportion of children, resulting in failure to complete the procedure (<a href="./references#CD011786-bbs2-0077" title="BeebeDS , TranP , BraggM , StillmanA , TruwittC , BelaniKG . Trained nurses can provide safe and effective sedation for MRI in pediatric patients. Canadian Journal of Anaesthesia2000;47(3):205-10. [PMID: 10730728]">Beebe 2000</a>; <a href="./references#CD011786-bbs2-0088" title="MalviyaS , Voepel-LewisT , TaitAR . Adverse events and risk factors associated with the sedation of children by nonanesthesiologists. Anesthesia and Analgesia1997;85(6):1207-13. [PMID: 9390581]">Malviya 1997</a>). Few randomised controlled trials (RCTs) have been conducted comparing the efficacy of chloral hydrate with other sedative agents and complementary therapy (e.g. music therapy). However, to date no meta‐analysis of the previously published RCTs has been performed in order to determine superiority amongst these agents. </p> <p>The aim of this review was to allow clinicians to take an evidence‐based approach in deciding which sedating agent is best for children undergoing neurodiagnostic procedures. The care of children would improve if both sedation failure rates and adverse effects due to sedation were kept to a minimum. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD011786-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD011786-sec-0014"></div> <p>To assess the effectiveness and adverse effects of chloral hydrate as a sedative agent for non‐invasive neurodiagnostic procedures in children. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD011786-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD011786-sec-0015"></div> <section id="CD011786-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD011786-sec-0017"> <h4 class="title">Types of studies</h4> <p>Randomised or quasi‐randomised trials.</p> </section> <section id="CD011786-sec-0018"> <h4 class="title">Types of participants</h4> <p>Children (from birth to 18 years old) who underwent non‐invasive neurodiagnostic procedures (including brain neuroimaging and sleep EEG) who required sedation before the procedure. </p> </section> <section id="CD011786-sec-0019"> <h4 class="title">Types of interventions</h4> <p>Oral or rectal chloral hydrate.</p> <p>Comparison: other sedative/sleep‐inducing agents (e.g. promethazine, hydroxyzine, melatonin, midazolam, pentobarbital, etomidate, sevoflurane, clonidine, sodium thiopental, dexmedetomidine) or complementary therapies (e.g. music therapy), or achieved sleep without a sedative agent, for instance after a milk feed. </p> </section> <section id="CD011786-sec-0020"> <h4 class="title">Types of outcome measures</h4> <section id="CD011786-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD011786-list-0002"> <li> <p>Proportion of children who successfully completed neurodiagnostic procedure without interruption by the child awakening. </p> </li> <li> <p>Proportion of children who required a further dose of either the same sedative agent or the addition of a different sedative agent. </p> </li> <li> <p>Time to adequate sedation (in minutes or as measured by specific validated scales such as the Ramsay Sedation Score). </p> </li> </ul> </p> </section> <section id="CD011786-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD011786-list-0003"> <li> <p>Proportion of children who had sedation failure or inadequate level of sedation.</p> </li> <li> <p>Sedation duration.</p> </li> <li> <p>Yield of EEG findings (expressed either as the rate of abnormal EEG findings or additional EEG artefact findings attributable to the sedative agent, which may prevent interpretation of the EEG) or yield of neuroimaging findings (expressed as the rate of non‐interpretable MRI attributable to motion artefact due to inadequate sedation). </p> </li> <li> <p>Number of children with clinical adverse effects and severe drug side effects (e.g. hypotension, hypoxia, apnoea, laryngospasm, significant vomiting, refractory agitation, bradycardia, persistent drowsiness, diarrhoea. </p> </li> </ul> </p> </section> </section> </section> <section id="CD011786-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD011786-sec-0024"> <h4 class="title">Electronic searches</h4> <p>We ran searches for the original review in July 2017 and subsequent searches in April 2019. For the latest update, we searched the following databases on 14 May 2020. </p> <p> <ul id="CD011786-list-0004"> <li> <p>Cochrane Register of Studies (CRS Web), using the search strategy shown in <a href="./appendices#CD011786-sec-0196">Appendix 1</a>. This includes randomised or quasi‐randomised controlled trials from PubMed, Embase, US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov, the World Health Organization International Clinical Trials Registry Platform (WHO ICTRP), the Cochrane Central Register of Controlled Trials (CENTRAL), Chinese Clinical Trials Registry, Iranian Registry of Clinical Trials and the specialised registers of Cochrane Review Groups including Cochrane Epilepsy. </p> </li> <li> <p>MEDLINE (Ovid, 1946 to 12 May 2020), using the search strategy shown in <a href="./appendices#CD011786-sec-0197">Appendix 2</a>. </p> </li> </ul> </p> <p>We previously searched Embase (1980 to 19 July 2017) separately using the search strategy shown in <a href="./appendices#CD011786-sec-0198">Appendix 3</a>. </p> <p>We did not apply any language restrictions in our searches.</p> </section> <section id="CD011786-sec-0025"> <h4 class="title">Searching other resources</h4> <p>We searched references cited in relevant studies, Cochrane Reviews, guidelines, review articles, and conference proceedings, including abstracts from the Society for Pediatric Anesthesia and the European Society for Paediatric Anaesthesiology. We also contacted experts in the field to identify further relevant studies. </p> </section> </section> <section id="CD011786-sec-0026"> <h3 class="title" id="CD011786-sec-0026">Data collection and analysis</h3> <section id="CD011786-sec-0027"> <h4 class="title">Selection of studies</h4> <p>Two review authors (WKL, LL) independently performed the first round of searching for potentially relevant studies. They then screened the identified studies for inclusion in the analysis with the help of an arbiter (CYF), using the predefined inclusion and exclusion criteria. </p> <p>We collected information on study design and setting, participant characteristics (including age and the presence of additional comorbidities such as cerebral palsy), study eligibility criteria, details of the intervention(s) given, and outcomes assessed. We also collected information on study funding source and any conflicts of interest stated by the investigators. </p> <p>We accepted published and unpublished studies, both in full article and abstract form, given that adequate extraction of outcome data was possible. We contacted the authors of unpublished studies and studies available only as abstracts to request further information, including specific details of the methodologies employed as well as the full outcome data, to permit inclusion in meta‐analysis. We only included final data from each study and not data from interim analyses. </p> </section> <section id="CD011786-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (WKL, LL) independently extracted relevant data from each included study using a data collection form adapted for this review. We gathered the following information from each study. </p> <p> <ul id="CD011786-list-0005"> <li> <p>Study design (RCT, quasi‐RCT, or cluster‐RCT, and the number of arms evaluated)</p> </li> <li> <p>Risk of bias items, including the methods used and our risk of bias judgement (low risk, high risk, or unclear risk) </p> <ul id="CD011786-list-0006"> <li> <p>Random sequence generation</p> </li> <li> <p>Allocation concealment</p> </li> <li> <p>Blinding of participants, care personnel, and evaluators</p> </li> <li> <p>Missing data (loss to follow‐up)</p> </li> <li> <p>Risk of selective outcome reporting</p> </li> <li> <p>Other possible sources of bias</p> </li> </ul> </li> <li> <p>Stratification factors</p> </li> <li> <p>Participant factors</p> <ul id="CD011786-list-0007"> <li> <p>Number (total per group)</p> </li> <li> <p>Setting</p> </li> <li> <p>Diagnostic criteria</p> </li> <li> <p>Country</p> </li> <li> <p>Age</p> </li> <li> <p>Sex</p> </li> <li> <p>Underlying diagnoses</p> </li> <li> <p>Indications for neurodiagnostic procedure: whether for diagnostic or monitoring purposes</p> </li> </ul> </li> <li> <p>Intervention data: route of administration, dosage, and duration of chloral hydrate and comparator medication, and whether chloral hydrate was administered alone or in combination with another medication </p> </li> <li> <p>Follow‐up data</p> <ul id="CD011786-list-0008"> <li> <p>Duration of follow‐up period</p> </li> <li> <p>Numbers lost to follow‐up</p> </li> <li> <p>Reasons for loss to follow‐up</p> </li> </ul> </li> <li> <p>Outcome data, grouped into dichotomous and continuous outcomes, including adverse events </p> </li> </ul> </p> <p>For studies with incomplete reporting of outcome data, we derived the necessary data for meta‐analysis when possible. For example, <a href="./references#CD011786-bbs2-0003" title="AshrafiMR , MohebbiH , MohamadiM , AziziE , ZamaniGR , TavasoliA , et al. Clonidine versus chloral hydrate for recording sleep EEG in children. Iranian Journal of Child Neurology2020;14(1):85-92. [PMID: 32021632]">Ashrafi 2020</a> reported the mean value of each group along with P value of the difference, without providing the corresponding standard deviation (SD). We worked out the average SD values to be used in both allocated groups by following the recommendations in Section 7.7.3.3 of the <i>Cochane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011786-bbs2-0083" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.">Higgins 2021</a>). </p> <p>For details of each outcome included in our review (names, definitions, and possible unit of measurement), please refer to <a href="#CD011786-sec-0020">Types of outcome measures</a>. </p> <p>We screened for multiple enrolment by matching the initial number of participants recruited against the total numbers at each step in the study. We contacted the authors of the study for clarity regarding important aspects of the trial where necessary. Any disagreements were resolved by discussion leading to consensus, or by involving an arbiter (CYF) if necessary. </p> </section> <section id="CD011786-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (WKL, LL) independently assessed the risk of bias for each trial using the Cochrane risk of bias tool as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011786-bbs2-0082" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>). Any inconsistencies were resolved by discussion with a third review author (CYF). We assessed the included studies as at low, high, or unclear risk of bias on six domains applicable to RCTs: randomisation method, allocation concealment, blinding methods, incomplete outcome data, selective outcome reporting, and other sources of bias. </p> </section> <section id="CD011786-sec-0030"> <h4 class="title">Measures of treatment effect</h4> <p>We reported the outcome estimates for categorical data using risk ratios (RRs), risk differences (RDs), and the number needed to treat for an additional beneficial outcome (NNTB) or the number needed to treat for an additional harmful outcome (NNTH), with their respective 95% confidence intervals (CIs). For continuous data, which included time to adequate sedation and duration of sedation, we used mean differences (MDs) with their respective 95% CIs. If pooled analyses were not possible for reasons such as major discrepancies in study characteristics or outcome reporting as detailed in <a href="#CD011786-sec-0033">Assessment of heterogeneity</a>, we reported the results of the studies narratively. </p> </section> <section id="CD011786-sec-0031"> <h4 class="title">Unit of analysis issues</h4> <p>We included no cluster‐RCTs in this review. Had we included cluster‐RCTs, we would have adopted the following strategy when dealing with such studies. </p> <p>For cluster‐RCTs (e.g. trials in which the assignment to the intervention or control group was made at the level of the unit or hospital ward), we would have assessed whether an adjustment had been made for the effects of clustering in order to account for non‐independence amongst the participants in a cluster via the use of an appropriate analysis model, such as the generalised estimating equation (GEE) model. If the unit of analysis was not stated in the study, we would have inspected the width of the standard error (SE) or 95% CI of the estimated treatment effects. Had we found an inappropriately small SE or a narrow 95% CI, we would have asked the authors of the study to provide information on the unit of analysis. </p> <p>If no adjustment was made for the effects of clustering, we would have performed adjustment by multiplying the SEs of the final effect estimates by the square root of the 'design effect', represented by the formula '1 + (M − 1) x ICC', where M is the average cluster size (number of children per cluster) and ICC is the intracluster correlation. We would have determined the average cluster size (M) from each trial by dividing the total number of children by the total number of clusters. We would have used a relatively large assumed ICC of 0.10, as we consider this to be a realistic estimate based on previous studies about implementation research (<a href="./references#CD011786-bbs2-0078" title="CampbellMK , MollisonJ , GrimshawJM . Cluster trials in implementation research: estimation of intracluster correlation coefficients and sample size. Statistics in Medicine2001;20(3):391-9. [PMID: 11180309]">Campbell 2001</a>). We would have combined the adjusted final effect estimates from each trial with their SEs in meta‐analysis using generic inverse‐variance methods, as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011786-bbs2-0083" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.">Higgins 2021</a>). </p> <p>If determination of the unit of analysis was not possible, we would have included the studies concerned in a meta‐analysis using whatever effect estimates were provided by the authors. We would have then performed a sensitivity analysis to assess how the overall results were affected by inclusion of these studies. </p> <p>For multiple‐arm studies, we would have adjusted the data according to the methods described in Chapter 16 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011786-bbs2-0083" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.">Higgins 2021</a>). Specifically, if only two arms were relevant, we would have only included the relevant arms. If there were more than two relevant arms (e.g. chloral hydrate of two different dosages versus placebo), we would have set up separate pair‐wise comparisons, for example higher‐dose chloral hydrate versus placebo (Comparison 1) and lower‐dose chloral hydrate versus placebo (Comparison 2). In such cases, we would not total the number of children in the placebo group to avoid double‐counting. </p> </section> <section id="CD011786-sec-0032"> <h4 class="title">Dealing with missing data</h4> <p>We determined the dropout rates for each study. We also assessed whether the authors analysed their data according to the intention‐to‐treat principle by comparing the number of children initially randomised and the total number analysed. We considered an absolute dropout rate of 20% or higher as important. We also adopted a 'worst‐case scenario' approach in judging the dropout rate: if we found that the direction of the effect estimate changed with the worst‐case scenario approach, we considered the dropout rate as significant. </p> <p>If we found a significant dropout rate with no reasonable explanation, we classified the study as having a high risk of attrition bias. If we considered the missing data to be critical to the final estimates in our meta‐analysis, we contacted the authors of the individual studies to request further data. </p> <p>We planned to perform sensitivity analyses to assess how the overall results were affected by the inclusion of studies with a high risk of attrition bias. </p> </section> <section id="CD011786-sec-0033"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed clinical heterogeneity by comparing the distribution of important participant factors between trials (age, gender, seizure type, duration of epilepsy) and trial factors (clinical setting of the studies, the use of co‐interventions, risk of bias items including random sequence generation, allocation concealment, blinding, and losses to follow‐up). </p> <p>To evaluate statistical heterogeneity, we first visually inspected the forest plots to see if there was any gross inconsistency in the trial results. We used the I<sup>2</sup> statistic to quantify the extent and importance of inconsistency in the results (<a href="./references#CD011786-bbs2-0083" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.">Higgins 2021</a>). We used the following cutoffs for the reporting of heterogeneity. </p> <p> <ul id="CD011786-list-0009"> <li> <p>0% to 40%: heterogeneity might not be important</p> </li> <li> <p>30% to 60%: may represent moderate heterogeneity</p> </li> <li> <p>50% to 90%: may represent substantial heterogeneity</p> </li> <li> <p>75% to 100%: considerable heterogeneity</p> </li> </ul> </p> <p>If we found moderate, substantial, or considerable heterogeneity, we re‐examined the clinical and methodological characteristics of the studies using the criteria listed above to determine whether the degree of heterogeneity could be explained by differences in those characteristics, and whether a pooled analysis would be appropriate. If we considered a pooled analysis to be appropriate, we performed the analysis using a random‐effects model. </p> </section> <section id="CD011786-sec-0034"> <h4 class="title">Assessment of reporting biases</h4> <p>Had there been more than 10 studies available for a given outcome to enable a meaningful assessment, we would have used a funnel plot to screen for publication bias. If we detected significant asymmetry in the funnel plot, which is suggestive of the possibility of publication bias, we would have assessed it further using Begg's rank correlation and Egger's test and would have included a statement in the Results with a corresponding note of caution in the Discussion. </p> </section> <section id="CD011786-sec-0035"> <h4 class="title">Data synthesis</h4> <p>We performed meta‐analyses using Review Manager 5 software with a fixed‐effect model (<a href="./references#CD011786-bbs2-0093" title="Nordic Cochrane Centre, The Cochrane CollaborationReview Manager (RevMan). Version 5.4. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2020.">Review Manager 2020</a>), unless there was moderate or high heterogeneity, in which case we used the random‐effects model alongside an exploration of possible causes of heterogeneity, as described in the <a href="#CD011786-sec-0033">Assessment of heterogeneity</a> section. Our primary data analyses followed the intention‐to‐treat principle; namely, we used the original number of participants allocated to each study arm as the denominator in subsequent analyses. We expressed our results as RRs, RDs, NNTB, NNTH, and MDs with their respective 95% CIs, as detailed in the <a href="#CD011786-sec-0030">Measures of treatment effect</a> section. </p> </section> <section id="CD011786-sec-0036"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to conduct the following subgroup analyses if sufficient data were available; however we were unable undertake these analyses due to insufficient data. </p> <p> <ul id="CD011786-list-0010"> <li> <p>Different neurodiagnostic procedures (e.g. brain MRI versus brain computed tomography (CT) versus EEG). </p> </li> <li> <p>Age group of children (e.g. neonates versus older children).</p> </li> </ul> </p> <p>In addition, we found a study (<a href="./references#CD011786-bbs2-0008" title="GumusH , BayramAK , PoyrazogluHG , CanpolatDG , PerH , CanpolatM , et al. Comparison of effects of different dexmedetomidine and chloral hydrate doses used in sedation on electroencephalography in pediatric patients. Journal of Child Neurology2015;30(8):983-8. [DOI: 10.1177/0883073814549582] [PMID: 25246305]">Gumus 2015</a>) which included separate data for high and low doses of chloral hydrate for the major outcomes assessed. We therefore incorporated on a post‐hoc basis the subgroups of high dose (100 mg/kg) and low dose (50 mg/kg) in the meta‐analysis of comparison between chloral hydrate and dexmedetomidine (<a href="./references#CD011786-fig-0004" title="">Analysis 1.1</a>, <a href="./references#CD011786-fig-0005" title="">Analysis 1.2</a>; <a href="./references#CD011786-fig-0006" title="">Analysis 1.3</a>; <a href="./references#CD011786-fig-0007" title="">Analysis 1.4</a>; <a href="./references#CD011786-fig-0008" title="">Analysis 1.5</a>; <a href="./references#CD011786-fig-0009" title="">Analysis 1.6</a>; <a href="./references#CD011786-fig-0010" title="">Analysis 1.7</a>; <a href="./references#CD011786-fig-0010" title="">Analysis 1.7</a>; <a href="./references#CD011786-fig-0011" title="">Analysis 1.8</a>; <a href="./references#CD011786-fig-0012" title="">Analysis 1.9</a>). </p> </section> <section id="CD011786-sec-0037"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to perform sensitivity analyses for the primary outcomes and any secondary outcomes for which sufficient numbers of studies were available, by evaluating the change in the effect estimates following exclusion of studies at high risk of: </p> <p> <ul id="CD011786-list-0011"> <li> <p>selection bias (high risk for random sequence generation or allocation concealment, or both); </p> </li> <li> <p>attrition bias.</p> </li> </ul> </p> <p>However, we were unable to perform the sensitivity analyses as specified above due to insufficient number of studies included in each comparison‐outcome combination. </p> </section> <section id="CD011786-sec-0038"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We used the GRADE approach, as outlined in the GRADE Handbook, to assess the certainty of evidence for the most important outcomes across all comparisons as listed below, whether or not data were available (<a href="./references#CD011786-bbs2-0095" title="SchünemannH , BrożekJ , GuyattG , OxmanA , editor(s). Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html.">Schünemann 2013</a>). </p> <section id="CD011786-sec-0039"> <h5 class="title">Prespecified primary outcomes</h5> <p> <ul id="CD011786-list-0012"> <li> <p>Proportion of children who successfully completed neurodiagnostic procedure without interruption by the child awakening. </p> </li> <li> <p>Proportion of children who required a further dose of either the same sedative agent or the addition of a different sedative agent. </p> </li> <li> <p>Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score). </p> </li> </ul> </p> </section> <section id="CD011786-sec-0040"> <h5 class="title">Prespecified secondary outcomes</h5> <p> <ul id="CD011786-list-0013"> <li> <p>Proportion of children who had sedation failure or inadequate level of sedation.</p> </li> <li> <p>Sedation duration (minutes).</p> </li> <li> <p>Yield of EEG findings, including non‐interpretable EEG or sedative‐induced artefact.</p> </li> <li> <p>Number of children with clinical adverse events (any).</p> </li> </ul> </p> <p>Two review authors independently assessed the certainty of the evidence for each of the outcomes listed above. We considered evidence from RCTs initially as high quality, downgrading the evidence one level for serious (or two levels for very serious) limitations based on the following: design (risk of bias), consistency across studies, directness of the evidence, precision of estimates, and presence of publication bias (<a href="./references#CD011786-bbs2-0080" title="GuyattGH , OxmanAD , VistGE , KunzR , Falck-YtterY , Alonso-CoelloP , et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (Clinical research ed.)2008;336(7650):924-6. [PMID: 18436948]">Guyatt 2008</a>; <a href="./references#CD011786-bbs2-0095" title="SchünemannH , BrożekJ , GuyattG , OxmanA , editor(s). Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html.">Schünemann 2013</a>). We used <a href="./references#CD011786-bbs2-0079" title="McMaster University (developed by Evidence Prime)GRADEpro GDT. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org (accessed 26 August 2020).">GRADEpro GDT</a> software to create summary of findings tables to report the certainty of the evidence (<a href="./references#CD011786-bbs2-0079" title="McMaster University (developed by Evidence Prime)GRADEpro GDT. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org (accessed 26 August 2020).">GRADEpro GDT</a>). </p> <p>The GRADE approach results in an assessment of the certainty of a body of evidence in one of four grades, as follows. </p> <p> <ul id="CD011786-list-0014"> <li> <p>High: we are very confident that the true effect lies close to that of the estimate of the effect. </p> </li> <li> <p>Moderate: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. </p> </li> <li> <p>Low: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect. </p> </li> <li> <p>Very low: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of the effect. </p> </li> </ul> </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD011786-sec-0041" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD011786-sec-0041"></div> <section id="CD011786-sec-0042"> <h3 class="title">Description of studies</h3> <section id="CD011786-sec-0043"> <h4 class="title">Results of the search</h4> <p>We identified 310 records from our search of CENTRAL, MEDLINE, and Embase. We identified a further 50 potentially relevant records from our search of ClinicalTrials.gov, Chinese Clinical Trials Registry, Iranian Registry of Clinical Trials, and the WHO ICTRP. After removal of duplicates, 233 records remained, of which 75 articles appeared to be relevant after title inspection. We excluded 54 of these 75 articles after evaluation of the abstract or full text, or both. Of the remaining 21 articles, we excluded one article that was a duplicate publication of an included study; assessed another article for which we have requested additional information from the authors as awaiting classification; and identified three ongoing studies awaiting further information from the authors regarding the research data. We included a total of 16 studies in the review. The study flow diagram from the initial search to the meta‐analysis is shown in <a href="#CD011786-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD011786-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD011786-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD011786-sec-0044"> <h4 class="title">Included studies</h4> <p>For details, see <a href="./references#CD011786-sec-0208" title="">Characteristics of included studies</a>. </p> <p>We included 16 RCTs that were conducted in six countries: Iran (6 studies), Turkey (3 studies), the USA (3 studies), and Israel, Chile, China, and Spain (1 study each). Fifteen trials were single‐centre RCTs, and 1 trial was dual‐centre RCT. The number of children recruited ranged from 40, in <a href="./references#CD011786-bbs2-0006" title="D'AgostinoJ , TerndrupTE . Chloral hydrate versus midazolam for sedation of children for neuroimaging: a randomized clinical trial. Pediatric Emergency Care2000;16(1):1-4. [PMID: 10698133]">D'Agostino 2000</a>, to 582, in <a href="./references#CD011786-bbs2-0015" title="ThompsonJR , SchneiderS , AshwalS . The choice of sedation for computed tomography in children. A prospective evaluation. Radiology1982;143(2):475-9. [PMID: 7071350]">Thompson 1982</a>. All studies were conducted on paediatric patients (age up to 18 years old). All studies included children of both sexes. </p> <p>Five trials were sedation trials conducted on neuroimaging studies (4 studies on brain CT, 2 studies on brain MRI, 1 study on brain MRI or CT) (<a href="./references#CD011786-bbs2-0004" title="AzizkhaniR , KananiS , SharifiA , GolshaniK , MasoumiB , AhmadiO . Oral chloral hydrate compare with rectal thiopental in pediatric procedural sedation and analgesia; a randomized clinical trial. Emergency (Tehran, Iran)2014;2(2):85-9. [PMID: 26495353]">Azizkhani 2014</a>; <a href="./references#CD011786-bbs2-0006" title="D'AgostinoJ , TerndrupTE . Chloral hydrate versus midazolam for sedation of children for neuroimaging: a randomized clinical trial. Pediatric Emergency Care2000;16(1):1-4. [PMID: 10698133]">D'Agostino 2000</a>; <a href="./references#CD011786-bbs2-0007" title="FallahR , NakhaeiMH , BehdadS , MoghaddamRN , ShamszadehA . Oral chloral hydrate vs. intranasal midazolam for sedation during computerized tomography. Indian Pediatrics2013;50(2):233-5. [PMID: 23024102]">Fallah 2013</a>; <a href="./references#CD011786-bbs2-0011" title="MalviyaS , Voepel-LewisT , TaitAR , ReynoldsPI , GujarSK , GebarskiSS , et al. Pentobarbital vs chloral hydrate for sedation of children undergoing MRI: efficacy and recovery characteristics. Paediatric Anaesthesia2004;14(7):589-95. [PMID: 15200658]">Malviya 2004</a>; <a href="./references#CD011786-bbs2-0012" title="Marti-BonmatiL , Ronchera-OmsCL , CasillasC , PoyatosC , TorrijoC , JimenezNV . Randomised double-blind clinical trial of intermediate- versus high-dose chloral hydrate for neuroimaging of children. Neuroradiology1995;37(8):687-91. [PMID: 8748907]">Marti‐Bonmati 1995</a>; <a href="./references#CD011786-bbs2-0015" title="ThompsonJR , SchneiderS , AshwalS . The choice of sedation for computed tomography in children. A prospective evaluation. Radiology1982;143(2):475-9. [PMID: 7071350]">Thompson 1982</a>; <a href="./references#CD011786-bbs2-0016" title="YuenVM , LiBL , CheukDK , LeungMKM , HuiTWC , WongIC , et al. A randomised controlled trial of oral chloral hydrate vs. intranasal dexmedetomidine before computerised tomography in children. Anaesthesia2017;72(10):1191-5. [PMID: 28741653]">Yuen 2017a</a>), whilst the remaining nine trials were sedation trials conducted on EEG studies (<a href="./references#CD011786-bbs2-0001" title="AshrafiMR , MohammadiM , TafarrojiJ , ShabanianR , SalamatiP , ZamaniGR . Melatonin versus chloral hydrate for recording sleep EEG. European Journal of Paediatric Neurology2010;14(3):235-8. [DOI: 10.1016/j.ejpn.2009.06.010] [PMID: 19616978]">Ashrafi 2010</a>; <a href="./references#CD011786-bbs2-0002" title="AshrafiMR , Azizi MalamiriR , ZamaniGR , MohammadiM , HosseiniF . Sleep inducing for EEG recording in children: a comparison between oral midazolam and chloral hydrate. Iranian Journal of Child Neurology2013;7(1):15-9. [PMID: 24665284]">Ashrafi 2013</a>; <a href="./references#CD011786-bbs2-0003" title="AshrafiMR , MohebbiH , MohamadiM , AziziE , ZamaniGR , TavasoliA , et al. Clonidine versus chloral hydrate for recording sleep EEG in children. Iranian Journal of Child Neurology2020;14(1):85-92. [PMID: 32021632]">Ashrafi 2020</a>; <a href="./references#CD011786-bbs2-0005" title="BektasO , AricaB , TeberS , YilmazA , ZeybekH , KaymakS , et al. Chloral hydrate and/or hydroxyzine for sedation in pediatric EEG recording. Brain &amp; Development2014;36(2):130-6. [DOI: 10.1016/j.braindev.2013.03.002] [PMID: 23582501]">Bektas 2014</a>; <a href="./references#CD011786-bbs2-0008" title="GumusH , BayramAK , PoyrazogluHG , CanpolatDG , PerH , CanpolatM , et al. Comparison of effects of different dexmedetomidine and chloral hydrate doses used in sedation on electroencephalography in pediatric patients. Journal of Child Neurology2015;30(8):983-8. [DOI: 10.1177/0883073814549582] [PMID: 25246305]">Gumus 2015</a>; <a href="./references#CD011786-bbs2-0009" title="LoewyJ , HallanC , FriedmanE , MartinezC . Sleep/sedation in children undergoing EEG testing: a comparison of chloral hydrate and music therapy. American Journal of Electroneurodiagnostic Technology2006;46(4):343-55. [PMID: 17285817]LoewyJ , HallanC , FriedmanE , MartinezC . Sleep/sedation in children undergoing EEG testing: a comparison of chloral hydrate and music therapy. Journal of Perianesthesia Nursing2005;20(5):323-32. [PMID: 16246809]">Loewy 2005</a>; <a href="./references#CD011786-bbs2-0010" title="LopezBME , LopezSI , TroncosoAL , Avaria de losBMA , NovoaSF . Chloral hydrate or midazolam to induce sleep for electroencephalographic records. Revista Chilena de Pediatria1995;66(4):204-8. ">Lopez 1995</a>; <a href="./references#CD011786-bbs2-0013" title="RaziehF , SharamJ , MotahharehG , SedighahAK , Mohammad-HoseinJ . Efficacy of chloral hydrate and promethazine for sedation during electroencephalography in children: a randomised clinical trial. Iranian Journal of Pediatrics2013;23(1):27-31. [PMID: 23550099]">Razieh 2013</a>; <a href="./references#CD011786-bbs2-0014" title="SezerT , AlehanF . Chloral hydrate versus hydroxyzine HCL for sedation prior to pediatric sleep EEG recording. International Journal of Neuroscience2013;123(10):719-23. [DOI: 10.3109/00207454.2013.796310] [PMID: 23594140]">Sezer 2013</a>). </p> <p>There were 13 comparisons.</p> <p> <ul id="CD011786-list-0015"> <li> <p>Oral chloral hydrate (50 mg/kg or 100 mg/kg) versus oral dexmedetomidine (<a href="./references#CD011786-bbs2-0008" title="GumusH , BayramAK , PoyrazogluHG , CanpolatDG , PerH , CanpolatM , et al. Comparison of effects of different dexmedetomidine and chloral hydrate doses used in sedation on electroencephalography in pediatric patients. Journal of Child Neurology2015;30(8):983-8. [DOI: 10.1177/0883073814549582] [PMID: 25246305]">Gumus 2015</a>). </p> </li> <li> <p>Oral chloral hydrate (75 mg/kg) versus intravenous pentobarbital (<a href="./references#CD011786-bbs2-0011" title="MalviyaS , Voepel-LewisT , TaitAR , ReynoldsPI , GujarSK , GebarskiSS , et al. Pentobarbital vs chloral hydrate for sedation of children undergoing MRI: efficacy and recovery characteristics. Paediatric Anaesthesia2004;14(7):589-95. [PMID: 15200658]">Malviya 2004</a>). </p> </li> <li> <p>Oral chloral hydrate (75 mg/kg or 100 mg/kg) versus midazolam (given either orally or intranasally) (<a href="./references#CD011786-bbs2-0002" title="AshrafiMR , Azizi MalamiriR , ZamaniGR , MohammadiM , HosseiniF . Sleep inducing for EEG recording in children: a comparison between oral midazolam and chloral hydrate. Iranian Journal of Child Neurology2013;7(1):15-9. [PMID: 24665284]">Ashrafi 2013</a>; <a href="./references#CD011786-bbs2-0006" title="D'AgostinoJ , TerndrupTE . Chloral hydrate versus midazolam for sedation of children for neuroimaging: a randomized clinical trial. Pediatric Emergency Care2000;16(1):1-4. [PMID: 10698133]">D'Agostino 2000</a>; <a href="./references#CD011786-bbs2-0007" title="FallahR , NakhaeiMH , BehdadS , MoghaddamRN , ShamszadehA . Oral chloral hydrate vs. intranasal midazolam for sedation during computerized tomography. Indian Pediatrics2013;50(2):233-5. [PMID: 23024102]">Fallah 2013</a>). </p> </li> <li> <p>Oral chloral hydrate (50 mg/kg) versus oral melatonin (<a href="./references#CD011786-bbs2-0001" title="AshrafiMR , MohammadiM , TafarrojiJ , ShabanianR , SalamatiP , ZamaniGR . Melatonin versus chloral hydrate for recording sleep EEG. European Journal of Paediatric Neurology2010;14(3):235-8. [DOI: 10.1016/j.ejpn.2009.06.010] [PMID: 19616978]">Ashrafi 2010</a>). </p> </li> <li> <p>Oral chloral hydrate (60 mg/kg) versus music therapy (<a href="./references#CD011786-bbs2-0009" title="LoewyJ , HallanC , FriedmanE , MartinezC . Sleep/sedation in children undergoing EEG testing: a comparison of chloral hydrate and music therapy. American Journal of Electroneurodiagnostic Technology2006;46(4):343-55. [PMID: 17285817]LoewyJ , HallanC , FriedmanE , MartinezC . Sleep/sedation in children undergoing EEG testing: a comparison of chloral hydrate and music therapy. Journal of Perianesthesia Nursing2005;20(5):323-32. [PMID: 16246809]">Loewy 2005</a>). </p> </li> <li> <p>Oral chloral hydrate (50 mg/kg) versus oral hydroxyzine hydrochloride (<a href="./references#CD011786-bbs2-0014" title="SezerT , AlehanF . Chloral hydrate versus hydroxyzine HCL for sedation prior to pediatric sleep EEG recording. International Journal of Neuroscience2013;123(10):719-23. [DOI: 10.3109/00207454.2013.796310] [PMID: 23594140]">Sezer 2013</a>). </p> </li> <li> <p>Oral chloral hydrate (70 mg/kg) versus oral promethazine (<a href="./references#CD011786-bbs2-0013" title="RaziehF , SharamJ , MotahharehG , SedighahAK , Mohammad-HoseinJ . Efficacy of chloral hydrate and promethazine for sedation during electroencephalography in children: a randomised clinical trial. Iranian Journal of Pediatrics2013;23(1):27-31. [PMID: 23550099]">Razieh 2013</a>). </p> </li> <li> <p>Rectal chloral hydrate (50 mg/kg) versus rectal midazolam (<a href="./references#CD011786-bbs2-0010" title="LopezBME , LopezSI , TroncosoAL , Avaria de losBMA , NovoaSF . Chloral hydrate or midazolam to induce sleep for electroencephalographic records. Revista Chilena de Pediatria1995;66(4):204-8. ">Lopez 1995</a>). </p> </li> <li> <p>High‐dose oral chloral hydrate (100 mg/kg) versus low‐dose oral chloral hydrate (70 mg/kg) (<a href="./references#CD011786-bbs2-0012" title="Marti-BonmatiL , Ronchera-OmsCL , CasillasC , PoyatosC , TorrijoC , JimenezNV . Randomised double-blind clinical trial of intermediate- versus high-dose chloral hydrate for neuroimaging of children. Neuroradiology1995;37(8):687-91. [PMID: 8748907]">Marti‐Bonmati 1995</a>). </p> </li> <li> <p>High‐dose oral chloral hydrate (100 mg/kg) versus low‐dose oral chloral hydrate (50 mg/kg) (<a href="./references#CD011786-bbs2-0008" title="GumusH , BayramAK , PoyrazogluHG , CanpolatDG , PerH , CanpolatM , et al. Comparison of effects of different dexmedetomidine and chloral hydrate doses used in sedation on electroencephalography in pediatric patients. Journal of Child Neurology2015;30(8):983-8. [DOI: 10.1177/0883073814549582] [PMID: 25246305]">Gumus 2015</a>). </p> </li> <li> <p>Oral chloral hydrate (50 mg/kg) versus rectal sodium thiopental (25 mg/kg) (<a href="./references#CD011786-bbs2-0004" title="AzizkhaniR , KananiS , SharifiA , GolshaniK , MasoumiB , AhmadiO . Oral chloral hydrate compare with rectal thiopental in pediatric procedural sedation and analgesia; a randomized clinical trial. Emergency (Tehran, Iran)2014;2(2):85-9. [PMID: 26495353]">Azizkhani 2014</a>). </p> </li> <li> <p>Oral chloral hydrate (50 mg/kg) versus oral clonidine (4 μg/kg) (<a href="./references#CD011786-bbs2-0003" title="AshrafiMR , MohebbiH , MohamadiM , AziziE , ZamaniGR , TavasoliA , et al. Clonidine versus chloral hydrate for recording sleep EEG in children. Iranian Journal of Child Neurology2020;14(1):85-92. [PMID: 32021632]">Ashrafi 2020</a>). </p> </li> <li> <p>Oral chloral hydrate (50 mg/kg) versus intranasal dexmedetomidine (3 μg/kg) (<a href="./references#CD011786-bbs2-0016" title="YuenVM , LiBL , CheukDK , LeungMKM , HuiTWC , WongIC , et al. A randomised controlled trial of oral chloral hydrate vs. intranasal dexmedetomidine before computerised tomography in children. Anaesthesia2017;72(10):1191-5. [PMID: 28741653]">Yuen 2017a</a>). </p> </li> </ul> </p> <p>The initial sedation dose of chloral hydrate used in the studies ranged from 25 mg/kg to 100 mg/kg oral and 50 mg/kg rectal. The type and doses of the sedation agents used varied amongst the included studies: dexmedetomidine either orally 2 or 3 μg/kg, <a href="./references#CD011786-bbs2-0008" title="GumusH , BayramAK , PoyrazogluHG , CanpolatDG , PerH , CanpolatM , et al. Comparison of effects of different dexmedetomidine and chloral hydrate doses used in sedation on electroencephalography in pediatric patients. Journal of Child Neurology2015;30(8):983-8. [DOI: 10.1177/0883073814549582] [PMID: 25246305]">Gumus 2015</a>, or intranasally 3 μg/kg (<a href="./references#CD011786-bbs2-0016" title="YuenVM , LiBL , CheukDK , LeungMKM , HuiTWC , WongIC , et al. A randomised controlled trial of oral chloral hydrate vs. intranasal dexmedetomidine before computerised tomography in children. Anaesthesia2017;72(10):1191-5. [PMID: 28741653]">Yuen 2017a</a>); intravenous pentobarbital 5 mg/kg (<a href="./references#CD011786-bbs2-0011" title="MalviyaS , Voepel-LewisT , TaitAR , ReynoldsPI , GujarSK , GebarskiSS , et al. Pentobarbital vs chloral hydrate for sedation of children undergoing MRI: efficacy and recovery characteristics. Paediatric Anaesthesia2004;14(7):589-95. [PMID: 15200658]">Malviya 2004</a>); midazolam either 0.5 mg/kg orally, <a href="./references#CD011786-bbs2-0002" title="AshrafiMR , Azizi MalamiriR , ZamaniGR , MohammadiM , HosseiniF . Sleep inducing for EEG recording in children: a comparison between oral midazolam and chloral hydrate. Iranian Journal of Child Neurology2013;7(1):15-9. [PMID: 24665284]">Ashrafi 2013</a>; <a href="./references#CD011786-bbs2-0006" title="D'AgostinoJ , TerndrupTE . Chloral hydrate versus midazolam for sedation of children for neuroimaging: a randomized clinical trial. Pediatric Emergency Care2000;16(1):1-4. [PMID: 10698133]">D'Agostino 2000</a>, 0.2 mg/kg intranasally, <a href="./references#CD011786-bbs2-0007" title="FallahR , NakhaeiMH , BehdadS , MoghaddamRN , ShamszadehA . Oral chloral hydrate vs. intranasal midazolam for sedation during computerized tomography. Indian Pediatrics2013;50(2):233-5. [PMID: 23024102]">Fallah 2013</a>, or rectal midazolam 1 mg/kg (<a href="./references#CD011786-bbs2-0010" title="LopezBME , LopezSI , TroncosoAL , Avaria de losBMA , NovoaSF . Chloral hydrate or midazolam to induce sleep for electroencephalographic records. Revista Chilena de Pediatria1995;66(4):204-8. ">Lopez 1995</a>); oral hydroxyzine hydrochloride 1 mg/kg (<a href="./references#CD011786-bbs2-0005" title="BektasO , AricaB , TeberS , YilmazA , ZeybekH , KaymakS , et al. Chloral hydrate and/or hydroxyzine for sedation in pediatric EEG recording. Brain &amp; Development2014;36(2):130-6. [DOI: 10.1016/j.braindev.2013.03.002] [PMID: 23582501]">Bektas 2014</a>; <a href="./references#CD011786-bbs2-0014" title="SezerT , AlehanF . Chloral hydrate versus hydroxyzine HCL for sedation prior to pediatric sleep EEG recording. International Journal of Neuroscience2013;123(10):719-23. [DOI: 10.3109/00207454.2013.796310] [PMID: 23594140]">Sezer 2013</a>); oral promethazine 1 mg/kg (<a href="./references#CD011786-bbs2-0013" title="RaziehF , SharamJ , MotahharehG , SedighahAK , Mohammad-HoseinJ . Efficacy of chloral hydrate and promethazine for sedation during electroencephalography in children: a randomised clinical trial. Iranian Journal of Pediatrics2013;23(1):27-31. [PMID: 23550099]">Razieh 2013</a>); intramuscular atropine/meperidine/promethazine/secobarbital (AMPS) cocktail 0.08 mL/kg (<a href="./references#CD011786-bbs2-0015" title="ThompsonJR , SchneiderS , AshwalS . The choice of sedation for computed tomography in children. A prospective evaluation. Radiology1982;143(2):475-9. [PMID: 7071350]">Thompson 1982</a>); rectal sodium thiopental 25 mg/kg (<a href="./references#CD011786-bbs2-0004" title="AzizkhaniR , KananiS , SharifiA , GolshaniK , MasoumiB , AhmadiO . Oral chloral hydrate compare with rectal thiopental in pediatric procedural sedation and analgesia; a randomized clinical trial. Emergency (Tehran, Iran)2014;2(2):85-9. [PMID: 26495353]">Azizkhani 2014</a>); and oral clonidine 4 μg/kg (<a href="./references#CD011786-bbs2-0003" title="AshrafiMR , MohebbiH , MohamadiM , AziziE , ZamaniGR , TavasoliA , et al. Clonidine versus chloral hydrate for recording sleep EEG in children. Iranian Journal of Child Neurology2020;14(1):85-92. [PMID: 32021632]">Ashrafi 2020</a>). Two studies compared sedation of high‐dose (100 mg/kg) chloral hydrate versus low‐dose (50 or 70 mg/kg) chloral hydrate orally (<a href="./references#CD011786-bbs2-0008" title="GumusH , BayramAK , PoyrazogluHG , CanpolatDG , PerH , CanpolatM , et al. Comparison of effects of different dexmedetomidine and chloral hydrate doses used in sedation on electroencephalography in pediatric patients. Journal of Child Neurology2015;30(8):983-8. [DOI: 10.1177/0883073814549582] [PMID: 25246305]">Gumus 2015</a>; <a href="./references#CD011786-bbs2-0012" title="Marti-BonmatiL , Ronchera-OmsCL , CasillasC , PoyatosC , TorrijoC , JimenezNV . Randomised double-blind clinical trial of intermediate- versus high-dose chloral hydrate for neuroimaging of children. Neuroradiology1995;37(8):687-91. [PMID: 8748907]">Marti‐Bonmati 1995</a>). Dose of melatonin was not stated (<a href="./references#CD011786-bbs2-0001" title="AshrafiMR , MohammadiM , TafarrojiJ , ShabanianR , SalamatiP , ZamaniGR . Melatonin versus chloral hydrate for recording sleep EEG. European Journal of Paediatric Neurology2010;14(3):235-8. [DOI: 10.1016/j.ejpn.2009.06.010] [PMID: 19616978]">Ashrafi 2010</a>), and dosing/intensity was not stated for music therapy (<a href="./references#CD011786-bbs2-0009" title="LoewyJ , HallanC , FriedmanE , MartinezC . Sleep/sedation in children undergoing EEG testing: a comparison of chloral hydrate and music therapy. American Journal of Electroneurodiagnostic Technology2006;46(4):343-55. [PMID: 17285817]LoewyJ , HallanC , FriedmanE , MartinezC . Sleep/sedation in children undergoing EEG testing: a comparison of chloral hydrate and music therapy. Journal of Perianesthesia Nursing2005;20(5):323-32. [PMID: 16246809]">Loewy 2005</a>). </p> <p>In general, the included studies assessed outcomes of success of sedation based on the following. </p> <p> <ul id="CD011786-list-0016"> <li> <p>Time to onset to adequate sedation in minutes in 11 studies (<a href="./references#CD011786-bbs2-0003" title="AshrafiMR , MohebbiH , MohamadiM , AziziE , ZamaniGR , TavasoliA , et al. Clonidine versus chloral hydrate for recording sleep EEG in children. Iranian Journal of Child Neurology2020;14(1):85-92. [PMID: 32021632]">Ashrafi 2020</a>; <a href="./references#CD011786-bbs2-0004" title="AzizkhaniR , KananiS , SharifiA , GolshaniK , MasoumiB , AhmadiO . Oral chloral hydrate compare with rectal thiopental in pediatric procedural sedation and analgesia; a randomized clinical trial. Emergency (Tehran, Iran)2014;2(2):85-9. [PMID: 26495353]">Azizkhani 2014</a>; <a href="./references#CD011786-bbs2-0007" title="FallahR , NakhaeiMH , BehdadS , MoghaddamRN , ShamszadehA . Oral chloral hydrate vs. intranasal midazolam for sedation during computerized tomography. Indian Pediatrics2013;50(2):233-5. [PMID: 23024102]">Fallah 2013</a>; <a href="./references#CD011786-bbs2-0008" title="GumusH , BayramAK , PoyrazogluHG , CanpolatDG , PerH , CanpolatM , et al. Comparison of effects of different dexmedetomidine and chloral hydrate doses used in sedation on electroencephalography in pediatric patients. Journal of Child Neurology2015;30(8):983-8. [DOI: 10.1177/0883073814549582] [PMID: 25246305]">Gumus 2015</a>; <a href="./references#CD011786-bbs2-0009" title="LoewyJ , HallanC , FriedmanE , MartinezC . Sleep/sedation in children undergoing EEG testing: a comparison of chloral hydrate and music therapy. American Journal of Electroneurodiagnostic Technology2006;46(4):343-55. [PMID: 17285817]LoewyJ , HallanC , FriedmanE , MartinezC . Sleep/sedation in children undergoing EEG testing: a comparison of chloral hydrate and music therapy. Journal of Perianesthesia Nursing2005;20(5):323-32. [PMID: 16246809]">Loewy 2005</a>; <a href="./references#CD011786-bbs2-0010" title="LopezBME , LopezSI , TroncosoAL , Avaria de losBMA , NovoaSF . Chloral hydrate or midazolam to induce sleep for electroencephalographic records. Revista Chilena de Pediatria1995;66(4):204-8. ">Lopez 1995</a>; <a href="./references#CD011786-bbs2-0011" title="MalviyaS , Voepel-LewisT , TaitAR , ReynoldsPI , GujarSK , GebarskiSS , et al. Pentobarbital vs chloral hydrate for sedation of children undergoing MRI: efficacy and recovery characteristics. Paediatric Anaesthesia2004;14(7):589-95. [PMID: 15200658]">Malviya 2004</a>; <a href="./references#CD011786-bbs2-0012" title="Marti-BonmatiL , Ronchera-OmsCL , CasillasC , PoyatosC , TorrijoC , JimenezNV . Randomised double-blind clinical trial of intermediate- versus high-dose chloral hydrate for neuroimaging of children. Neuroradiology1995;37(8):687-91. [PMID: 8748907]">Marti‐Bonmati 1995</a>; <a href="./references#CD011786-bbs2-0013" title="RaziehF , SharamJ , MotahharehG , SedighahAK , Mohammad-HoseinJ . Efficacy of chloral hydrate and promethazine for sedation during electroencephalography in children: a randomised clinical trial. Iranian Journal of Pediatrics2013;23(1):27-31. [PMID: 23550099]">Razieh 2013</a>; <a href="./references#CD011786-bbs2-0014" title="SezerT , AlehanF . Chloral hydrate versus hydroxyzine HCL for sedation prior to pediatric sleep EEG recording. International Journal of Neuroscience2013;123(10):719-23. [DOI: 10.3109/00207454.2013.796310] [PMID: 23594140]">Sezer 2013</a>; <a href="./references#CD011786-bbs2-0016" title="YuenVM , LiBL , CheukDK , LeungMKM , HuiTWC , WongIC , et al. A randomised controlled trial of oral chloral hydrate vs. intranasal dexmedetomidine before computerised tomography in children. Anaesthesia2017;72(10):1191-5. [PMID: 28741653]">Yuen 2017a</a>). </p> </li> <li> <p>Failure of sedation preventing successful completion of neurodiagnostic investigation in nine studies (<a href="./references#CD011786-bbs2-0004" title="AzizkhaniR , KananiS , SharifiA , GolshaniK , MasoumiB , AhmadiO . Oral chloral hydrate compare with rectal thiopental in pediatric procedural sedation and analgesia; a randomized clinical trial. Emergency (Tehran, Iran)2014;2(2):85-9. [PMID: 26495353]">Azizkhani 2014</a>; <a href="./references#CD011786-bbs2-0006" title="D'AgostinoJ , TerndrupTE . Chloral hydrate versus midazolam for sedation of children for neuroimaging: a randomized clinical trial. Pediatric Emergency Care2000;16(1):1-4. [PMID: 10698133]">D'Agostino 2000</a>; <a href="./references#CD011786-bbs2-0007" title="FallahR , NakhaeiMH , BehdadS , MoghaddamRN , ShamszadehA . Oral chloral hydrate vs. intranasal midazolam for sedation during computerized tomography. Indian Pediatrics2013;50(2):233-5. [PMID: 23024102]">Fallah 2013</a>; <a href="./references#CD011786-bbs2-0008" title="GumusH , BayramAK , PoyrazogluHG , CanpolatDG , PerH , CanpolatM , et al. Comparison of effects of different dexmedetomidine and chloral hydrate doses used in sedation on electroencephalography in pediatric patients. Journal of Child Neurology2015;30(8):983-8. [DOI: 10.1177/0883073814549582] [PMID: 25246305]">Gumus 2015</a>; <a href="./references#CD011786-bbs2-0009" title="LoewyJ , HallanC , FriedmanE , MartinezC . Sleep/sedation in children undergoing EEG testing: a comparison of chloral hydrate and music therapy. American Journal of Electroneurodiagnostic Technology2006;46(4):343-55. [PMID: 17285817]LoewyJ , HallanC , FriedmanE , MartinezC . Sleep/sedation in children undergoing EEG testing: a comparison of chloral hydrate and music therapy. Journal of Perianesthesia Nursing2005;20(5):323-32. [PMID: 16246809]">Loewy 2005</a>; <a href="./references#CD011786-bbs2-0011" title="MalviyaS , Voepel-LewisT , TaitAR , ReynoldsPI , GujarSK , GebarskiSS , et al. Pentobarbital vs chloral hydrate for sedation of children undergoing MRI: efficacy and recovery characteristics. Paediatric Anaesthesia2004;14(7):589-95. [PMID: 15200658]">Malviya 2004</a>; <a href="./references#CD011786-bbs2-0012" title="Marti-BonmatiL , Ronchera-OmsCL , CasillasC , PoyatosC , TorrijoC , JimenezNV . Randomised double-blind clinical trial of intermediate- versus high-dose chloral hydrate for neuroimaging of children. Neuroradiology1995;37(8):687-91. [PMID: 8748907]">Marti‐Bonmati 1995</a>; <a href="./references#CD011786-bbs2-0013" title="RaziehF , SharamJ , MotahharehG , SedighahAK , Mohammad-HoseinJ . Efficacy of chloral hydrate and promethazine for sedation during electroencephalography in children: a randomised clinical trial. Iranian Journal of Pediatrics2013;23(1):27-31. [PMID: 23550099]">Razieh 2013</a>; <a href="./references#CD011786-bbs2-0014" title="SezerT , AlehanF . Chloral hydrate versus hydroxyzine HCL for sedation prior to pediatric sleep EEG recording. International Journal of Neuroscience2013;123(10):719-23. [DOI: 10.3109/00207454.2013.796310] [PMID: 23594140]">Sezer 2013</a>). </p> </li> <li> <p>Total sedation/sleep duration in eight studies (<a href="./references#CD011786-bbs2-0003" title="AshrafiMR , MohebbiH , MohamadiM , AziziE , ZamaniGR , TavasoliA , et al. Clonidine versus chloral hydrate for recording sleep EEG in children. Iranian Journal of Child Neurology2020;14(1):85-92. [PMID: 32021632]">Ashrafi 2020</a>; <a href="./references#CD011786-bbs2-0004" title="AzizkhaniR , KananiS , SharifiA , GolshaniK , MasoumiB , AhmadiO . Oral chloral hydrate compare with rectal thiopental in pediatric procedural sedation and analgesia; a randomized clinical trial. Emergency (Tehran, Iran)2014;2(2):85-9. [PMID: 26495353]">Azizkhani 2014</a>; <a href="./references#CD011786-bbs2-0006" title="D'AgostinoJ , TerndrupTE . Chloral hydrate versus midazolam for sedation of children for neuroimaging: a randomized clinical trial. Pediatric Emergency Care2000;16(1):1-4. [PMID: 10698133]">D'Agostino 2000</a>; <a href="./references#CD011786-bbs2-0008" title="GumusH , BayramAK , PoyrazogluHG , CanpolatDG , PerH , CanpolatM , et al. Comparison of effects of different dexmedetomidine and chloral hydrate doses used in sedation on electroencephalography in pediatric patients. Journal of Child Neurology2015;30(8):983-8. [DOI: 10.1177/0883073814549582] [PMID: 25246305]">Gumus 2015</a>; <a href="./references#CD011786-bbs2-0009" title="LoewyJ , HallanC , FriedmanE , MartinezC . Sleep/sedation in children undergoing EEG testing: a comparison of chloral hydrate and music therapy. American Journal of Electroneurodiagnostic Technology2006;46(4):343-55. [PMID: 17285817]LoewyJ , HallanC , FriedmanE , MartinezC . Sleep/sedation in children undergoing EEG testing: a comparison of chloral hydrate and music therapy. Journal of Perianesthesia Nursing2005;20(5):323-32. [PMID: 16246809]">Loewy 2005</a>; <a href="./references#CD011786-bbs2-0010" title="LopezBME , LopezSI , TroncosoAL , Avaria de losBMA , NovoaSF . Chloral hydrate or midazolam to induce sleep for electroencephalographic records. Revista Chilena de Pediatria1995;66(4):204-8. ">Lopez 1995</a>; <a href="./references#CD011786-bbs2-0012" title="Marti-BonmatiL , Ronchera-OmsCL , CasillasC , PoyatosC , TorrijoC , JimenezNV . Randomised double-blind clinical trial of intermediate- versus high-dose chloral hydrate for neuroimaging of children. Neuroradiology1995;37(8):687-91. [PMID: 8748907]">Marti‐Bonmati 1995</a>; <a href="./references#CD011786-bbs2-0014" title="SezerT , AlehanF . Chloral hydrate versus hydroxyzine HCL for sedation prior to pediatric sleep EEG recording. International Journal of Neuroscience2013;123(10):719-23. [DOI: 10.3109/00207454.2013.796310] [PMID: 23594140]">Sezer 2013</a>). </p> </li> <li> <p>Sedative adverse events in 12 studies (<a href="./references#CD011786-bbs2-0001" title="AshrafiMR , MohammadiM , TafarrojiJ , ShabanianR , SalamatiP , ZamaniGR . Melatonin versus chloral hydrate for recording sleep EEG. European Journal of Paediatric Neurology2010;14(3):235-8. [DOI: 10.1016/j.ejpn.2009.06.010] [PMID: 19616978]">Ashrafi 2010</a>; <a href="./references#CD011786-bbs2-0002" title="AshrafiMR , Azizi MalamiriR , ZamaniGR , MohammadiM , HosseiniF . Sleep inducing for EEG recording in children: a comparison between oral midazolam and chloral hydrate. Iranian Journal of Child Neurology2013;7(1):15-9. [PMID: 24665284]">Ashrafi 2013</a>; <a href="./references#CD011786-bbs2-0003" title="AshrafiMR , MohebbiH , MohamadiM , AziziE , ZamaniGR , TavasoliA , et al. Clonidine versus chloral hydrate for recording sleep EEG in children. Iranian Journal of Child Neurology2020;14(1):85-92. [PMID: 32021632]">Ashrafi 2020</a>; <a href="./references#CD011786-bbs2-0004" title="AzizkhaniR , KananiS , SharifiA , GolshaniK , MasoumiB , AhmadiO . Oral chloral hydrate compare with rectal thiopental in pediatric procedural sedation and analgesia; a randomized clinical trial. Emergency (Tehran, Iran)2014;2(2):85-9. [PMID: 26495353]">Azizkhani 2014</a>; <a href="./references#CD011786-bbs2-0006" title="D'AgostinoJ , TerndrupTE . Chloral hydrate versus midazolam for sedation of children for neuroimaging: a randomized clinical trial. Pediatric Emergency Care2000;16(1):1-4. [PMID: 10698133]">D'Agostino 2000</a>; <a href="./references#CD011786-bbs2-0007" title="FallahR , NakhaeiMH , BehdadS , MoghaddamRN , ShamszadehA . Oral chloral hydrate vs. intranasal midazolam for sedation during computerized tomography. Indian Pediatrics2013;50(2):233-5. [PMID: 23024102]">Fallah 2013</a>; <a href="./references#CD011786-bbs2-0008" title="GumusH , BayramAK , PoyrazogluHG , CanpolatDG , PerH , CanpolatM , et al. Comparison of effects of different dexmedetomidine and chloral hydrate doses used in sedation on electroencephalography in pediatric patients. Journal of Child Neurology2015;30(8):983-8. [DOI: 10.1177/0883073814549582] [PMID: 25246305]">Gumus 2015</a>; <a href="./references#CD011786-bbs2-0011" title="MalviyaS , Voepel-LewisT , TaitAR , ReynoldsPI , GujarSK , GebarskiSS , et al. Pentobarbital vs chloral hydrate for sedation of children undergoing MRI: efficacy and recovery characteristics. Paediatric Anaesthesia2004;14(7):589-95. [PMID: 15200658]">Malviya 2004</a>; <a href="./references#CD011786-bbs2-0012" title="Marti-BonmatiL , Ronchera-OmsCL , CasillasC , PoyatosC , TorrijoC , JimenezNV . Randomised double-blind clinical trial of intermediate- versus high-dose chloral hydrate for neuroimaging of children. Neuroradiology1995;37(8):687-91. [PMID: 8748907]">Marti‐Bonmati 1995</a>; <a href="./references#CD011786-bbs2-0013" title="RaziehF , SharamJ , MotahharehG , SedighahAK , Mohammad-HoseinJ . Efficacy of chloral hydrate and promethazine for sedation during electroencephalography in children: a randomised clinical trial. Iranian Journal of Pediatrics2013;23(1):27-31. [PMID: 23550099]">Razieh 2013</a>; <a href="./references#CD011786-bbs2-0014" title="SezerT , AlehanF . Chloral hydrate versus hydroxyzine HCL for sedation prior to pediatric sleep EEG recording. International Journal of Neuroscience2013;123(10):719-23. [DOI: 10.3109/00207454.2013.796310] [PMID: 23594140]">Sezer 2013</a>; <a href="./references#CD011786-bbs2-0016" title="YuenVM , LiBL , CheukDK , LeungMKM , HuiTWC , WongIC , et al. A randomised controlled trial of oral chloral hydrate vs. intranasal dexmedetomidine before computerised tomography in children. Anaesthesia2017;72(10):1191-5. [PMID: 28741653]">Yuen 2017a</a>). </p> </li> <li> <p>Uninterpretable neurodiagnostic investigation due to either excessive motion artefact for neuroimaging studies or excessive fast background activity on EEG studies in five studies (<a href="./references#CD011786-bbs2-0001" title="AshrafiMR , MohammadiM , TafarrojiJ , ShabanianR , SalamatiP , ZamaniGR . Melatonin versus chloral hydrate for recording sleep EEG. European Journal of Paediatric Neurology2010;14(3):235-8. [DOI: 10.1016/j.ejpn.2009.06.010] [PMID: 19616978]">Ashrafi 2010</a>; <a href="./references#CD011786-bbs2-0002" title="AshrafiMR , Azizi MalamiriR , ZamaniGR , MohammadiM , HosseiniF . Sleep inducing for EEG recording in children: a comparison between oral midazolam and chloral hydrate. Iranian Journal of Child Neurology2013;7(1):15-9. [PMID: 24665284]">Ashrafi 2013</a>; <a href="./references#CD011786-bbs2-0010" title="LopezBME , LopezSI , TroncosoAL , Avaria de losBMA , NovoaSF . Chloral hydrate or midazolam to induce sleep for electroencephalographic records. Revista Chilena de Pediatria1995;66(4):204-8. ">Lopez 1995</a>; <a href="./references#CD011786-bbs2-0011" title="MalviyaS , Voepel-LewisT , TaitAR , ReynoldsPI , GujarSK , GebarskiSS , et al. Pentobarbital vs chloral hydrate for sedation of children undergoing MRI: efficacy and recovery characteristics. Paediatric Anaesthesia2004;14(7):589-95. [PMID: 15200658]">Malviya 2004</a>; <a href="./references#CD011786-bbs2-0014" title="SezerT , AlehanF . Chloral hydrate versus hydroxyzine HCL for sedation prior to pediatric sleep EEG recording. International Journal of Neuroscience2013;123(10):719-23. [DOI: 10.3109/00207454.2013.796310] [PMID: 23594140]">Sezer 2013</a>). </p> </li> </ul> </p> <p>Other outcomes assessed included caregiver's satisfaction scale (<a href="./references#CD011786-bbs2-0013" title="RaziehF , SharamJ , MotahharehG , SedighahAK , Mohammad-HoseinJ . Efficacy of chloral hydrate and promethazine for sedation during electroencephalography in children: a randomised clinical trial. Iranian Journal of Pediatrics2013;23(1):27-31. [PMID: 23550099]">Razieh 2013</a>), hospital stay post sedation (<a href="./references#CD011786-bbs2-0013" title="RaziehF , SharamJ , MotahharehG , SedighahAK , Mohammad-HoseinJ . Efficacy of chloral hydrate and promethazine for sedation during electroencephalography in children: a randomised clinical trial. Iranian Journal of Pediatrics2013;23(1):27-31. [PMID: 23550099]">Razieh 2013</a>), and return to normal baseline activity (<a href="./references#CD011786-bbs2-0011" title="MalviyaS , Voepel-LewisT , TaitAR , ReynoldsPI , GujarSK , GebarskiSS , et al. Pentobarbital vs chloral hydrate for sedation of children undergoing MRI: efficacy and recovery characteristics. Paediatric Anaesthesia2004;14(7):589-95. [PMID: 15200658]">Malviya 2004</a>; <a href="./references#CD011786-bbs2-0016" title="YuenVM , LiBL , CheukDK , LeungMKM , HuiTWC , WongIC , et al. A randomised controlled trial of oral chloral hydrate vs. intranasal dexmedetomidine before computerised tomography in children. Anaesthesia2017;72(10):1191-5. [PMID: 28741653]">Yuen 2017a</a>). </p> </section> <section id="CD011786-sec-0045"> <h4 class="title">Excluded studies</h4> <p>For details of the excluded studies and the reasons for their exclusion, see <a href="./references#CD011786-sec-0209" title="">Characteristics of excluded studies</a>. </p> <p>We excluded a total of 54 studies based on one or more of the following.</p> <p> <ul id="CD011786-list-0017"> <li> <p>Study design or article type (37 studies): retrospective or prospective cohort studies, cross‐over study, prospective non‐randomised intervention studies, literature review articles, a questionnaire study, studies with research questions or outcomes that did not match our review, or commentaries. </p> </li> <li> <p>Population (6 studies): children undergoing dental procedures, auditory brainstem response tests, or ophthalmic examination. </p> </li> <li> <p>Intervention (22 studies): the studies either assessed efficacy of chloral hydrate alone or in combination with other sedative agents, or efficacy of other sedative agents that were not the intervention of interest. </p> </li> <li> <p>Outcome (2 studies): the studies reported effects of sedation on EEG results and did not assess the success of sedation. </p> </li> </ul> </p> </section> </section> <section id="CD011786-sec-0046"> <h3 class="title">Risk of bias in included studies</h3> <p>Risk of bias in the included studies varied widely. There was at least one high‐risk domain in 10 of the 16 included studies (<a href="./references#CD011786-bbs2-0001" title="AshrafiMR , MohammadiM , TafarrojiJ , ShabanianR , SalamatiP , ZamaniGR . Melatonin versus chloral hydrate for recording sleep EEG. European Journal of Paediatric Neurology2010;14(3):235-8. [DOI: 10.1016/j.ejpn.2009.06.010] [PMID: 19616978]">Ashrafi 2010</a>; <a href="./references#CD011786-bbs2-0002" title="AshrafiMR , Azizi MalamiriR , ZamaniGR , MohammadiM , HosseiniF . Sleep inducing for EEG recording in children: a comparison between oral midazolam and chloral hydrate. Iranian Journal of Child Neurology2013;7(1):15-9. [PMID: 24665284]">Ashrafi 2013</a>; <a href="./references#CD011786-bbs2-0003" title="AshrafiMR , MohebbiH , MohamadiM , AziziE , ZamaniGR , TavasoliA , et al. Clonidine versus chloral hydrate for recording sleep EEG in children. Iranian Journal of Child Neurology2020;14(1):85-92. [PMID: 32021632]">Ashrafi 2020</a>; <a href="./references#CD011786-bbs2-0005" title="BektasO , AricaB , TeberS , YilmazA , ZeybekH , KaymakS , et al. Chloral hydrate and/or hydroxyzine for sedation in pediatric EEG recording. Brain &amp; Development2014;36(2):130-6. [DOI: 10.1016/j.braindev.2013.03.002] [PMID: 23582501]">Bektas 2014</a>; <a href="./references#CD011786-bbs2-0008" title="GumusH , BayramAK , PoyrazogluHG , CanpolatDG , PerH , CanpolatM , et al. Comparison of effects of different dexmedetomidine and chloral hydrate doses used in sedation on electroencephalography in pediatric patients. Journal of Child Neurology2015;30(8):983-8. [DOI: 10.1177/0883073814549582] [PMID: 25246305]">Gumus 2015</a>; <a href="./references#CD011786-bbs2-0009" title="LoewyJ , HallanC , FriedmanE , MartinezC . Sleep/sedation in children undergoing EEG testing: a comparison of chloral hydrate and music therapy. American Journal of Electroneurodiagnostic Technology2006;46(4):343-55. [PMID: 17285817]LoewyJ , HallanC , FriedmanE , MartinezC . Sleep/sedation in children undergoing EEG testing: a comparison of chloral hydrate and music therapy. Journal of Perianesthesia Nursing2005;20(5):323-32. [PMID: 16246809]">Loewy 2005</a>; <a href="./references#CD011786-bbs2-0010" title="LopezBME , LopezSI , TroncosoAL , Avaria de losBMA , NovoaSF . Chloral hydrate or midazolam to induce sleep for electroencephalographic records. Revista Chilena de Pediatria1995;66(4):204-8. ">Lopez 1995</a>; <a href="./references#CD011786-bbs2-0011" title="MalviyaS , Voepel-LewisT , TaitAR , ReynoldsPI , GujarSK , GebarskiSS , et al. Pentobarbital vs chloral hydrate for sedation of children undergoing MRI: efficacy and recovery characteristics. Paediatric Anaesthesia2004;14(7):589-95. [PMID: 15200658]">Malviya 2004</a>; <a href="./references#CD011786-bbs2-0015" title="ThompsonJR , SchneiderS , AshwalS . The choice of sedation for computed tomography in children. A prospective evaluation. Radiology1982;143(2):475-9. [PMID: 7071350]">Thompson 1982</a>; <a href="./references#CD011786-bbs2-0016" title="YuenVM , LiBL , CheukDK , LeungMKM , HuiTWC , WongIC , et al. A randomised controlled trial of oral chloral hydrate vs. intranasal dexmedetomidine before computerised tomography in children. Anaesthesia2017;72(10):1191-5. [PMID: 28741653]">Yuen 2017a</a>). We judged all of these 10 studies to be at high risk for blinding of participants, except <a href="./references#CD011786-bbs2-0005" title="BektasO , AricaB , TeberS , YilmazA , ZeybekH , KaymakS , et al. Chloral hydrate and/or hydroxyzine for sedation in pediatric EEG recording. Brain &amp; Development2014;36(2):130-6. [DOI: 10.1016/j.braindev.2013.03.002] [PMID: 23582501]">Bektas 2014</a> and <a href="./references#CD011786-bbs2-0003" title="AshrafiMR , MohebbiH , MohamadiM , AziziE , ZamaniGR , TavasoliA , et al. Clonidine versus chloral hydrate for recording sleep EEG in children. Iranian Journal of Child Neurology2020;14(1):85-92. [PMID: 32021632]">Ashrafi 2020</a>, which we judged to be at unclear risk. Three studies were at low risk of bias for all domains (<a href="./references#CD011786-bbs2-0007" title="FallahR , NakhaeiMH , BehdadS , MoghaddamRN , ShamszadehA . Oral chloral hydrate vs. intranasal midazolam for sedation during computerized tomography. Indian Pediatrics2013;50(2):233-5. [PMID: 23024102]">Fallah 2013</a>; <a href="./references#CD011786-bbs2-0010" title="LopezBME , LopezSI , TroncosoAL , Avaria de losBMA , NovoaSF . Chloral hydrate or midazolam to induce sleep for electroencephalographic records. Revista Chilena de Pediatria1995;66(4):204-8. ">Lopez 1995</a>; <a href="./references#CD011786-bbs2-0012" title="Marti-BonmatiL , Ronchera-OmsCL , CasillasC , PoyatosC , TorrijoC , JimenezNV . Randomised double-blind clinical trial of intermediate- versus high-dose chloral hydrate for neuroimaging of children. Neuroradiology1995;37(8):687-91. [PMID: 8748907]">Marti‐Bonmati 1995</a>). The proportions of included studies at low, high, and unclear risk of bias in each domain, and the risk of bias judgement of each included study in each domain, are illustrated in <a href="#CD011786-fig-0002">Figure 2</a> and <a href="#CD011786-fig-0003">Figure 3</a>. A detailed description of the risk of bias of each study is provided in the risk of bias table in <a href="./references#CD011786-sec-0208" title="">Characteristics of included studies</a>. </p> <div class="figure" id="CD011786-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011786-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD011786-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011786-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD011786-sec-0047"> <h4 class="title">Allocation</h4> <p>We judged eight studies to be at low risk of bias for random sequence generation (<a href="./references#CD011786-bbs2-0004" title="AzizkhaniR , KananiS , SharifiA , GolshaniK , MasoumiB , AhmadiO . Oral chloral hydrate compare with rectal thiopental in pediatric procedural sedation and analgesia; a randomized clinical trial. Emergency (Tehran, Iran)2014;2(2):85-9. [PMID: 26495353]">Azizkhani 2014</a>; <a href="./references#CD011786-bbs2-0006" title="D'AgostinoJ , TerndrupTE . Chloral hydrate versus midazolam for sedation of children for neuroimaging: a randomized clinical trial. Pediatric Emergency Care2000;16(1):1-4. [PMID: 10698133]">D'Agostino 2000</a>; <a href="./references#CD011786-bbs2-0007" title="FallahR , NakhaeiMH , BehdadS , MoghaddamRN , ShamszadehA . Oral chloral hydrate vs. intranasal midazolam for sedation during computerized tomography. Indian Pediatrics2013;50(2):233-5. [PMID: 23024102]">Fallah 2013</a>; <a href="./references#CD011786-bbs2-0008" title="GumusH , BayramAK , PoyrazogluHG , CanpolatDG , PerH , CanpolatM , et al. Comparison of effects of different dexmedetomidine and chloral hydrate doses used in sedation on electroencephalography in pediatric patients. Journal of Child Neurology2015;30(8):983-8. [DOI: 10.1177/0883073814549582] [PMID: 25246305]">Gumus 2015</a>; <a href="./references#CD011786-bbs2-0010" title="LopezBME , LopezSI , TroncosoAL , Avaria de losBMA , NovoaSF . Chloral hydrate or midazolam to induce sleep for electroencephalographic records. Revista Chilena de Pediatria1995;66(4):204-8. ">Lopez 1995</a>; <a href="./references#CD011786-bbs2-0011" title="MalviyaS , Voepel-LewisT , TaitAR , ReynoldsPI , GujarSK , GebarskiSS , et al. Pentobarbital vs chloral hydrate for sedation of children undergoing MRI: efficacy and recovery characteristics. Paediatric Anaesthesia2004;14(7):589-95. [PMID: 15200658]">Malviya 2004</a>; <a href="./references#CD011786-bbs2-0012" title="Marti-BonmatiL , Ronchera-OmsCL , CasillasC , PoyatosC , TorrijoC , JimenezNV . Randomised double-blind clinical trial of intermediate- versus high-dose chloral hydrate for neuroimaging of children. Neuroradiology1995;37(8):687-91. [PMID: 8748907]">Marti‐Bonmati 1995</a>; <a href="./references#CD011786-bbs2-0013" title="RaziehF , SharamJ , MotahharehG , SedighahAK , Mohammad-HoseinJ . Efficacy of chloral hydrate and promethazine for sedation during electroencephalography in children: a randomised clinical trial. Iranian Journal of Pediatrics2013;23(1):27-31. [PMID: 23550099]">Razieh 2013</a>), and five studies to be at low risk of bias for allocation concealment (<a href="./references#CD011786-bbs2-0006" title="D'AgostinoJ , TerndrupTE . Chloral hydrate versus midazolam for sedation of children for neuroimaging: a randomized clinical trial. Pediatric Emergency Care2000;16(1):1-4. [PMID: 10698133]">D'Agostino 2000</a>; <a href="./references#CD011786-bbs2-0010" title="LopezBME , LopezSI , TroncosoAL , Avaria de losBMA , NovoaSF . Chloral hydrate or midazolam to induce sleep for electroencephalographic records. Revista Chilena de Pediatria1995;66(4):204-8. ">Lopez 1995</a>; <a href="./references#CD011786-bbs2-0012" title="Marti-BonmatiL , Ronchera-OmsCL , CasillasC , PoyatosC , TorrijoC , JimenezNV . Randomised double-blind clinical trial of intermediate- versus high-dose chloral hydrate for neuroimaging of children. Neuroradiology1995;37(8):687-91. [PMID: 8748907]">Marti‐Bonmati 1995</a>; <a href="./references#CD011786-bbs2-0013" title="RaziehF , SharamJ , MotahharehG , SedighahAK , Mohammad-HoseinJ . Efficacy of chloral hydrate and promethazine for sedation during electroencephalography in children: a randomised clinical trial. Iranian Journal of Pediatrics2013;23(1):27-31. [PMID: 23550099]">Razieh 2013</a>; <a href="./references#CD011786-bbs2-0016" title="YuenVM , LiBL , CheukDK , LeungMKM , HuiTWC , WongIC , et al. A randomised controlled trial of oral chloral hydrate vs. intranasal dexmedetomidine before computerised tomography in children. Anaesthesia2017;72(10):1191-5. [PMID: 28741653]">Yuen 2017a</a>). The authors of these studies clearly stated the method of sequence generation, which involved some form of random number scheme using either computers, random number table, or the toss of a coin. There were also clear statements in the methods confirming the independence between sequence generation and allocation. We judged three studies to be at high risk of bias for sequence generation as well as allocation concealment (<a href="./references#CD011786-bbs2-0003" title="AshrafiMR , MohebbiH , MohamadiM , AziziE , ZamaniGR , TavasoliA , et al. Clonidine versus chloral hydrate for recording sleep EEG in children. Iranian Journal of Child Neurology2020;14(1):85-92. [PMID: 32021632]">Ashrafi 2020</a>; <a href="./references#CD011786-bbs2-0009" title="LoewyJ , HallanC , FriedmanE , MartinezC . Sleep/sedation in children undergoing EEG testing: a comparison of chloral hydrate and music therapy. American Journal of Electroneurodiagnostic Technology2006;46(4):343-55. [PMID: 17285817]LoewyJ , HallanC , FriedmanE , MartinezC . Sleep/sedation in children undergoing EEG testing: a comparison of chloral hydrate and music therapy. Journal of Perianesthesia Nursing2005;20(5):323-32. [PMID: 16246809]">Loewy 2005</a>; <a href="./references#CD011786-bbs2-0015" title="ThompsonJR , SchneiderS , AshwalS . The choice of sedation for computed tomography in children. A prospective evaluation. Radiology1982;143(2):475-9. [PMID: 7071350]">Thompson 1982</a>), as children were allocated following a predictable sequence based on the day of the week they were admitted or via alternating and rotational assignments. We assessed six studies as at unclear risk of bias in one or both domains as the information provided in the articles was insufficient to permit a judgement of low or high risk of bias (<a href="./references#CD011786-bbs2-0001" title="AshrafiMR , MohammadiM , TafarrojiJ , ShabanianR , SalamatiP , ZamaniGR . Melatonin versus chloral hydrate for recording sleep EEG. European Journal of Paediatric Neurology2010;14(3):235-8. [DOI: 10.1016/j.ejpn.2009.06.010] [PMID: 19616978]">Ashrafi 2010</a>; <a href="./references#CD011786-bbs2-0002" title="AshrafiMR , Azizi MalamiriR , ZamaniGR , MohammadiM , HosseiniF . Sleep inducing for EEG recording in children: a comparison between oral midazolam and chloral hydrate. Iranian Journal of Child Neurology2013;7(1):15-9. [PMID: 24665284]">Ashrafi 2013</a>; <a href="./references#CD011786-bbs2-0004" title="AzizkhaniR , KananiS , SharifiA , GolshaniK , MasoumiB , AhmadiO . Oral chloral hydrate compare with rectal thiopental in pediatric procedural sedation and analgesia; a randomized clinical trial. Emergency (Tehran, Iran)2014;2(2):85-9. [PMID: 26495353]">Azizkhani 2014</a>; <a href="./references#CD011786-bbs2-0005" title="BektasO , AricaB , TeberS , YilmazA , ZeybekH , KaymakS , et al. Chloral hydrate and/or hydroxyzine for sedation in pediatric EEG recording. Brain &amp; Development2014;36(2):130-6. [DOI: 10.1016/j.braindev.2013.03.002] [PMID: 23582501]">Bektas 2014</a>; <a href="./references#CD011786-bbs2-0014" title="SezerT , AlehanF . Chloral hydrate versus hydroxyzine HCL for sedation prior to pediatric sleep EEG recording. International Journal of Neuroscience2013;123(10):719-23. [DOI: 10.3109/00207454.2013.796310] [PMID: 23594140]">Sezer 2013</a>; <a href="./references#CD011786-bbs2-0016" title="YuenVM , LiBL , CheukDK , LeungMKM , HuiTWC , WongIC , et al. A randomised controlled trial of oral chloral hydrate vs. intranasal dexmedetomidine before computerised tomography in children. Anaesthesia2017;72(10):1191-5. [PMID: 28741653]">Yuen 2017a</a>). </p> </section> <section id="CD011786-sec-0048"> <h4 class="title">Blinding</h4> <p>We judged eight studies to be at high risk of bias for blinding of participants (<a href="./references#CD011786-bbs2-0001" title="AshrafiMR , MohammadiM , TafarrojiJ , ShabanianR , SalamatiP , ZamaniGR . Melatonin versus chloral hydrate for recording sleep EEG. European Journal of Paediatric Neurology2010;14(3):235-8. [DOI: 10.1016/j.ejpn.2009.06.010] [PMID: 19616978]">Ashrafi 2010</a>; <a href="./references#CD011786-bbs2-0002" title="AshrafiMR , Azizi MalamiriR , ZamaniGR , MohammadiM , HosseiniF . Sleep inducing for EEG recording in children: a comparison between oral midazolam and chloral hydrate. Iranian Journal of Child Neurology2013;7(1):15-9. [PMID: 24665284]">Ashrafi 2013</a>; <a href="./references#CD011786-bbs2-0005" title="BektasO , AricaB , TeberS , YilmazA , ZeybekH , KaymakS , et al. Chloral hydrate and/or hydroxyzine for sedation in pediatric EEG recording. Brain &amp; Development2014;36(2):130-6. [DOI: 10.1016/j.braindev.2013.03.002] [PMID: 23582501]">Bektas 2014</a>; <a href="./references#CD011786-bbs2-0008" title="GumusH , BayramAK , PoyrazogluHG , CanpolatDG , PerH , CanpolatM , et al. Comparison of effects of different dexmedetomidine and chloral hydrate doses used in sedation on electroencephalography in pediatric patients. Journal of Child Neurology2015;30(8):983-8. [DOI: 10.1177/0883073814549582] [PMID: 25246305]">Gumus 2015</a>; <a href="./references#CD011786-bbs2-0009" title="LoewyJ , HallanC , FriedmanE , MartinezC . Sleep/sedation in children undergoing EEG testing: a comparison of chloral hydrate and music therapy. American Journal of Electroneurodiagnostic Technology2006;46(4):343-55. [PMID: 17285817]LoewyJ , HallanC , FriedmanE , MartinezC . Sleep/sedation in children undergoing EEG testing: a comparison of chloral hydrate and music therapy. Journal of Perianesthesia Nursing2005;20(5):323-32. [PMID: 16246809]">Loewy 2005</a>; <a href="./references#CD011786-bbs2-0011" title="MalviyaS , Voepel-LewisT , TaitAR , ReynoldsPI , GujarSK , GebarskiSS , et al. Pentobarbital vs chloral hydrate for sedation of children undergoing MRI: efficacy and recovery characteristics. Paediatric Anaesthesia2004;14(7):589-95. [PMID: 15200658]">Malviya 2004</a>; <a href="./references#CD011786-bbs2-0015" title="ThompsonJR , SchneiderS , AshwalS . The choice of sedation for computed tomography in children. A prospective evaluation. Radiology1982;143(2):475-9. [PMID: 7071350]">Thompson 1982</a>; <a href="./references#CD011786-bbs2-0016" title="YuenVM , LiBL , CheukDK , LeungMKM , HuiTWC , WongIC , et al. A randomised controlled trial of oral chloral hydrate vs. intranasal dexmedetomidine before computerised tomography in children. Anaesthesia2017;72(10):1191-5. [PMID: 28741653]">Yuen 2017a</a>). In four studies (<a href="./references#CD011786-bbs2-0004" title="AzizkhaniR , KananiS , SharifiA , GolshaniK , MasoumiB , AhmadiO . Oral chloral hydrate compare with rectal thiopental in pediatric procedural sedation and analgesia; a randomized clinical trial. Emergency (Tehran, Iran)2014;2(2):85-9. [PMID: 26495353]">Azizkhani 2014</a>; <a href="./references#CD011786-bbs2-0006" title="D'AgostinoJ , TerndrupTE . Chloral hydrate versus midazolam for sedation of children for neuroimaging: a randomized clinical trial. Pediatric Emergency Care2000;16(1):1-4. [PMID: 10698133]">D'Agostino 2000</a>; <a href="./references#CD011786-bbs2-0007" title="FallahR , NakhaeiMH , BehdadS , MoghaddamRN , ShamszadehA . Oral chloral hydrate vs. intranasal midazolam for sedation during computerized tomography. Indian Pediatrics2013;50(2):233-5. [PMID: 23024102]">Fallah 2013</a>; <a href="./references#CD011786-bbs2-0012" title="Marti-BonmatiL , Ronchera-OmsCL , CasillasC , PoyatosC , TorrijoC , JimenezNV . Randomised double-blind clinical trial of intermediate- versus high-dose chloral hydrate for neuroimaging of children. Neuroradiology1995;37(8):687-91. [PMID: 8748907]">Marti‐Bonmati 1995</a>), it was stated clearly that blinding of participants was achieved, whilst in the other four studies (<a href="./references#CD011786-bbs2-0003" title="AshrafiMR , MohebbiH , MohamadiM , AziziE , ZamaniGR , TavasoliA , et al. Clonidine versus chloral hydrate for recording sleep EEG in children. Iranian Journal of Child Neurology2020;14(1):85-92. [PMID: 32021632]">Ashrafi 2020</a>; <a href="./references#CD011786-bbs2-0010" title="LopezBME , LopezSI , TroncosoAL , Avaria de losBMA , NovoaSF . Chloral hydrate or midazolam to induce sleep for electroencephalographic records. Revista Chilena de Pediatria1995;66(4):204-8. ">Lopez 1995</a>; <a href="./references#CD011786-bbs2-0013" title="RaziehF , SharamJ , MotahharehG , SedighahAK , Mohammad-HoseinJ . Efficacy of chloral hydrate and promethazine for sedation during electroencephalography in children: a randomised clinical trial. Iranian Journal of Pediatrics2013;23(1):27-31. [PMID: 23550099]">Razieh 2013</a>; <a href="./references#CD011786-bbs2-0014" title="SezerT , AlehanF . Chloral hydrate versus hydroxyzine HCL for sedation prior to pediatric sleep EEG recording. International Journal of Neuroscience2013;123(10):719-23. [DOI: 10.3109/00207454.2013.796310] [PMID: 23594140]">Sezer 2013</a>), no statements were made regarding the blinding status of the participants. We considered blinding for these four studies to be unlikely because they compared chloral hydrate with another solution of a different appearance/preparation and taste. </p> <p>Nine studies did not report blinding of outcome assessors (<a href="./references#CD011786-bbs2-0001" title="AshrafiMR , MohammadiM , TafarrojiJ , ShabanianR , SalamatiP , ZamaniGR . Melatonin versus chloral hydrate for recording sleep EEG. European Journal of Paediatric Neurology2010;14(3):235-8. [DOI: 10.1016/j.ejpn.2009.06.010] [PMID: 19616978]">Ashrafi 2010</a>; <a href="./references#CD011786-bbs2-0002" title="AshrafiMR , Azizi MalamiriR , ZamaniGR , MohammadiM , HosseiniF . Sleep inducing for EEG recording in children: a comparison between oral midazolam and chloral hydrate. Iranian Journal of Child Neurology2013;7(1):15-9. [PMID: 24665284]">Ashrafi 2013</a>; <a href="./references#CD011786-bbs2-0003" title="AshrafiMR , MohebbiH , MohamadiM , AziziE , ZamaniGR , TavasoliA , et al. Clonidine versus chloral hydrate for recording sleep EEG in children. Iranian Journal of Child Neurology2020;14(1):85-92. [PMID: 32021632]">Ashrafi 2020</a>; <a href="./references#CD011786-bbs2-0004" title="AzizkhaniR , KananiS , SharifiA , GolshaniK , MasoumiB , AhmadiO . Oral chloral hydrate compare with rectal thiopental in pediatric procedural sedation and analgesia; a randomized clinical trial. Emergency (Tehran, Iran)2014;2(2):85-9. [PMID: 26495353]">Azizkhani 2014</a>; <a href="./references#CD011786-bbs2-0005" title="BektasO , AricaB , TeberS , YilmazA , ZeybekH , KaymakS , et al. Chloral hydrate and/or hydroxyzine for sedation in pediatric EEG recording. Brain &amp; Development2014;36(2):130-6. [DOI: 10.1016/j.braindev.2013.03.002] [PMID: 23582501]">Bektas 2014</a>; <a href="./references#CD011786-bbs2-0008" title="GumusH , BayramAK , PoyrazogluHG , CanpolatDG , PerH , CanpolatM , et al. Comparison of effects of different dexmedetomidine and chloral hydrate doses used in sedation on electroencephalography in pediatric patients. Journal of Child Neurology2015;30(8):983-8. [DOI: 10.1177/0883073814549582] [PMID: 25246305]">Gumus 2015</a>; <a href="./references#CD011786-bbs2-0011" title="MalviyaS , Voepel-LewisT , TaitAR , ReynoldsPI , GujarSK , GebarskiSS , et al. Pentobarbital vs chloral hydrate for sedation of children undergoing MRI: efficacy and recovery characteristics. Paediatric Anaesthesia2004;14(7):589-95. [PMID: 15200658]">Malviya 2004</a>; <a href="./references#CD011786-bbs2-0014" title="SezerT , AlehanF . Chloral hydrate versus hydroxyzine HCL for sedation prior to pediatric sleep EEG recording. International Journal of Neuroscience2013;123(10):719-23. [DOI: 10.3109/00207454.2013.796310] [PMID: 23594140]">Sezer 2013</a>; <a href="./references#CD011786-bbs2-0015" title="ThompsonJR , SchneiderS , AshwalS . The choice of sedation for computed tomography in children. A prospective evaluation. Radiology1982;143(2):475-9. [PMID: 7071350]">Thompson 1982</a>). We judged one study to be at high risk of detection bias, as the modality of sedation intervention given in this study (oral chloral hydrate versus music therapy via music therapist) was clearly different, precluding blinding of the outcome assessors (<a href="./references#CD011786-bbs2-0009" title="LoewyJ , HallanC , FriedmanE , MartinezC . Sleep/sedation in children undergoing EEG testing: a comparison of chloral hydrate and music therapy. American Journal of Electroneurodiagnostic Technology2006;46(4):343-55. [PMID: 17285817]LoewyJ , HallanC , FriedmanE , MartinezC . Sleep/sedation in children undergoing EEG testing: a comparison of chloral hydrate and music therapy. Journal of Perianesthesia Nursing2005;20(5):323-32. [PMID: 16246809]">Loewy 2005</a>). In the remaining six studies (<a href="./references#CD011786-bbs2-0006" title="D'AgostinoJ , TerndrupTE . Chloral hydrate versus midazolam for sedation of children for neuroimaging: a randomized clinical trial. Pediatric Emergency Care2000;16(1):1-4. [PMID: 10698133]">D'Agostino 2000</a>; <a href="./references#CD011786-bbs2-0007" title="FallahR , NakhaeiMH , BehdadS , MoghaddamRN , ShamszadehA . Oral chloral hydrate vs. intranasal midazolam for sedation during computerized tomography. Indian Pediatrics2013;50(2):233-5. [PMID: 23024102]">Fallah 2013</a>; <a href="./references#CD011786-bbs2-0010" title="LopezBME , LopezSI , TroncosoAL , Avaria de losBMA , NovoaSF . Chloral hydrate or midazolam to induce sleep for electroencephalographic records. Revista Chilena de Pediatria1995;66(4):204-8. ">Lopez 1995</a>; <a href="./references#CD011786-bbs2-0012" title="Marti-BonmatiL , Ronchera-OmsCL , CasillasC , PoyatosC , TorrijoC , JimenezNV . Randomised double-blind clinical trial of intermediate- versus high-dose chloral hydrate for neuroimaging of children. Neuroradiology1995;37(8):687-91. [PMID: 8748907]">Marti‐Bonmati 1995</a>; <a href="./references#CD011786-bbs2-0013" title="RaziehF , SharamJ , MotahharehG , SedighahAK , Mohammad-HoseinJ . Efficacy of chloral hydrate and promethazine for sedation during electroencephalography in children: a randomised clinical trial. Iranian Journal of Pediatrics2013;23(1):27-31. [PMID: 23550099]">Razieh 2013</a>; <a href="./references#CD011786-bbs2-0016" title="YuenVM , LiBL , CheukDK , LeungMKM , HuiTWC , WongIC , et al. A randomised controlled trial of oral chloral hydrate vs. intranasal dexmedetomidine before computerised tomography in children. Anaesthesia2017;72(10):1191-5. [PMID: 28741653]">Yuen 2017a</a>), it was clearly stated that the outcome assessors were blinded. </p> </section> <section id="CD011786-sec-0049"> <h4 class="title">Incomplete outcome data</h4> <p>In all studies except two (<a href="./references#CD011786-bbs2-0010" title="LopezBME , LopezSI , TroncosoAL , Avaria de losBMA , NovoaSF . Chloral hydrate or midazolam to induce sleep for electroencephalographic records. Revista Chilena de Pediatria1995;66(4):204-8. ">Lopez 1995</a>; <a href="./references#CD011786-bbs2-0015" title="ThompsonJR , SchneiderS , AshwalS . The choice of sedation for computed tomography in children. A prospective evaluation. Radiology1982;143(2):475-9. [PMID: 7071350]">Thompson 1982</a>), all children enrolled appeared to be included in the analysis. Both studies with missing data had a dropout rate of over 20% (22% in <a href="./references#CD011786-bbs2-0010" title="LopezBME , LopezSI , TroncosoAL , Avaria de losBMA , NovoaSF . Chloral hydrate or midazolam to induce sleep for electroencephalographic records. Revista Chilena de Pediatria1995;66(4):204-8. ">Lopez 1995</a> and 42.3% in <a href="./references#CD011786-bbs2-0015" title="ThompsonJR , SchneiderS , AshwalS . The choice of sedation for computed tomography in children. A prospective evaluation. Radiology1982;143(2):475-9. [PMID: 7071350]">Thompson 1982</a>), resulting in a judgement of high risk of bias for this domain. We judged a third study as having a high risk of attrition bias, as the authors did not conduct an intention‐to‐treat analysis (<a href="./references#CD011786-bbs2-0005" title="BektasO , AricaB , TeberS , YilmazA , ZeybekH , KaymakS , et al. Chloral hydrate and/or hydroxyzine for sedation in pediatric EEG recording. Brain &amp; Development2014;36(2):130-6. [DOI: 10.1016/j.braindev.2013.03.002] [PMID: 23582501]">Bektas 2014</a>). </p> </section> <section id="CD011786-sec-0050"> <h4 class="title">Selective reporting</h4> <p>We judged 13 studies as at low risk of bias for this domain (<a href="./references#CD011786-bbs2-0001" title="AshrafiMR , MohammadiM , TafarrojiJ , ShabanianR , SalamatiP , ZamaniGR . Melatonin versus chloral hydrate for recording sleep EEG. European Journal of Paediatric Neurology2010;14(3):235-8. [DOI: 10.1016/j.ejpn.2009.06.010] [PMID: 19616978]">Ashrafi 2010</a>; <a href="./references#CD011786-bbs2-0002" title="AshrafiMR , Azizi MalamiriR , ZamaniGR , MohammadiM , HosseiniF . Sleep inducing for EEG recording in children: a comparison between oral midazolam and chloral hydrate. Iranian Journal of Child Neurology2013;7(1):15-9. [PMID: 24665284]">Ashrafi 2013</a>; <a href="./references#CD011786-bbs2-0003" title="AshrafiMR , MohebbiH , MohamadiM , AziziE , ZamaniGR , TavasoliA , et al. Clonidine versus chloral hydrate for recording sleep EEG in children. Iranian Journal of Child Neurology2020;14(1):85-92. [PMID: 32021632]">Ashrafi 2020</a>; <a href="./references#CD011786-bbs2-0004" title="AzizkhaniR , KananiS , SharifiA , GolshaniK , MasoumiB , AhmadiO . Oral chloral hydrate compare with rectal thiopental in pediatric procedural sedation and analgesia; a randomized clinical trial. Emergency (Tehran, Iran)2014;2(2):85-9. [PMID: 26495353]">Azizkhani 2014</a>; <a href="./references#CD011786-bbs2-0006" title="D'AgostinoJ , TerndrupTE . Chloral hydrate versus midazolam for sedation of children for neuroimaging: a randomized clinical trial. Pediatric Emergency Care2000;16(1):1-4. [PMID: 10698133]">D'Agostino 2000</a>; <a href="./references#CD011786-bbs2-0007" title="FallahR , NakhaeiMH , BehdadS , MoghaddamRN , ShamszadehA . Oral chloral hydrate vs. intranasal midazolam for sedation during computerized tomography. Indian Pediatrics2013;50(2):233-5. [PMID: 23024102]">Fallah 2013</a>; <a href="./references#CD011786-bbs2-0008" title="GumusH , BayramAK , PoyrazogluHG , CanpolatDG , PerH , CanpolatM , et al. Comparison of effects of different dexmedetomidine and chloral hydrate doses used in sedation on electroencephalography in pediatric patients. Journal of Child Neurology2015;30(8):983-8. [DOI: 10.1177/0883073814549582] [PMID: 25246305]">Gumus 2015</a>; <a href="./references#CD011786-bbs2-0010" title="LopezBME , LopezSI , TroncosoAL , Avaria de losBMA , NovoaSF . Chloral hydrate or midazolam to induce sleep for electroencephalographic records. Revista Chilena de Pediatria1995;66(4):204-8. ">Lopez 1995</a>; <a href="./references#CD011786-bbs2-0011" title="MalviyaS , Voepel-LewisT , TaitAR , ReynoldsPI , GujarSK , GebarskiSS , et al. Pentobarbital vs chloral hydrate for sedation of children undergoing MRI: efficacy and recovery characteristics. Paediatric Anaesthesia2004;14(7):589-95. [PMID: 15200658]">Malviya 2004</a>; <a href="./references#CD011786-bbs2-0012" title="Marti-BonmatiL , Ronchera-OmsCL , CasillasC , PoyatosC , TorrijoC , JimenezNV . Randomised double-blind clinical trial of intermediate- versus high-dose chloral hydrate for neuroimaging of children. Neuroradiology1995;37(8):687-91. [PMID: 8748907]">Marti‐Bonmati 1995</a>; <a href="./references#CD011786-bbs2-0013" title="RaziehF , SharamJ , MotahharehG , SedighahAK , Mohammad-HoseinJ . Efficacy of chloral hydrate and promethazine for sedation during electroencephalography in children: a randomised clinical trial. Iranian Journal of Pediatrics2013;23(1):27-31. [PMID: 23550099]">Razieh 2013</a>; <a href="./references#CD011786-bbs2-0014" title="SezerT , AlehanF . Chloral hydrate versus hydroxyzine HCL for sedation prior to pediatric sleep EEG recording. International Journal of Neuroscience2013;123(10):719-23. [DOI: 10.3109/00207454.2013.796310] [PMID: 23594140]">Sezer 2013</a>; <a href="./references#CD011786-bbs2-0016" title="YuenVM , LiBL , CheukDK , LeungMKM , HuiTWC , WongIC , et al. A randomised controlled trial of oral chloral hydrate vs. intranasal dexmedetomidine before computerised tomography in children. Anaesthesia2017;72(10):1191-5. [PMID: 28741653]">Yuen 2017a</a>). We judged three studies, <a href="./references#CD011786-bbs2-0005" title="BektasO , AricaB , TeberS , YilmazA , ZeybekH , KaymakS , et al. Chloral hydrate and/or hydroxyzine for sedation in pediatric EEG recording. Brain &amp; Development2014;36(2):130-6. [DOI: 10.1016/j.braindev.2013.03.002] [PMID: 23582501]">Bektas 2014</a>; <a href="./references#CD011786-bbs2-0009" title="LoewyJ , HallanC , FriedmanE , MartinezC . Sleep/sedation in children undergoing EEG testing: a comparison of chloral hydrate and music therapy. American Journal of Electroneurodiagnostic Technology2006;46(4):343-55. [PMID: 17285817]LoewyJ , HallanC , FriedmanE , MartinezC . Sleep/sedation in children undergoing EEG testing: a comparison of chloral hydrate and music therapy. Journal of Perianesthesia Nursing2005;20(5):323-32. [PMID: 16246809]">Loewy 2005</a>; <a href="./references#CD011786-bbs2-0015" title="ThompsonJR , SchneiderS , AshwalS . The choice of sedation for computed tomography in children. A prospective evaluation. Radiology1982;143(2):475-9. [PMID: 7071350]">Thompson 1982</a>, as at high risk of reporting bias; <a href="./references#CD011786-bbs2-0009" title="LoewyJ , HallanC , FriedmanE , MartinezC . Sleep/sedation in children undergoing EEG testing: a comparison of chloral hydrate and music therapy. American Journal of Electroneurodiagnostic Technology2006;46(4):343-55. [PMID: 17285817]LoewyJ , HallanC , FriedmanE , MartinezC . Sleep/sedation in children undergoing EEG testing: a comparison of chloral hydrate and music therapy. Journal of Perianesthesia Nursing2005;20(5):323-32. [PMID: 16246809]">Loewy 2005</a> used a different categorical outcome sedation score between both comparison groups (reported sleep score 4 for chloral hydrate group and sleep score 3 for music therapy), making it unsuitable for direct comparison, or the studies reported outcomes without sufficient detail for a meta‐analysis, for example reporting means without standard deviations (<a href="./references#CD011786-bbs2-0015" title="ThompsonJR , SchneiderS , AshwalS . The choice of sedation for computed tomography in children. A prospective evaluation. Radiology1982;143(2):475-9. [PMID: 7071350]">Thompson 1982</a>). </p> </section> <section id="CD011786-sec-0051"> <h4 class="title">Other potential sources of bias</h4> <p>We identified an additional potential source of bias in one study (<a href="./references#CD011786-bbs2-0003" title="AshrafiMR , MohebbiH , MohamadiM , AziziE , ZamaniGR , TavasoliA , et al. Clonidine versus chloral hydrate for recording sleep EEG in children. Iranian Journal of Child Neurology2020;14(1):85-92. [PMID: 32021632]">Ashrafi 2020</a>). There was an imbalance in participant characteristics in which there was skewness in data, with the mean age of children assigned to the clonidine group (mean 57.4 months) being older than the mean age of children assigned to the chloral hydrate group (mean 21.8 months), and the difference showing a tendency towards statistical significance (P &lt; 0.05). </p> </section> </section> <section id="CD011786-sec-0052"> <h3 class="title" id="CD011786-sec-0052">Effects of interventions</h3> <p>See: <a href="./full#CD011786-tbl-0001"><b>Summary of findings 1</b> Chloral hydrate oral (50 mg/kg or 100 mg/kg) compared to dexmedetomidine oral (2 µg/kg or 3 µg/kg) as sedating agents for neurodiagnostic procedures in children</a>; <a href="./full#CD011786-tbl-0002"><b>Summary of findings 2</b> Chloral hydrate oral (75 mg/kg) compared to pentobarbital intravenous (5 mg/kg) as sedating agents for neurodiagnostic procedures in children</a>; <a href="./full#CD011786-tbl-0003"><b>Summary of findings 3</b> Chloral hydrate oral (100 mg/kg or 75 mg/kg) compared to midazolam (intranasal 0.2 mg/kg or oral 0.5 mg/kg) as sedating agents for neurodiagnostic procedures in children</a>; <a href="./full#CD011786-tbl-0004"><b>Summary of findings 4</b> Chloral hydrate oral (50 mg/kg) compared to melatonin oral as sedating agents for neurodiagnostic procedures in children</a>; <a href="./full#CD011786-tbl-0005"><b>Summary of findings 5</b> Chloral hydrate oral (50 mg/kg + 50 mg/kg) compared to hydroxyzine hydrochloride oral (1 mg/kg + 1 mg/kg) as sedating agents for neurodiagnostic procedures in children</a>; <a href="./full#CD011786-tbl-0006"><b>Summary of findings 6</b> Chloral hydrate oral (70 mg/kg) compared to promethazine oral (1 mg/kg) as sedating agents for neurodiagnostic procedures in children</a>; <a href="./full#CD011786-tbl-0007"><b>Summary of findings 7</b> Chloral hydrate oral (60 mg/kg) compared to music therapy as sedating agents for neurodiagnostic procedures in children</a>; <a href="./full#CD011786-tbl-0008"><b>Summary of findings 8</b> Chloral hydrate oral (50 mg/kg) compared to sodium thiopental rectal (25 mg/kg) for neurodiagnostic procedures in children</a>; <a href="./full#CD011786-tbl-0009"><b>Summary of findings 9</b> Chloral hydrate oral (50 mg/kg) compared to clonidine oral (4 μg/kg) for neurodiagnostic procedures in children</a>; <a href="./full#CD011786-tbl-0010"><b>Summary of findings 10</b> Chloral hydrate oral (50 mg/kg) compared to dexmedetomidine intranasal (3 μg/kg) for neurodiagnostic procedures in children</a> </p> <p>Overall, we carried out 13 comparisons, with variations related to the specific interventions compared in Comparison 3 (difference in mode of administration of midazolam, i.e. either intranasal or oral), Comparison 7 (difference with non‐drug music therapy), and Comparisons 9 and 10 (difference between different doses of chloral hydrate). We did not include four studies in the analysis as the data were skewed (<a href="./references#CD011786-bbs2-0001" title="AshrafiMR , MohammadiM , TafarrojiJ , ShabanianR , SalamatiP , ZamaniGR . Melatonin versus chloral hydrate for recording sleep EEG. European Journal of Paediatric Neurology2010;14(3):235-8. [DOI: 10.1016/j.ejpn.2009.06.010] [PMID: 19616978]">Ashrafi 2010</a>; <a href="./references#CD011786-bbs2-0002" title="AshrafiMR , Azizi MalamiriR , ZamaniGR , MohammadiM , HosseiniF . Sleep inducing for EEG recording in children: a comparison between oral midazolam and chloral hydrate. Iranian Journal of Child Neurology2013;7(1):15-9. [PMID: 24665284]">Ashrafi 2013</a>; <a href="./references#CD011786-bbs2-0005" title="BektasO , AricaB , TeberS , YilmazA , ZeybekH , KaymakS , et al. Chloral hydrate and/or hydroxyzine for sedation in pediatric EEG recording. Brain &amp; Development2014;36(2):130-6. [DOI: 10.1016/j.braindev.2013.03.002] [PMID: 23582501]">Bektas 2014</a>; <a href="./references#CD011786-bbs2-0015" title="ThompsonJR , SchneiderS , AshwalS . The choice of sedation for computed tomography in children. A prospective evaluation. Radiology1982;143(2):475-9. [PMID: 7071350]">Thompson 1982</a>). <a href="./references#CD011786-bbs2-0015" title="ThompsonJR , SchneiderS , AshwalS . The choice of sedation for computed tomography in children. A prospective evaluation. Radiology1982;143(2):475-9. [PMID: 7071350]">Thompson 1982</a> had a high dropout rate (42.3%), with no details provided regarding the missing data; <a href="./references#CD011786-bbs2-0005" title="BektasO , AricaB , TeberS , YilmazA , ZeybekH , KaymakS , et al. Chloral hydrate and/or hydroxyzine for sedation in pediatric EEG recording. Brain &amp; Development2014;36(2):130-6. [DOI: 10.1016/j.braindev.2013.03.002] [PMID: 23582501]">Bektas 2014</a> also had incomplete outcome data, and the study did not follow an intention‐to‐treat analysis. Details of these studies are provided in <a href="#CD011786-tbl-0011">Table 1</a>. </p> <div class="table" id="CD011786-tbl-0011"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Outcomes with skewed data as reported by individual studies</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Comparison</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Outcome</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Effect estimate</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>P value</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Chloral hydrate versus melatonin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sleep onset latency</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011786-bbs2-0001" title="AshrafiMR , MohammadiM , TafarrojiJ , ShabanianR , SalamatiP , ZamaniGR . Melatonin versus chloral hydrate for recording sleep EEG. European Journal of Paediatric Neurology2010;14(3):235-8. [DOI: 10.1016/j.ejpn.2009.06.010] [PMID: 19616978]">Ashrafi 2010</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Median (range) in minutes</b> </p> <p>Chloral hydrate group (35 (10 to 150)), melatonin group (45 (5 to 210))</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.113</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sleep duration</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011786-bbs2-0001" title="AshrafiMR , MohammadiM , TafarrojiJ , ShabanianR , SalamatiP , ZamaniGR . Melatonin versus chloral hydrate for recording sleep EEG. European Journal of Paediatric Neurology2010;14(3):235-8. [DOI: 10.1016/j.ejpn.2009.06.010] [PMID: 19616978]">Ashrafi 2010</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Median (range) in minutes</b> </p> <p>Chloral hydrate group (60 (15 to 240)), melatonin group (30 (15 to 240))</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.001</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Drowsiness time</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011786-bbs2-0001" title="AshrafiMR , MohammadiM , TafarrojiJ , ShabanianR , SalamatiP , ZamaniGR . Melatonin versus chloral hydrate for recording sleep EEG. European Journal of Paediatric Neurology2010;14(3):235-8. [DOI: 10.1016/j.ejpn.2009.06.010] [PMID: 19616978]">Ashrafi 2010</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Median (range) in minutes</b> </p> <p>Chloral hydrate group (60 (0 to 300)), melatonin group (20 (0 to 300))</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.001</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Chloral hydrate versus midazolam</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sleep onset latency</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011786-bbs2-0002" title="AshrafiMR , Azizi MalamiriR , ZamaniGR , MohammadiM , HosseiniF . Sleep inducing for EEG recording in children: a comparison between oral midazolam and chloral hydrate. Iranian Journal of Child Neurology2013;7(1):15-9. [PMID: 24665284]">Ashrafi 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Median (range) in minutes</b> </p> <p>Chloral hydrate group (32 (20 to 95)), midazolam group (20 (0 to 300))</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.001</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sleep duration</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011786-bbs2-0002" title="AshrafiMR , Azizi MalamiriR , ZamaniGR , MohammadiM , HosseiniF . Sleep inducing for EEG recording in children: a comparison between oral midazolam and chloral hydrate. Iranian Journal of Child Neurology2013;7(1):15-9. [PMID: 24665284]">Ashrafi 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Median (range) in minutes</b> </p> <p>Chloral hydrate group (66.5 (56 to 98)), midazolam group (25.5 (12 to 38))</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.001</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Drowsiness time</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011786-bbs2-0002" title="AshrafiMR , Azizi MalamiriR , ZamaniGR , MohammadiM , HosseiniF . Sleep inducing for EEG recording in children: a comparison between oral midazolam and chloral hydrate. Iranian Journal of Child Neurology2013;7(1):15-9. [PMID: 24665284]">Ashrafi 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Median (range) in minutes</b> </p> <p>Chloral hydrate group (32 (21 to 36)), midazolam group (6 (2 to 9))</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.001</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Chloral hydrate versus hydroxyzine</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time of sleep</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011786-bbs2-0005" title="BektasO , AricaB , TeberS , YilmazA , ZeybekH , KaymakS , et al. Chloral hydrate and/or hydroxyzine for sedation in pediatric EEG recording. Brain &amp; Development2014;36(2):130-6. [DOI: 10.1016/j.braindev.2013.03.002] [PMID: 23582501]">Bektas 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Median (range) in minutes</b> </p> <p>Chloral hydrate group (20 (5 to 120)), hydroxyzine group (30 (5 to 240))</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.309</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excessive fast activity</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011786-bbs2-0005" title="BektasO , AricaB , TeberS , YilmazA , ZeybekH , KaymakS , et al. Chloral hydrate and/or hydroxyzine for sedation in pediatric EEG recording. Brain &amp; Development2014;36(2):130-6. [DOI: 10.1016/j.braindev.2013.03.002] [PMID: 23582501]">Bektas 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Percentage</b> </p> <p>Chloral hydrate (24.5%) vs hydroxyzine (11.6%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.02</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Success in falling asleep</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011786-bbs2-0005" title="BektasO , AricaB , TeberS , YilmazA , ZeybekH , KaymakS , et al. Chloral hydrate and/or hydroxyzine for sedation in pediatric EEG recording. Brain &amp; Development2014;36(2):130-6. [DOI: 10.1016/j.braindev.2013.03.002] [PMID: 23582501]">Bektas 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Percentage</b> </p> <p>Chloral hydrate (90.7%) vs hydroxyzine (89.6%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.841</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Chloral hydrate versus intramuscular AMPS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to sedation</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011786-bbs2-0015" title="ThompsonJR , SchneiderS , AshwalS . The choice of sedation for computed tomography in children. A prospective evaluation. Radiology1982;143(2):475-9. [PMID: 7071350]">Thompson 1982</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean (minutes)</b> </p> <p>Chloral hydrate (55) vs AMPS (53)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Imaging failure</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011786-bbs2-0015" title="ThompsonJR , SchneiderS , AshwalS . The choice of sedation for computed tomography in children. A prospective evaluation. Radiology1982;143(2):475-9. [PMID: 7071350]">Thompson 1982</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Percentage</b> </p> <p>Chloral hydrate (15%) vs AMPS (12%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>AMPS: atropine/meperidine/promethazine/secobarbital<br/>N/A: not applicable </p> </div> </div> <p>We performed analysis on the remaining 10 studies with a total of 1794 children in the 13 comparisons. </p> <p> <ul id="CD011786-list-0018"> <li> <p>Comparison 1: Chloral hydrate oral (50 mg/kg or 100 mg/kg) compared to dexmedetomidine oral (2 µg/kg or 3 µg/kg) (160 children) (<a href="./references#CD011786-bbs2-0008" title="GumusH , BayramAK , PoyrazogluHG , CanpolatDG , PerH , CanpolatM , et al. Comparison of effects of different dexmedetomidine and chloral hydrate doses used in sedation on electroencephalography in pediatric patients. Journal of Child Neurology2015;30(8):983-8. [DOI: 10.1177/0883073814549582] [PMID: 25246305]">Gumus 2015</a>). </p> </li> <li> <p>Comparison 2: Chloral hydrate oral (75 mg/kg) compared to pentobarbital intravenous (5 mg/kg) (70 children) (<a href="./references#CD011786-bbs2-0011" title="MalviyaS , Voepel-LewisT , TaitAR , ReynoldsPI , GujarSK , GebarskiSS , et al. Pentobarbital vs chloral hydrate for sedation of children undergoing MRI: efficacy and recovery characteristics. Paediatric Anaesthesia2004;14(7):589-95. [PMID: 15200658]">Malviya 2004</a>). </p> </li> <li> <p>Comparison 3: Chloral hydrate oral (100 mg/kg or 75 mg/kg) compared to midazolam (intranasal 0.2 mg/kg or oral 0.5 mg/kg) (291 children) (<a href="./references#CD011786-bbs2-0002" title="AshrafiMR , Azizi MalamiriR , ZamaniGR , MohammadiM , HosseiniF . Sleep inducing for EEG recording in children: a comparison between oral midazolam and chloral hydrate. Iranian Journal of Child Neurology2013;7(1):15-9. [PMID: 24665284]">Ashrafi 2013</a>; <a href="./references#CD011786-bbs2-0006" title="D'AgostinoJ , TerndrupTE . Chloral hydrate versus midazolam for sedation of children for neuroimaging: a randomized clinical trial. Pediatric Emergency Care2000;16(1):1-4. [PMID: 10698133]">D'Agostino 2000</a>; <a href="./references#CD011786-bbs2-0007" title="FallahR , NakhaeiMH , BehdadS , MoghaddamRN , ShamszadehA . Oral chloral hydrate vs. intranasal midazolam for sedation during computerized tomography. Indian Pediatrics2013;50(2):233-5. [PMID: 23024102]">Fallah 2013</a>). </p> </li> <li> <p>Comparison 4: Chloral hydrate oral (50 mg/kg) compared to melatonin oral (348 children) (<a href="./references#CD011786-bbs2-0001" title="AshrafiMR , MohammadiM , TafarrojiJ , ShabanianR , SalamatiP , ZamaniGR . Melatonin versus chloral hydrate for recording sleep EEG. European Journal of Paediatric Neurology2010;14(3):235-8. [DOI: 10.1016/j.ejpn.2009.06.010] [PMID: 19616978]">Ashrafi 2010</a>). </p> </li> <li> <p>Comparison 5: Chloral hydrate oral (50 mg/kg + 50 mg/kg) compared to hydroxyzine hydrochloride oral (1 mg/kg + 1 mg/kg) (282 children) (<a href="./references#CD011786-bbs2-0014" title="SezerT , AlehanF . Chloral hydrate versus hydroxyzine HCL for sedation prior to pediatric sleep EEG recording. International Journal of Neuroscience2013;123(10):719-23. [DOI: 10.3109/00207454.2013.796310] [PMID: 23594140]">Sezer 2013</a>). </p> </li> <li> <p>Comparison 6: Chloral hydrate oral (70 mg/kg) compared to promethazine oral (1 mg/kg) (60 children) (<a href="./references#CD011786-bbs2-0013" title="RaziehF , SharamJ , MotahharehG , SedighahAK , Mohammad-HoseinJ . Efficacy of chloral hydrate and promethazine for sedation during electroencephalography in children: a randomised clinical trial. Iranian Journal of Pediatrics2013;23(1):27-31. [PMID: 23550099]">Razieh 2013</a>). </p> </li> <li> <p>Comparison 7: Chloral hydrate oral (60 mg/kg) compared to music therapy (58 children) (<a href="./references#CD011786-bbs2-0009" title="LoewyJ , HallanC , FriedmanE , MartinezC . Sleep/sedation in children undergoing EEG testing: a comparison of chloral hydrate and music therapy. American Journal of Electroneurodiagnostic Technology2006;46(4):343-55. [PMID: 17285817]LoewyJ , HallanC , FriedmanE , MartinezC . Sleep/sedation in children undergoing EEG testing: a comparison of chloral hydrate and music therapy. Journal of Perianesthesia Nursing2005;20(5):323-32. [PMID: 16246809]">Loewy 2005</a>). </p> </li> <li> <p>Comparison 8: Chloral hydrate oral (50 mg/kg) compared to midazolam rectal (1 mg/kg) (59 children) (<a href="./references#CD011786-bbs2-0010" title="LopezBME , LopezSI , TroncosoAL , Avaria de losBMA , NovoaSF . Chloral hydrate or midazolam to induce sleep for electroencephalographic records. Revista Chilena de Pediatria1995;66(4):204-8. ">Lopez 1995</a>). </p> </li> <li> <p>Comparison 9: Chloral hydrate oral high dose (100 mg/kg) compared to chloral hydrate oral low dose (70 mg/kg) (97 children) (<a href="./references#CD011786-bbs2-0012" title="Marti-BonmatiL , Ronchera-OmsCL , CasillasC , PoyatosC , TorrijoC , JimenezNV . Randomised double-blind clinical trial of intermediate- versus high-dose chloral hydrate for neuroimaging of children. Neuroradiology1995;37(8):687-91. [PMID: 8748907]">Marti‐Bonmati 1995</a>). </p> </li> <li> <p>Comparison 10: Chloral hydrate oral high dose (100 mg/kg) compared to chloral hydrate oral low dose (50 mg/kg) (76 children) (<a href="./references#CD011786-bbs2-0008" title="GumusH , BayramAK , PoyrazogluHG , CanpolatDG , PerH , CanpolatM , et al. Comparison of effects of different dexmedetomidine and chloral hydrate doses used in sedation on electroencephalography in pediatric patients. Journal of Child Neurology2015;30(8):983-8. [DOI: 10.1177/0883073814549582] [PMID: 25246305]">Gumus 2015</a>). </p> </li> <li> <p>Comparison 11: Chloral hydrate oral (50 mg/kg) compared to sodium thiopental rectal (25 mg/kg) (140 children) (<a href="./references#CD011786-bbs2-0004" title="AzizkhaniR , KananiS , SharifiA , GolshaniK , MasoumiB , AhmadiO . Oral chloral hydrate compare with rectal thiopental in pediatric procedural sedation and analgesia; a randomized clinical trial. Emergency (Tehran, Iran)2014;2(2):85-9. [PMID: 26495353]">Azizkhani 2014</a>). </p> </li> <li> <p>Comparison 12: Chloral hydrate oral (50 mg/kg) compared to clonidine oral (4 μg/kg) (198 children) (<a href="./references#CD011786-bbs2-0003" title="AshrafiMR , MohebbiH , MohamadiM , AziziE , ZamaniGR , TavasoliA , et al. Clonidine versus chloral hydrate for recording sleep EEG in children. Iranian Journal of Child Neurology2020;14(1):85-92. [PMID: 32021632]">Ashrafi 2020</a>). </p> </li> <li> <p>Comparison 13: Chloral hydrate oral (50 mg/kg) compared to dexmedetomidine intranasal (3 μg/kg) (194 children) (<a href="./references#CD011786-bbs2-0016" title="YuenVM , LiBL , CheukDK , LeungMKM , HuiTWC , WongIC , et al. A randomised controlled trial of oral chloral hydrate vs. intranasal dexmedetomidine before computerised tomography in children. Anaesthesia2017;72(10):1191-5. [PMID: 28741653]">Yuen 2017a</a>). </p> </li> </ul> </p> <p>Our outcomes of interest for each comparison are reported below.</p> <section id="CD011786-sec-0053"> <h4 class="title">Comparison 1: Chloral hydrate versus dexmedetomidine</h4> <p><a href="./references#CD011786-bbs2-0008" title="GumusH , BayramAK , PoyrazogluHG , CanpolatDG , PerH , CanpolatM , et al. Comparison of effects of different dexmedetomidine and chloral hydrate doses used in sedation on electroencephalography in pediatric patients. Journal of Child Neurology2015;30(8):983-8. [DOI: 10.1177/0883073814549582] [PMID: 25246305]">Gumus 2015</a> was the only study comparing oral chloral hydrate to oral dexmedetomidine, in two different dosing regimens. There were four arms in this study, namely low‐dose chloral hydrate (50 mg/kg), high‐dose chloral hydrate (100 mg/kg), low‐dose dexmedetomidine (2 µg/kg), and high‐dose dexmedetomidine (3 µg/kg). This made two pair‐wise comparisons of comparable dosages possible, thus we formed two separate subgroups in our analysis: one comparing low‐dose chloral hydrate against low‐dose dexmedetomidine, and another comparing high‐dose chloral hydrate against high‐dose dexmedetomidine. The major outcomes for this comparison with the corresponding certainty of evidence are displayed in <a href="./full#CD011786-tbl-0001">summary of findings Table 1</a>. </p> <section id="CD011786-sec-0054"> <h5 class="title">Primary outcomes</h5> <section id="CD011786-sec-0055"> <h6 class="title">Proportion of children who successfully completed neurodiagnostic procedure without interruption by the child awakening </h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0056"> <h6 class="title">Proportion of children who required a further dose of either the same sedative agent or the addition of a different sedative agent </h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0057"> <h6 class="title">Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) </h6> <p>Children who received oral chloral hydrate had a significantly shorter mean EEG time onset for adequate sedation compared with children who received oral dexmedetomidine (mean difference (MD) −3.86, 95% confidence interval (CI) −5.12 to −2.60; 160 children, moderate‐certainty evidence, downgraded one level due to imprecision) (<a href="./references#CD011786-fig-0004" title="">Analysis 1.1</a>). Our subgroup analysis showed that high‐dose oral chloral hydrate (100 mg/kg) achieved a significantly shorter mean onset of sedation of 5.6 minutes compared with high‐dose oral dexmedetomidine, whilst low‐dose oral chloral hydrate (50 mg/kg) achieved a significantly shorter mean onset of sedation of 1.9 minutes compared with low‐dose oral dexmedetomidine. The test of subgroup differences was significant (P = 0.004). No studies assessed the outcome of adequate sedation with validated scales. </p> </section> </section> <section id="CD011786-sec-0058"> <h5 class="title">Secondary outcomes</h5> <section id="CD011786-sec-0059"> <h6 class="title">Proportion of children who had sedation failure or inadequate level of sedation</h6> <p>There was no significant difference in sedation failure between oral chloral hydrate and oral dexmedetomidine (risk ratio (RR) 1.14, 95% CI 0.51 to 2.53; 160 children, moderate‐certainty evidence, downgraded one level due to imprecision) (<a href="./references#CD011786-fig-0005" title="">Analysis 1.2</a>). There were no significant differences between the high‐ and low‐dose subgroup comparisons. </p> </section> <section id="CD011786-sec-0060"> <h6 class="title">Sedation duration</h6> <p>The duration of sedation was significantly longer in the oral chloral hydrate group by 16.5 minutes compared with oral dexmedetomidine (MD 16.47, 95% CI 9.21 to 23.72; 160 children, moderate‐certainty evidence, downgraded one level due to imprecision) (<a href="./references#CD011786-fig-0006" title="">Analysis 1.3</a>). There were no significant differences between the high‐ and low‐dose subgroup comparisons. </p> </section> <section id="CD011786-sec-0061"> <h6 class="title">Yield of EEG or neuroimaging findings</h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0062"> <h6 class="title">Adverse effects (any)</h6> <p>Oral chloral hydrate had significantly more adverse events in total when compared with oral dexmedetomidine (RR 7.66, 95% CI 1.78 to 32.91; 160 children, low‐certainty evidence, downgraded two levels due to serious imprecision) (<a href="./references#CD011786-fig-0007" title="">Analysis 1.4</a>). There were no significant differences between the high‐ and low‐dose subgroup comparisons. Regarding individual adverse events, there were no significant differences between the two groups for all adverse events (<a href="./references#CD011786-fig-0008" title="">Analysis 1.5</a>; <a href="./references#CD011786-fig-0009" title="">Analysis 1.6</a>; <a href="./references#CD011786-fig-0010" title="">Analysis 1.7</a>; <a href="./references#CD011786-fig-0012" title="">Analysis 1.9</a>), except for nausea or vomiting, for which children who received oral chloral hydrate were reported to have significantly higher risk compared to children who received oral dexmedetomidine (RR 12.04, 95% CI 1.58 to 91.96; 160 children) (<a href="./references#CD011786-fig-0011" title="">Analysis 1.8</a>). There were no significant differences between the high‐ and low‐dose subgroup comparisons. </p> </section> </section> </section> <section id="CD011786-sec-0063"> <h4 class="title">Comparison 2: Chloral hydrate versus pentobarbital</h4> <p><a href="./references#CD011786-bbs2-0011" title="MalviyaS , Voepel-LewisT , TaitAR , ReynoldsPI , GujarSK , GebarskiSS , et al. Pentobarbital vs chloral hydrate for sedation of children undergoing MRI: efficacy and recovery characteristics. Paediatric Anaesthesia2004;14(7):589-95. [PMID: 15200658]">Malviya 2004</a> was the only study comparing oral chloral hydrate to intravenous pentobarbital. The major outcomes for this comparison with the corresponding certainty of evidence are displayed in <a href="./full#CD011786-tbl-0002">summary of findings Table 2</a>. </p> <section id="CD011786-sec-0064"> <h5 class="title">Primary outcomes</h5> <section id="CD011786-sec-0065"> <h6 class="title">Proportion of children who successfully completed neurodiagnostic procedure without interruption by the child awakening </h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0066"> <h6 class="title">Proportion of children who required a further dose of either the same sedative agent or the addition of a different sedative agent </h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0067"> <h6 class="title">Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) </h6> <p>Children who received oral chloral hydrate had a significantly longer mean time to adequate sedation compared with children who received intravenous pentobarbital (MD 19, 95% CI 16.61 to 21.39; 70 children, low‐certainty evidence, downgraded due to risk of bias (one level) and imprecision (one level)) (<a href="./references#CD011786-fig-0013" title="">Analysis 2.1</a>). No studies assessed the outcome of adequate sedation with validated scales. However, there was no significant difference in sedation failure between groups after two doses (RR 3.00, 95% CI 0.33 to 27.46; 1 study, very low‐certainty evidence, downgraded three levels due to risk of bias (one level) and very serious imprecision (two levels)) (<a href="./references#CD011786-fig-0014" title="">Analysis 2.2</a>). </p> </section> </section> <section id="CD011786-sec-0068"> <h5 class="title">Secondary outcomes</h5> <section id="CD011786-sec-0069"> <h6 class="title">Proportion of children who had sedation failure or inadequate level of sedation</h6> <p>Oral chloral hydrate had significantly more sedation failure after one dose than intravenous pentobarbital (RR 4.33, 95% CI 1.35 to 13.89; 70 children, low‐certainty evidence, downgraded two levels due to very serious imprecision) (<a href="./references#CD011786-fig-0015" title="">Analysis 2.3</a>). </p> </section> <section id="CD011786-sec-0070"> <h6 class="title">Sedation duration</h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0071"> <h6 class="title">Yield of EEG or neuroimaging findings</h6> <p>There was no significant difference in non‐interpretable neuroimaging findings between the two groups (RR 0.23, 95% CI 0.03 to 1.94; 54 children, very low‐certainty evidence, downgraded three levels due to risk of bias (one level) and very serious imprecision (two levels)) (<a href="./references#CD011786-fig-0016" title="">Analysis 2.4</a>). </p> </section> <section id="CD011786-sec-0072"> <h6 class="title">Adverse effects (any)</h6> <p>The study did not evaluate overall adverse effects between the two groups. Regarding individual adverse events, there was no significant difference in oxygen desaturation (RR 0.67, 95% CI 0.21 to 2.16; 70 children, very low‐certainty evidence, downgraded three levels due to risk of bias (one level) and serious imprecision (two levels)) (<a href="./references#CD011786-fig-0017" title="">Analysis 2.5</a>); nausea or vomiting; and paradoxical reaction between the two groups (<a href="./references#CD011786-fig-0018" title="">Analysis 2.6</a>; <a href="./references#CD011786-fig-0019" title="">Analysis 2.7</a>). Children who received oral chloral hydrate had a significantly shorter mean time (hours) to return to normal behaviour postdischarge when compared with intravenous pentobarbital (MD −6.0, 95% CI −11.43 to −0.57; 70 children) (<a href="./references#CD011786-fig-0020" title="">Analysis 2.8</a>). </p> </section> </section> </section> <section id="CD011786-sec-0073"> <h4 class="title">Comparison 3: Chloral hydrate versus midazolam</h4> <p>Three studies compared oral chloral hydrate to midazolam: <a href="./references#CD011786-bbs2-0007" title="FallahR , NakhaeiMH , BehdadS , MoghaddamRN , ShamszadehA . Oral chloral hydrate vs. intranasal midazolam for sedation during computerized tomography. Indian Pediatrics2013;50(2):233-5. [PMID: 23024102]">Fallah 2013</a>, which used intranasal midazolam, and <a href="./references#CD011786-bbs2-0006" title="D'AgostinoJ , TerndrupTE . Chloral hydrate versus midazolam for sedation of children for neuroimaging: a randomized clinical trial. Pediatric Emergency Care2000;16(1):1-4. [PMID: 10698133]">D'Agostino 2000</a> and <a href="./references#CD011786-bbs2-0002" title="AshrafiMR , Azizi MalamiriR , ZamaniGR , MohammadiM , HosseiniF . Sleep inducing for EEG recording in children: a comparison between oral midazolam and chloral hydrate. Iranian Journal of Child Neurology2013;7(1):15-9. [PMID: 24665284]">Ashrafi 2013</a>, which used oral midazolam. Data in <a href="./references#CD011786-bbs2-0002" title="AshrafiMR , Azizi MalamiriR , ZamaniGR , MohammadiM , HosseiniF . Sleep inducing for EEG recording in children: a comparison between oral midazolam and chloral hydrate. Iranian Journal of Child Neurology2013;7(1):15-9. [PMID: 24665284]">Ashrafi 2013</a> were skewed and were therefore not included in the meta‐analysis. The major outcomes for this comparison with the corresponding certainty of evidence are displayed in <a href="./full#CD011786-tbl-0003">summary of findings Table 3</a>. </p> <section id="CD011786-sec-0074"> <h5 class="title">Primary outcomes</h5> <section id="CD011786-sec-0075"> <h6 class="title">Proportion of children who successfully completed neurodiagnostic procedure without interruption by the child awakening </h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0076"> <h6 class="title">Proportion of children who required a further dose of either the same sedative agent or the addition of a different sedative agent </h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0077"> <h6 class="title">Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) </h6> <p><a href="./references#CD011786-bbs2-0002" title="AshrafiMR , Azizi MalamiriR , ZamaniGR , MohammadiM , HosseiniF . Sleep inducing for EEG recording in children: a comparison between oral midazolam and chloral hydrate. Iranian Journal of Child Neurology2013;7(1):15-9. [PMID: 24665284]">Ashrafi 2013</a> reported that children who received oral chloral hydrate had significantly shorter sleep onset latency, but significantly longer sleep duration and drowsiness time (<a href="#CD011786-tbl-0011">Table 1</a>). <a href="./references#CD011786-bbs2-0007" title="FallahR , NakhaeiMH , BehdadS , MoghaddamRN , ShamszadehA . Oral chloral hydrate vs. intranasal midazolam for sedation during computerized tomography. Indian Pediatrics2013;50(2):233-5. [PMID: 23024102]">Fallah 2013</a> reported that children who received oral chloral hydrate took a significantly longer time in minutes to achieve adequate sedation compared with intranasal midazolam (MD 12.83, 95% CI 7.22 to 18.44; 60 children, 1 study, moderate‐certainty evidence, downgraded one level due to imprecision) (<a href="./references#CD011786-fig-0021" title="">Analysis 3.1</a>). Children who received oral chloral hydrate appeared to be significantly less likely to suffer from an inadequate level of sedation (Ramsay score below 4) compared with intranasal midazolam (RR 0.11, 95% CI 0.03 to 0.44; 60 children, 1 study, moderate‐certainty evidence, downgraded one level due to imprecision) (<a href="./references#CD011786-fig-0022" title="">Analysis 3.2</a>). </p> </section> </section> <section id="CD011786-sec-0078"> <h5 class="title">Secondary outcomes</h5> <section id="CD011786-sec-0079"> <h6 class="title">Proportion of children who had sedation failure or inadequate level of sedation</h6> <p>There was no significant difference for sedation failure after one dose of sedative agent between oral chloral hydrate and oral midazolam (RR 0.17, 95% CI 0.02 to 1.12; 33 children, 1 study, low‐certainty evidence, downgraded two levels due to very serious imprecision) (<a href="./references#CD011786-fig-0023" title="">Analysis 3.3</a>). </p> </section> <section id="CD011786-sec-0080"> <h6 class="title">Sedation duration</h6> <p><a href="./references#CD011786-bbs2-0006" title="D'AgostinoJ , TerndrupTE . Chloral hydrate versus midazolam for sedation of children for neuroimaging: a randomized clinical trial. Pediatric Emergency Care2000;16(1):1-4. [PMID: 10698133]">D'Agostino 2000</a> reported that there was no significant difference in the mean duration of sedation between oral chloral hydrate and oral midazolam, with mean time for chloral sedation 19 minutes longer (MD 19, 95% CI −3.4 to 41.4; 33 children, 1 study, low‐certainty evidence, downgraded two levels due to very serious imprecision) (<a href="./references#CD011786-fig-0024" title="">Analysis 3.4</a>). </p> </section> <section id="CD011786-sec-0081"> <h6 class="title">Yield of EEG or neuroimaging findings</h6> <p><a href="./references#CD011786-bbs2-0002" title="AshrafiMR , Azizi MalamiriR , ZamaniGR , MohammadiM , HosseiniF . Sleep inducing for EEG recording in children: a comparison between oral midazolam and chloral hydrate. Iranian Journal of Child Neurology2013;7(1):15-9. [PMID: 24665284]">Ashrafi 2013</a> reported that children who received oral chloral hydrate were significantly less likely to have sedative‐induced artefact on their EEG recording compared to children who received intranasal midazolam (RR 0.58, 95% CI 0.44 to 0.76; 198 children, 1 study, high‐certainty evidence) (<a href="./references#CD011786-fig-0025" title="">Analysis 3.5</a>). </p> </section> <section id="CD011786-sec-0082"> <h6 class="title">Adverse effects (any)</h6> <p>There was no statistical significant difference in any adverse effects between oral chloral hydrate and oral midazolam groups (RR 0.20, 95% CI 0.01 to 4.2; 198 children, 1 study, low‐certainty evidence, downgraded two levels due to very serious imprecision) (<a href="./references#CD011786-fig-0026" title="">Analysis 3.6</a>). </p> </section> </section> </section> <section id="CD011786-sec-0083"> <h4 class="title">Comparison 4: Chloral hydrate versus melatonin</h4> <p><a href="./references#CD011786-bbs2-0001" title="AshrafiMR , MohammadiM , TafarrojiJ , ShabanianR , SalamatiP , ZamaniGR . Melatonin versus chloral hydrate for recording sleep EEG. European Journal of Paediatric Neurology2010;14(3):235-8. [DOI: 10.1016/j.ejpn.2009.06.010] [PMID: 19616978]">Ashrafi 2010</a> was the only study comparing oral chloral hydrate to oral melatonin; however, the data were skewed and were therefore not included in the meta‐analysis. The major outcomes for this comparison with the corresponding certainty of evidence are displayed in <a href="./full#CD011786-tbl-0004">summary of findings Table 4</a>. </p> <section id="CD011786-sec-0084"> <h5 class="title">Primary outcomes</h5> <section id="CD011786-sec-0085"> <h6 class="title">Proportion of children who successfully completed neurodiagnostic procedure without interruption by the child awakening </h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0086"> <h6 class="title">Proportion of children who required a further dose of either the same sedative agent or the addition of a different sedative agent </h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0087"> <h6 class="title">Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) </h6> <p>Data in <a href="./references#CD011786-bbs2-0001" title="AshrafiMR , MohammadiM , TafarrojiJ , ShabanianR , SalamatiP , ZamaniGR . Melatonin versus chloral hydrate for recording sleep EEG. European Journal of Paediatric Neurology2010;14(3):235-8. [DOI: 10.1016/j.ejpn.2009.06.010] [PMID: 19616978]">Ashrafi 2010</a> were skewed and were therefore not included in the meta‐analysis. <a href="./references#CD011786-bbs2-0001" title="AshrafiMR , MohammadiM , TafarrojiJ , ShabanianR , SalamatiP , ZamaniGR . Melatonin versus chloral hydrate for recording sleep EEG. European Journal of Paediatric Neurology2010;14(3):235-8. [DOI: 10.1016/j.ejpn.2009.06.010] [PMID: 19616978]">Ashrafi 2010</a> reported no significant difference between children who received oral chloral hydrate and those who received oral melatonin in sleep onset latency, but children who received oral chloral hydrate had significantly longer sleep duration and drowsiness time (<a href="#CD011786-tbl-0011">Table 1</a>). No studies assessed the outcome of adequate sedation with validated scales. </p> </section> </section> <section id="CD011786-sec-0088"> <h5 class="title">Secondary outcomes</h5> <section id="CD011786-sec-0089"> <h6 class="title">Proportion of children who had sedation failure or inadequate level of sedation</h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0090"> <h6 class="title">Sedation duration</h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0091"> <h6 class="title">Yield of EEG or neuroimaging findings</h6> <p>The occurrence of EEG sedative drug artefact (increased fast activity and slow dysrhythmia) was significantly less likely in the oral chloral hydrate group compared to the oral melatonin group (RR 0.33, 95% CI 0.14 to 0.82; 348 children, low‐certainty evidence, downgraded due to risk of bias (one level) and imprecision (one level)) (<a href="./references#CD011786-fig-0031" title="">Analysis 4.1</a>). </p> </section> <section id="CD011786-sec-0092"> <h6 class="title">Adverse effects (any)</h6> <p>There was no significant difference in any adverse effects between the two groups (RR 1.00, 95% CI 0.25 to 3.93; 348 children, low‐certainty evidence, downgraded due to risk of bias (one level) and imprecision (one level)) (<a href="./references#CD011786-fig-0032" title="">Analysis 4.2</a>). </p> </section> </section> </section> <section id="CD011786-sec-0093"> <h4 class="title">Comparison 5: Chloral hydrate versus hydroxyzine hydrochloride</h4> <p><a href="./references#CD011786-bbs2-0014" title="SezerT , AlehanF . Chloral hydrate versus hydroxyzine HCL for sedation prior to pediatric sleep EEG recording. International Journal of Neuroscience2013;123(10):719-23. [DOI: 10.3109/00207454.2013.796310] [PMID: 23594140]">Sezer 2013</a> was the only study comparing oral chloral hydrate to oral hydroxyzine hydrochloride. The major outcomes for this comparison with the corresponding certainty of evidence are displayed in <a href="./full#CD011786-tbl-0005">summary of findings Table 5</a>. </p> <section id="CD011786-sec-0094"> <h5 class="title">Primary outcomes</h5> <section id="CD011786-sec-0095"> <h6 class="title">Proportion of children who successfully completed neurodiagnostic procedure without interruption by the child awakening </h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0096"> <h6 class="title">Proportion of children who required a further dose of either the same sedative agent or the addition of a different sedative agent </h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0097"> <h6 class="title">Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) </h6> <p>Children receiving oral chloral hydrate had a significantly shorter mean time to adequate sedation compared with oral hydroxyzine hydrochloride (MD −7.5, 95% CI −7.85 to −7.15; 282 children, moderate‐certainty evidence, downgraded one level due to imprecision) (<a href="./references#CD011786-fig-0033" title="">Analysis 5.1</a>). No studies assessed the outcome of adequate sedation using validated scales. </p> </section> </section> <section id="CD011786-sec-0098"> <h5 class="title">Secondary outcomes</h5> <section id="CD011786-sec-0099"> <h6 class="title">Proportion of children who had sedation failure or inadequate level of sedation</h6> <p>There was no statistically significant difference in risk of sedation failure between the two groups (RR 0.33, 95% CI 0.11 to 1.01; 282 children, low‐certainty evidence, downgraded due to risk of bias (one level) and imprecision (one level)) (<a href="./references#CD011786-fig-0034" title="">Analysis 5.2</a>). </p> </section> <section id="CD011786-sec-0100"> <h6 class="title">Sedation duration</h6> <p>Children receiving oral chloral hydrate had a significantly longer mean sleep duration compared to those receiving oral hydroxyzine hydrochloride (MD 3.1, 95% CI 2.23 to 3.97; 282 children, moderate‐certainty evidence, downgraded one level due to imprecision) (<a href="./references#CD011786-fig-0035" title="">Analysis 5.3</a>). </p> </section> <section id="CD011786-sec-0101"> <h6 class="title">Yield of EEG or neuroimaging findings</h6> <p>There was no significant difference in EEG sedative drug artefact between the two groups (RR 1.33, 95% CI 0.47 to 3.74; 282 children, moderate‐certainty evidence, downgraded one level due to imprecision) (<a href="./references#CD011786-fig-0036" title="">Analysis 5.4</a>). </p> </section> <section id="CD011786-sec-0102"> <h6 class="title">Adverse effects (behavioural change and nausea or vomiting)</h6> <p>There was no significant difference between the two groups for behavioural change (RR 1.17, 95% CI 0.40 to 3.38; 282 children, low‐certainty evidence, downgraded due to risk of bias (one level) and imprecision (one level)) (<a href="./references#CD011786-fig-0037" title="">Analysis 5.5</a>), or for nausea or vomiting (RR 1.25, 95% CI 0.34 to 4.56; 282 children, low‐certainty evidence, downgraded due to risk of bias (one level) and imprecision (one level)) (<a href="./references#CD011786-fig-0038" title="">Analysis 5.6</a>). </p> </section> </section> </section> <section id="CD011786-sec-0103"> <h4 class="title">Comparison 6: Chloral hydrate versus promethazine</h4> <p><a href="./references#CD011786-bbs2-0013" title="RaziehF , SharamJ , MotahharehG , SedighahAK , Mohammad-HoseinJ . Efficacy of chloral hydrate and promethazine for sedation during electroencephalography in children: a randomised clinical trial. Iranian Journal of Pediatrics2013;23(1):27-31. [PMID: 23550099]">Razieh 2013</a> was the only study comparing oral chloral hydrate to oral promethazine. The major outcomes for this comparison with the corresponding certainty of evidence are displayed in <a href="./full#CD011786-tbl-0006">summary of findings Table 6</a>. </p> <section id="CD011786-sec-0104"> <h5 class="title">Primary outcomes</h5> <section id="CD011786-sec-0105"> <h6 class="title">Proportion of children who successfully completed neurodiagnostic procedure without interruption by the child awakening </h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0106"> <h6 class="title">Proportion of children who required a further dose of either the same sedative agent or the addition of a different sedative agent </h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0107"> <h6 class="title">Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) </h6> <p>Children in the chloral hydrate group had a significantly shorter mean time to adequate sedation compared with promethazine (MD −12.11, 95% CI −18.48 to −5.74; 60 children, moderate‐certainty evidence, downgraded one level due to imprecision) (<a href="./references#CD011786-fig-0040" title="">Analysis 6.1</a>). A significantly lower number of children who received oral chloral hydrate had an inadequate level of sedation (Ramsay score below 4) compared with oral promethazine (RR 0.03, 95% CI 0.00 to 0.45; 60 children, low‐certainty evidence, downgraded two levels due to very serious imprecision) (<a href="./references#CD011786-fig-0041" title="">Analysis 6.2</a>). </p> </section> <section id="CD011786-sec-0108"> <h6 class="title">Sedation duration</h6> <p>No studies assessed this outcome.</p> </section> </section> <section id="CD011786-sec-0109"> <h5 class="title">Secondary outcomes</h5> <section id="CD011786-sec-0110"> <h6 class="title">Proportion of children who had sedation failure or inadequate level of sedation</h6> <p>Children in the oral chloral hydrate group had significantly less sedation failure compared with oral promethazine (RR 0.11, 95% CI 0.01 to 0.82; 60 children, moderate‐certainty evidence, downgraded one level due to imprecision) (<a href="./references#CD011786-fig-0042" title="">Analysis 6.3</a>). </p> </section> <section id="CD011786-sec-0111"> <h6 class="title">Sedation duration</h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0112"> <h6 class="title">Yield of EEG or neuroimaging findings</h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0113"> <h6 class="title">Adverse effects (behavioural change and nausea or vomiting)</h6> <p>There was no significant difference between the two groups for behavioural change (RR 0.20, 95% CI 0.01 to 4.00; 60 children, moderate‐certainty evidence, downgraded one level due to imprecision) (<a href="./references#CD011786-fig-0043" title="">Analysis 6.4</a>), or for nausea or vomiting (RR 13.00, 95% CI 0.76 to 220.96; 60 children, low‐certainty evidence, downgraded two levels due to very serious imprecision) (<a href="./references#CD011786-fig-0044" title="">Analysis 6.5</a>). </p> </section> </section> </section> <section id="CD011786-sec-0114"> <h4 class="title">Comparison 7: Chloral hydrate versus music therapy</h4> <p><a href="./references#CD011786-bbs2-0009" title="LoewyJ , HallanC , FriedmanE , MartinezC . Sleep/sedation in children undergoing EEG testing: a comparison of chloral hydrate and music therapy. American Journal of Electroneurodiagnostic Technology2006;46(4):343-55. [PMID: 17285817]LoewyJ , HallanC , FriedmanE , MartinezC . Sleep/sedation in children undergoing EEG testing: a comparison of chloral hydrate and music therapy. Journal of Perianesthesia Nursing2005;20(5):323-32. [PMID: 16246809]">Loewy 2005</a> was the only study comparing oral chloral hydrate to music therapy. The major outcomes for this comparison with the corresponding certainty of evidence are displayed in <a href="./full#CD011786-tbl-0007">summary of findings Table 7</a>. </p> <section id="CD011786-sec-0115"> <h5 class="title">Primary outcomes</h5> <section id="CD011786-sec-0116"> <h6 class="title">Proportion of children who successfully completed neurodiagnostic procedure without interruption by the child awakening </h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0117"> <h6 class="title">Proportion of children who required a further dose of either the same sedative agent or the addition of a different sedative agent </h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0118"> <h6 class="title">Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) </h6> <p>There was no difference between the two groups in time to adequate sedation (MD 9.00 minutes, 95% CI −2.15 to 20.15; 58 children, very low‐certainty evidence, downgraded due to very serious risk of bias (two levels) and imprecision (one level)) (<a href="./references#CD011786-fig-0046" title="">Analysis 7.1</a>). No studies assessed the outcome of adequate sedation with validated scales. </p> </section> </section> <section id="CD011786-sec-0119"> <h5 class="title">Secondary outcomes</h5> <section id="CD011786-sec-0120"> <h6 class="title">Proportion of children who had sedation failure or inadequate level of sedation</h6> <p>Children who received oral chloral hydrate had significantly higher sedation failure compared with children who received music therapy (RR 17.00, 95% CI 2.37 to 122.14; 58 children, very low‐certainty evidence, downgraded due to very serious risk of bias (two levels) and very serious imprecision (two levels)) (<a href="./references#CD011786-fig-0047" title="">Analysis 7.2</a>). </p> </section> <section id="CD011786-sec-0121"> <h6 class="title">Sedation duration</h6> <p>The duration of sedation was significantly longer in the oral chloral hydrate group by 160 minutes compared with the music therapy group (MD 160.00, 95% CI 121.07 to 198.93; 58 children, very low‐certainty evidence, downgraded due to very serious risk of bias (two levels) and imprecision (one level)) (<a href="./references#CD011786-fig-0048" title="">Analysis 7.3</a>). </p> </section> <section id="CD011786-sec-0122"> <h6 class="title">Yield of EEG or neuroimaging findings</h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0123"> <h6 class="title">Adverse effects (any)</h6> <p>No studies assessed this outcome.</p> </section> </section> </section> <section id="CD011786-sec-0124"> <h4 class="title">Comparison 8: Chloral hydrate versus midazolam</h4> <p><a href="./references#CD011786-bbs2-0010" title="LopezBME , LopezSI , TroncosoAL , Avaria de losBMA , NovoaSF . Chloral hydrate or midazolam to induce sleep for electroencephalographic records. Revista Chilena de Pediatria1995;66(4):204-8. ">Lopez 1995</a> was the only study comparing oral chloral hydrate to rectal midazolam. </p> <section id="CD011786-sec-0125"> <h5 class="title">Primary outcomes</h5> <section id="CD011786-sec-0126"> <h6 class="title">Proportion of children who successfully completed neurodiagnostic procedure without interruption by the child awakening </h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0127"> <h6 class="title">Proportion of children who required a further dose of either the same sedative agent or the addition of a different sedative agent </h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0128"> <h6 class="title">Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) </h6> <p>Children receiving oral chloral hydrate had a significantly shorter mean time to adequate sedation (in minutes) compared with rectal midazolam (MD −95.70, 95% CI −114.51 to −76.89; 59 children) (<a href="./references#CD011786-fig-0049" title="">Analysis 8.1</a>). No studies assessed the outcome of adequate sedation with validated scales. </p> </section> </section> <section id="CD011786-sec-0129"> <h5 class="title">Secondary outcomes</h5> <section id="CD011786-sec-0130"> <h6 class="title">Proportion of children who had sedation failure or inadequate level of sedation</h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0131"> <h6 class="title">Sedation duration</h6> <p>The duration of sedation (in minutes) was significantly longer in the oral chloral hydrate group compared with the rectal midazolam group (MD 15.10, 95% CI 3.35 to 26.85; 59 children) (<a href="./references#CD011786-fig-0050" title="">Analysis 8.2</a>). </p> </section> <section id="CD011786-sec-0132"> <h6 class="title">Yield of EEG or neuroimaging findings</h6> <p>There was no significant difference in EEG sedative drug artefact between the two groups (RR 1.25, 95% CI 0.73 to 2.12; 53 children) (<a href="./references#CD011786-fig-0051" title="">Analysis 8.3</a>). </p> </section> <section id="CD011786-sec-0133"> <h6 class="title">Adverse effects (any)</h6> <p>No studies assessed this outcome.</p> </section> </section> </section> <section id="CD011786-sec-0134"> <h4 class="title">Comparison 9: Chloral hydrate high dose versus chloral hydrate low dose</h4> <p><a href="./references#CD011786-bbs2-0012" title="Marti-BonmatiL , Ronchera-OmsCL , CasillasC , PoyatosC , TorrijoC , JimenezNV . Randomised double-blind clinical trial of intermediate- versus high-dose chloral hydrate for neuroimaging of children. Neuroradiology1995;37(8):687-91. [PMID: 8748907]">Marti‐Bonmati 1995</a> was the only study comparing high‐dose oral chloral hydrate (100 mg/kg) to low‐dose oral chloral hydrate (70 mg/kg). </p> <section id="CD011786-sec-0135"> <h5 class="title">Primary outcomes</h5> <section id="CD011786-sec-0136"> <h6 class="title">Proportion of children who successfully completed neurodiagnostic procedure without interruption by the child awakening </h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0137"> <h6 class="title">Proportion of children who required a further dose of either the same sedative agent or the addition of a different sedative agent </h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0138"> <h6 class="title">Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) </h6> <p>Children receiving high‐dose oral chloral hydrate had a significantly shorter mean time to adequate sedation (in minutes) compared with those receiving low‐dose oral chloral hydrate (MD −7.00, 95% CI −7.62 to −6.38; 97 children) (<a href="./references#CD011786-fig-0052" title="">Analysis 9.1</a>). No studies assessed the outcome of adequate sedation with validated scales. </p> </section> </section> <section id="CD011786-sec-0139"> <h5 class="title">Secondary outcomes</h5> <section id="CD011786-sec-0140"> <h6 class="title">Proportion of children who had sedation failure or inadequate level of sedation</h6> <p>There was no significant difference in the proportion of children who had sedation failure between groups (RR 0.46, 95% CI 0.19 to 1.09; 97 children) (<a href="./references#CD011786-fig-0053" title="">Analysis 9.2</a>). </p> </section> <section id="CD011786-sec-0141"> <h6 class="title">Sedation duration</h6> <p>The duration of sedation was longer in the high‐dose oral chloral hydrate group by 8 minutes compared with the low‐dose oral chloral hydrate group (MD 8.00, 95% CI 5.81 to 10.19; 97 children) (<a href="./references#CD011786-fig-0054" title="">Analysis 9.3</a>). </p> </section> <section id="CD011786-sec-0142"> <h6 class="title">Yield of EEG or neuroimaging findings</h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0143"> <h6 class="title">Adverse effects (any)</h6> <p>There was no significant difference in adverse effects between groups (RR 1.06, 95% CI 0.49 to 2.32; 97 children) (<a href="./references#CD011786-fig-0055" title="">Analysis 9.4</a>). </p> </section> </section> </section> <section id="CD011786-sec-0144"> <h4 class="title">Comparison 10: Chloral hydrate high dose versus chloral hydrate low dose</h4> <p><a href="./references#CD011786-bbs2-0008" title="GumusH , BayramAK , PoyrazogluHG , CanpolatDG , PerH , CanpolatM , et al. Comparison of effects of different dexmedetomidine and chloral hydrate doses used in sedation on electroencephalography in pediatric patients. Journal of Child Neurology2015;30(8):983-8. [DOI: 10.1177/0883073814549582] [PMID: 25246305]">Gumus 2015</a> was the only study comparing high‐dose oral chloral hydrate (100 mg/kg) to low‐dose oral chloral hydrate (50 mg/kg). </p> <section id="CD011786-sec-0145"> <h5 class="title">Primary outcomes</h5> <section id="CD011786-sec-0146"> <h6 class="title">Proportion of children who successfully completed neurodiagnostic procedure without interruption by the child awakening </h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0147"> <h6 class="title">Proportion of children who required a further dose of either the same sedative agent or the addition of a different sedative agent </h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0148"> <h6 class="title">Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) </h6> <p>Children receiving high‐dose oral chloral hydrate had a significantly shorter time to adequate sedation (in minutes) compared with those receiving low‐dose oral chloral hydrate (MD −5.10, 95% CI −7.05 to −3.15; 76 children) (<a href="./references#CD011786-fig-0056" title="">Analysis 10.1</a>). No studies assessed the outcome of adequate sedation with validated scales. </p> </section> </section> <section id="CD011786-sec-0149"> <h5 class="title">Secondary outcomes</h5> <section id="CD011786-sec-0150"> <h6 class="title">Proportion of children who had sedation failure or inadequate level of sedation</h6> <p>Children receiving high‐dose oral chloral hydrate were significantly less likely to have sedation failure compared with those receiving low‐dose oral chloral hydrate (RR 0.23, 95% CI 0.05 to 0.99; 76 children) (<a href="./references#CD011786-fig-0057" title="">Analysis 10.2</a>). </p> </section> <section id="CD011786-sec-0151"> <h6 class="title">Sedation duration</h6> <p>The duration of sedation (in minutes) was significantly longer in the high‐dose oral chloral hydrate group compared with the low‐dose oral chloral hydrate group (MD 17.80, 95% CI 8.50 to 27.10; 76 children) (<a href="./references#CD011786-fig-0058" title="">Analysis 10.3</a>). </p> </section> <section id="CD011786-sec-0152"> <h6 class="title">Yield of EEG or neuroimaging findings</h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0153"> <h6 class="title">Adverse effects (any)</h6> <p>There was no significant difference in adverse effects between groups (RR 2.25, 95% CI 0.77 to 6.55; 76 children) (<a href="./references#CD011786-fig-0059" title="">Analysis 10.4</a>). </p> </section> </section> </section> <section id="CD011786-sec-0154"> <h4 class="title">Comparison 11: Chloral hydrate versus sodium thiopental</h4> <p><a href="./references#CD011786-bbs2-0004" title="AzizkhaniR , KananiS , SharifiA , GolshaniK , MasoumiB , AhmadiO . Oral chloral hydrate compare with rectal thiopental in pediatric procedural sedation and analgesia; a randomized clinical trial. Emergency (Tehran, Iran)2014;2(2):85-9. [PMID: 26495353]">Azizkhani 2014</a> was the only study comparing oral chloral hydrate (50 mg/kg) to rectal sodium thiopental (25 mg/kg). </p> <section id="CD011786-sec-0155"> <h5 class="title">Primary outcomes</h5> <section id="CD011786-sec-0156"> <h6 class="title">Proportion of children who successfully completed neurodiagnostic procedure without interruption by the child awakening </h6> <p>Children receiving sodium thiopental were significantly more likely to complete the neurodiagnostic procedure than those receiving chloral hydrate (RR 0.95, 95% CI 0.83 to 1.09; 140 children) (<a href="./references#CD011786-fig-0063" title="">Analysis 11.1</a>). </p> </section> <section id="CD011786-sec-0157"> <h6 class="title">Proportion of children who required a further dose of either the same sedative agent or the addition of a different sedative agent </h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0158"> <h6 class="title">Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) </h6> <p>Children receiving chloral hydrate had a significantly shorter time to adequate sedation (in minutes) as assessed by Ramsay Sedation Score &gt; 3 compared with those receiving sodium thiopental (MD −4.20, 95% CI −6.08 to −2.32; 140 children) (<a href="./references#CD011786-fig-0064" title="">Analysis 11.2</a>). </p> </section> </section> <section id="CD011786-sec-0159"> <h5 class="title">Secondary outcomes</h5> <section id="CD011786-sec-0160"> <h6 class="title">Proportion of children who had sedation failure or inadequate level of sedation</h6> <p>Children receiving sodium thiopental were significantly less likely to have sedation failure compared with those receiving chloral hydrate (RR 1.33, 95% CI 0.60 to 2.96; 140 children) (<a href="./references#CD011786-fig-0065" title="">Analysis 11.3</a>). </p> </section> <section id="CD011786-sec-0161"> <h6 class="title">Sedation duration</h6> <p>There was no significant difference between the two groups for the duration of sedation (in minutes) (MD −0.80, 95% CI −1.70 to 0.10; 140 children) (<a href="./references#CD011786-fig-0066" title="">Analysis 11.4</a>). </p> </section> <section id="CD011786-sec-0162"> <h6 class="title">Yield of EEG or neuroimaging findings</h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0163"> <h6 class="title">Adverse effects (desaturation, diarrhoea, mean diastolic blood pressure during procedure)</h6> <p>Children receiving sodium thiopental were significantly less likely to have desaturation compared with those receiving chloral hydrate (RR 5.00, 95% 0.24 to 102.30; 140 children) (<a href="./references#CD011786-fig-0067" title="">Analysis 11.5</a>). On the other hand, children receiving chloral hydrate were significantly less likely to have diarrhoea (RR 0.04, 95% CI 0.00 to 0.72; 140 children) or mean diastolic blood pressure during procedure (mmHg) (MD 7.40, 95% CI 5.11 to 9.69; 140 children) compared with those receiving sodium thiopental (<a href="./references#CD011786-fig-0068" title="">Analysis 11.6</a>; <a href="./references#CD011786-fig-0069" title="">Analysis 11.7</a>). </p> </section> </section> </section> <section id="CD011786-sec-0164"> <h4 class="title">Comparison 12: Chloral hydrate versus clonidine</h4> <p><a href="./references#CD011786-bbs2-0003" title="AshrafiMR , MohebbiH , MohamadiM , AziziE , ZamaniGR , TavasoliA , et al. Clonidine versus chloral hydrate for recording sleep EEG in children. Iranian Journal of Child Neurology2020;14(1):85-92. [PMID: 32021632]">Ashrafi 2020</a> was the only study comparing oral chloral hydrate (50 mg/kg) to oral clonidine (4 μg/kg). </p> <section id="CD011786-sec-0165"> <h5 class="title">Primary outcomes</h5> <section id="CD011786-sec-0166"> <h6 class="title">Proportion of children who successfully completed neurodiagnostic procedure without interruption by the child awakening </h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0167"> <h6 class="title">Proportion of children who required a further dose of either the same sedative agent or the addition of a different sedative agent </h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0168"> <h6 class="title">Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) </h6> <p>Children receiving chloral hydrate had a significantly shorter time to adequate sedation (in minutes) compared with those receiving clonidine (MD −37.48, 95% CI −55.97 to −18.99; 198 children) (<a href="./references#CD011786-fig-0070" title="">Analysis 12.1</a>). No studies assessed the outcome of adequate sedation with validated scales. </p> </section> </section> <section id="CD011786-sec-0169"> <h5 class="title">Secondary outcomes</h5> <section id="CD011786-sec-0170"> <h6 class="title">Proportion of children who had sedation failure or inadequate level of sedation</h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0171"> <h6 class="title">Sedation duration</h6> <p>There was no significant difference in the duration of sedation (in minutes) between chloral hydrate and clonidine (MD −6.07, 95% CI −15.32 to 3.18; 198 children) (<a href="./references#CD011786-fig-0071" title="">Analysis 12.2</a>). </p> </section> <section id="CD011786-sec-0172"> <h6 class="title">Yield of EEG or neuroimaging findings</h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0173"> <h6 class="title">Adverse effects (drowsiness, vertigo)</h6> <p>Children receiving chloral hydrate were statistically significantly less likely to have drowsiness (RR 0.44, 95% CI 0.30 to 0.64; 198 children) (<a href="./references#CD011786-fig-0072" title="">Analysis 12.3</a>) or vertigo (RR 0.15, 95% CI 0.01 to 2.79; 198 children) (<a href="./references#CD011786-fig-0073" title="">Analysis 12.4</a>) compared with those receiving clonidine. </p> </section> </section> </section> <section id="CD011786-sec-0174"> <h4 class="title">Comparison 13: Chloral hydrate versus dexmedetomidine</h4> <p><a href="./references#CD011786-bbs2-0016" title="YuenVM , LiBL , CheukDK , LeungMKM , HuiTWC , WongIC , et al. A randomised controlled trial of oral chloral hydrate vs. intranasal dexmedetomidine before computerised tomography in children. Anaesthesia2017;72(10):1191-5. [PMID: 28741653]">Yuen 2017a</a> was the only study comparing oral chloral hydrate (50 mg/kg) to intranasal dexmedetomidine (3 μg/kg). </p> <section id="CD011786-sec-0175"> <h5 class="title">Primary outcomes</h5> <section id="CD011786-sec-0176"> <h6 class="title">Proportion of children who successfully completed neurodiagnostic procedure without interruption by the child awakening </h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0177"> <h6 class="title">Proportion of children who required a further dose of either the same sedative agent or the addition of a different sedative agent </h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0178"> <h6 class="title">Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) </h6> <p>Children receiving dexmedetomidine had a significantly shorter time to adequate sedation (in minutes) based on the 'somnolent' component of the University of Michigan Sedation Scale compared with those receiving chloral hydrate (MD 2.80, 95% CI 0.77 to 4.83; 194 children) (<a href="./references#CD011786-fig-0074" title="">Analysis 13.1</a>). </p> </section> </section> <section id="CD011786-sec-0179"> <h5 class="title">Secondary outcomes</h5> <section id="CD011786-sec-0180"> <h6 class="title">Proportion of children who had sedation failure or inadequate level of sedation</h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0181"> <h6 class="title">Sedation duration</h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0182"> <h6 class="title">Yield of EEG or neuroimaging findings</h6> <p>No studies assessed this outcome.</p> </section> <section id="CD011786-sec-0183"> <h6 class="title">Adverse effects (bradycardia, unsteadiness, crying during administration of sedation, vomiting) </h6> <p>Children receiving chloral hydrate were less likely to have bradycardia compared with those receiving dexmedetomidine (MD 0.17, 95% CI 0.05 to 0.59; 194 children) (<a href="./references#CD011786-fig-0075" title="">Analysis 13.2</a>). Compared with those receiving chloral hydrate, children receiving dexmedetomidine were less likely to experience the following adverse effects: unsteadiness within 24 hours after discharge (MD 10.21, 95% CI 0.58 to 178.52; 194 children) (<a href="./references#CD011786-fig-0076" title="">Analysis 13.3</a>); crying during administration of sedation (MD 1.39, 95% CI 1.08 to 1.80; 194 children) (<a href="./references#CD011786-fig-0077" title="">Analysis 13.4</a>); or vomiting (MD 10.59, 95% CI 0.61 to 185.45; 194 children) (<a href="./references#CD011786-fig-0078" title="">Analysis 13.5</a>). </p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD011786-sec-0184" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD011786-sec-0184"></div> <section id="CD011786-sec-0185"> <h3 class="title" id="CD011786-sec-0185">Summary of main results</h3> <p>Apart from oral chloral hydrate, this review identified a variety of sedation agents used for neurodiagnostic procedures, of which the majority were given in an oral preparation (dexmedetomidine, midazolam, melatonin, hydroxyzine hydrochloride, promethazine, and clonidine). Five studies used non‐oral preparation (intranasal midazolam, intranasal dexmedetomidine, rectal midazolam, rectal sodium thiopental, or intravenous pentobarbital), and one study used a non‐drug therapy (music therapy). Despite a wide variety of agents used, each sedation agent was represented by a very small number of studies, and all were only evaluated by a single study. Our review also identified paediatric participants undergoing neurodiagnostic procedures from all age groups, ranging from birth to 18 years old. </p> <p>For the primary outcome measure of time to adequate sedation, the efficacy of oral chloral hydrate when compared with other sedative agents was mixed. Six studies showed that oral chloral hydrate had a shorter time to achieve adequate sedation when compared with oral dexmedetomidine, oral hydroxyzine hydrochloride, oral promethazine, oral clonidine, rectal midazolam, or rectal sodium thiopental. On the other hand, another three studies showed that chloral hydrate took a longer time to achieve adequate sedation when compared with intravenous pentobarbital, intranasal midazolam, or intranasal dexmedetomidine. Children had a shorter time to achieve adequate sedation with a higher dose of oral chloral hydrate compared to a lower dose. </p> <p>For the primary outcome measure of successfully completing neurodiagnostic procedure without the child awaking, one study showed that rectal sodium thiopental appeared be more successful than oral chloral hydrate in completing the procedure. No other studies assessed this outcome measure. </p> <p>For the secondary outcome of proportion of children who had sedation failure or inadequate level of sedation, oral chloral hydrate appeared to have lower sedation failure when compared with oral promethazine. Chloral hydrate had more sedation failure after one dose compared with intravenous pentobarbital, but there was no difference between groups after two doses. Another two studies showed that chloral hydrate appeared to have more sedation failure compared with music therapy and rectal sodium thiopental. Sedation failure rates appeared to be similar between oral chloral hydrate and oral dexmedetomidine, oral midazolam, and oral hydroxyzine hydrochloride. Two comparative oral chloral hydrate dosing studies showed oral chloral hydrate 100 mg/kg to have lower sedation failure than oral chloral hydrate 50 mg/kg, and no difference between groups when compared with oral chloral hydrate 70 mg/kg. Most analyses were underpowered with insufficient evidence to enable any clear conclusions. </p> <p>For the secondary outcome of sedation duration, oral chloral hydrate achieved a longer duration of sedation when compared with oral hydroxyzine hydrochloride and music therapy. Three studies found no difference in duration of sedation between oral chloral hydrate and oral midazolam, oral clonidine, and rectal sodium thiopental. Another study showed oral chloral hydrate to have a shorter duration of sedation when compared with oral dexmedetomidine. A higher dose of oral chloral hydrate appeared to achieve longer sedation duration than a lower dose. </p> <p>Five studies assessed the secondary outcome measure of sedative effect on yield of neurodiagnostic procedure (four studies evaluated yield of EEG procedure, and one study evaluated yield of neuroimaging procedure). Two of the four EEG studies showed oral chloral hydrate to have less sedative EEG artefact when compared with intranasal midazolam or oral melatonin. The other two studies showed no difference in sedative artefact on EEG when compared with oral hydroxyzine hydrochloride or rectal midazolam. In the single study evaluating yield of neuroimaging procedure, no difference was seen between oral chloral hydrate and intravenous pentobarbital. </p> <p>Eleven studies assessed the secondary outcome measure of adverse effects of sedation. Seven of these studies showed no difference between groups in adverse effects. One study found that children receiving oral chloral hydrate had a higher total number of adverse effects compared to those receiving oral dexmedetomidine. One study showed mixed adverse effects between children receiving oral chloral hydrate compared to those receiving rectal sodium thiopental, with a higher total number of desaturation seen amongst children receiving oral chloral hydrate, and a higher total number of diarrhoea and hypotension amongst children receiving rectal sodium thiopental. Another study also showed mixed adverse effects between children receiving oral chloral hydrate compared to those receiving intranasal dexmedetomidine, with a higher total number of bradycardia seen amongst children receiving intranasal dexmedetomidine, and a higher total number of unsteadiness within 24 hours postdischarge, vomiting, or crying during sedation procedure seen amongst children receiving oral chloral hydrate. The remaining study showed children receiving oral clonidine to have a higher total number of drowsiness and vertigo compared to those receiving oral chloral hydrate. </p> </section> <section id="CD011786-sec-0186"> <h3 class="title" id="CD011786-sec-0186">Overall completeness and applicability of evidence</h3> <p>We identified 16 studies that matched our inclusion criteria in terms of population, sedation intervention, comparison, and outcomes. A total of 2922 children (age range from birth to 18 years old) were assessed. The studies were conducted in Asia, Europe, and the USA, from 1982 to 2020. The included studies were performed in hospitals that provided neurodiagnostic services. Most of the agents evaluated in comparison with oral chloral hydrate were those commonly used in practice, and the doses of oral chloral hydrate evaluated were commonly used doses. However, there are certain limitations in the completeness of this review. For example, some of our key prespecified outcomes were not assessed in most of the included studies, such as proportion of children who successfully completed neurodiagnostic procedure without interruption by the child awakening and proportion of children who required a further dose of either the same sedative agent or the addition of a different sedative agent. </p> </section> <section id="CD011786-sec-0187"> <h3 class="title" id="CD011786-sec-0187">Quality of the evidence</h3> <p>The evidence for the majority of the outcomes assessed was overall of very low to moderate certainty, due to the small number of studies included in each comparison and variable risk of bias of the included studies. The strongest evidence came from studies that compared oral chloral hydrate with either intranasal midazolam, oral midazolam (<a href="./references#CD011786-bbs2-0006" title="D'AgostinoJ , TerndrupTE . Chloral hydrate versus midazolam for sedation of children for neuroimaging: a randomized clinical trial. Pediatric Emergency Care2000;16(1):1-4. [PMID: 10698133]">D'Agostino 2000</a>; <a href="./references#CD011786-bbs2-0007" title="FallahR , NakhaeiMH , BehdadS , MoghaddamRN , ShamszadehA . Oral chloral hydrate vs. intranasal midazolam for sedation during computerized tomography. Indian Pediatrics2013;50(2):233-5. [PMID: 23024102]">Fallah 2013</a>), or oral promethazine (<a href="./references#CD011786-bbs2-0013" title="RaziehF , SharamJ , MotahharehG , SedighahAK , Mohammad-HoseinJ . Efficacy of chloral hydrate and promethazine for sedation during electroencephalography in children: a randomised clinical trial. Iranian Journal of Pediatrics2013;23(1):27-31. [PMID: 23550099]">Razieh 2013</a>), for which there were three studies. However, all the comparisons in this review involved small numbers of trials and participants, which in most cases translated to imprecision that required downgrading of the certainty of the evidence. Also, in the case of statistically significant difference, an analysis with a small number of trials lessens the reliability of the results due to concerns about the effects of small studies exacerbating the impact of biases (<a href="./references#CD011786-bbs2-0101" title="SterneJAC , EggerM , Moher D on behalf of the Cochrane Bias Methods Group. Chapter 10: Addressing reporting biases. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Sterne 2011</a>). A second major limitation in the quality of evidence gathered was related to performance bias, for which eight studies had high risk and four had unclear risk. In studies at high risk of performance bias or detection bias, lack of blinding of participants or assessors, or both, makes it highly likely that the outcome results were influenced, thus affecting the quality of evidence. Overall, the body of evidence gathered in this review did not allow us to draw a robust conclusion regarding the effectiveness of chloral hydrate as a sedating agent for neurodiagnostic procedures in children. </p> </section> <section id="CD011786-sec-0188"> <h3 class="title" id="CD011786-sec-0188">Potential biases in the review process</h3> <p>We performed a comprehensive search of multiple databases with independent screening, selection, and assessment of identified studies. However, we were unable to obtain all relevant data, as one study is still awaiting assessment despite our contacting the author via email. We excluded some RCTs on the basis of wrong type of outcome measure whereby these studies did not have a direct comparison with another sedative agent. These studies assessed the efficacy of chloral hydrate with other second‐line sedative agents after failure of first‐line chloral hydrate sedation. In addition, the primary outcome measure of efficacy of chloral hydrate was made by assessing adequacy of sedation, proportion of sedation failure, and sedation duration as a whole. We did not differentiate efficacy of chloral hydrate according to EEG or neuroimaging procedure. Our failure to adjust for type of neurodiagnostic procedure may also have affected the summary of the results. </p> </section> <section id="CD011786-sec-0189"> <h3 class="title" id="CD011786-sec-0189">Agreements and disagreements with other studies or reviews</h3> <p>There are three reviews on this topic. Meyer and colleagues 2007 is a narrative review discussing the current status of sedation for brief diagnostic procedures in children (<a href="./references#CD011786-bbs2-0089" title="MeyerS , GrundmannU , GottschlingS , KleinschmidtS , GortnerL . Sedation and analgesia for brief diagnostic and therapeutic procedures in children. European Journal of Pediatrics2007;166:291-302.">Meyer 2007</a>). Mace and colleagues 2008 is a systematic review of the literature between 1976 to 2006 to develop a clinical policy of effective and safe medications for providing procedural sedation in the emergency department (<a href="./references#CD011786-bbs2-0087" title="MaceSE , BrownLA , FrancisL , GodwinSA , HahnSA , HowardPK , et al, EMSC Panel (Writing Committee) on Critical Issues in the Sedation of Pediatric Patients in the Emergency. Clinical policy: critical issues in the sedation of pediatric patients in the emergency department. Annals of Emergency Medicine2008;51(4):378-99. [PMID: 18359378]">Mace 2008</a>). <a href="./references#CD011786-bbs2-0090" title="National Institute for Health and Care Excellence. Sedation in under 19s: using sedation for diagnostic and therapeutic procedures. National Institute for Health and Care Excellence Clinical Guideline (CG 112) 15 December 2010. [https://www.nice.org.uk/guidance/cg112]">NICE 2010</a> is a systematic review of the literature between 1950 to 2010 to develop a clinical guideline offering evidence‐based advice on the care and treatment of children and young people having sedation for therapeutic or diagnostic procedures (<a href="./references#CD011786-bbs2-0090" title="National Institute for Health and Care Excellence. Sedation in under 19s: using sedation for diagnostic and therapeutic procedures. National Institute for Health and Care Excellence Clinical Guideline (CG 112) 15 December 2010. [https://www.nice.org.uk/guidance/cg112]">NICE 2010</a>). </p> <p>The findings of our review are broadly in line with the conclusions of these other reviews, which state that oral chloral hydrate is one of the preferred sedative drugs for non‐invasive procedural studies in children with a wide margin of safety (<a href="./references#CD011786-bbs2-0087" title="MaceSE , BrownLA , FrancisL , GodwinSA , HahnSA , HowardPK , et al, EMSC Panel (Writing Committee) on Critical Issues in the Sedation of Pediatric Patients in the Emergency. Clinical policy: critical issues in the sedation of pediatric patients in the emergency department. Annals of Emergency Medicine2008;51(4):378-99. [PMID: 18359378]">Mace 2008</a>; <a href="./references#CD011786-bbs2-0089" title="MeyerS , GrundmannU , GottschlingS , KleinschmidtS , GortnerL . Sedation and analgesia for brief diagnostic and therapeutic procedures in children. European Journal of Pediatrics2007;166:291-302.">Meyer 2007</a>; <a href="./references#CD011786-bbs2-0090" title="National Institute for Health and Care Excellence. Sedation in under 19s: using sedation for diagnostic and therapeutic procedures. National Institute for Health and Care Excellence Clinical Guideline (CG 112) 15 December 2010. [https://www.nice.org.uk/guidance/cg112]">NICE 2010</a>), with a dosing of 50 to 100 mg/kg (<a href="./references#CD011786-bbs2-0087" title="MaceSE , BrownLA , FrancisL , GodwinSA , HahnSA , HowardPK , et al, EMSC Panel (Writing Committee) on Critical Issues in the Sedation of Pediatric Patients in the Emergency. Clinical policy: critical issues in the sedation of pediatric patients in the emergency department. Annals of Emergency Medicine2008;51(4):378-99. [PMID: 18359378]">Mace 2008</a>). Based on the two comparative oral chloral hydrate studies (<a href="./references#CD011786-bbs2-0008" title="GumusH , BayramAK , PoyrazogluHG , CanpolatDG , PerH , CanpolatM , et al. Comparison of effects of different dexmedetomidine and chloral hydrate doses used in sedation on electroencephalography in pediatric patients. Journal of Child Neurology2015;30(8):983-8. [DOI: 10.1177/0883073814549582] [PMID: 25246305]">Gumus 2015</a>; <a href="./references#CD011786-bbs2-0012" title="Marti-BonmatiL , Ronchera-OmsCL , CasillasC , PoyatosC , TorrijoC , JimenezNV . Randomised double-blind clinical trial of intermediate- versus high-dose chloral hydrate for neuroimaging of children. Neuroradiology1995;37(8):687-91. [PMID: 8748907]">Marti‐Bonmati 1995</a>), chloral hydrate of 100 mg/kg or 70 mg/kg appeared to be more effective than chloral hydrate 50 mg/kg. Our review differed from the conclusion of previous reviews that oral chloral hydrate should only be considered in young children either under 3 years old (<a href="./references#CD011786-bbs2-0089" title="MeyerS , GrundmannU , GottschlingS , KleinschmidtS , GortnerL . Sedation and analgesia for brief diagnostic and therapeutic procedures in children. European Journal of Pediatrics2007;166:291-302.">Meyer 2007</a>), under 15 kg (<a href="./references#CD011786-bbs2-0090" title="National Institute for Health and Care Excellence. Sedation in under 19s: using sedation for diagnostic and therapeutic procedures. National Institute for Health and Care Excellence Clinical Guideline (CG 112) 15 December 2010. [https://www.nice.org.uk/guidance/cg112]">NICE 2010</a>), or under 2 years old (<a href="./references#CD011786-bbs2-0087" title="MaceSE , BrownLA , FrancisL , GodwinSA , HahnSA , HowardPK , et al, EMSC Panel (Writing Committee) on Critical Issues in the Sedation of Pediatric Patients in the Emergency. Clinical policy: critical issues in the sedation of pediatric patients in the emergency department. Annals of Emergency Medicine2008;51(4):378-99. [PMID: 18359378]">Mace 2008</a>), with one review stating that this was due to reduced efficacy in older children (<a href="./references#CD011786-bbs2-0087" title="MaceSE , BrownLA , FrancisL , GodwinSA , HahnSA , HowardPK , et al, EMSC Panel (Writing Committee) on Critical Issues in the Sedation of Pediatric Patients in the Emergency. Clinical policy: critical issues in the sedation of pediatric patients in the emergency department. Annals of Emergency Medicine2008;51(4):378-99. [PMID: 18359378]">Mace 2008</a>). However, the number of paediatric chloral hydrate RCTs prior to 2010 when these three reviews were written was limited; since 2010 there have been 10 paediatric chloral hydrate RCTs. The majority of chloral hydrate RCTs included the whole range of paediatric age group, up to 14 years old, and not just confined to children under 3 years of age (<a href="./references#CD011786-bbs2-0002" title="AshrafiMR , Azizi MalamiriR , ZamaniGR , MohammadiM , HosseiniF . Sleep inducing for EEG recording in children: a comparison between oral midazolam and chloral hydrate. Iranian Journal of Child Neurology2013;7(1):15-9. [PMID: 24665284]">Ashrafi 2013</a>; <a href="./references#CD011786-bbs2-0003" title="AshrafiMR , MohebbiH , MohamadiM , AziziE , ZamaniGR , TavasoliA , et al. Clonidine versus chloral hydrate for recording sleep EEG in children. Iranian Journal of Child Neurology2020;14(1):85-92. [PMID: 32021632]">Ashrafi 2020</a>; <a href="./references#CD011786-bbs2-0004" title="AzizkhaniR , KananiS , SharifiA , GolshaniK , MasoumiB , AhmadiO . Oral chloral hydrate compare with rectal thiopental in pediatric procedural sedation and analgesia; a randomized clinical trial. Emergency (Tehran, Iran)2014;2(2):85-9. [PMID: 26495353]">Azizkhani 2014</a>; <a href="./references#CD011786-bbs2-0005" title="BektasO , AricaB , TeberS , YilmazA , ZeybekH , KaymakS , et al. Chloral hydrate and/or hydroxyzine for sedation in pediatric EEG recording. Brain &amp; Development2014;36(2):130-6. [DOI: 10.1016/j.braindev.2013.03.002] [PMID: 23582501]">Bektas 2014</a>; <a href="./references#CD011786-bbs2-0006" title="D'AgostinoJ , TerndrupTE . Chloral hydrate versus midazolam for sedation of children for neuroimaging: a randomized clinical trial. Pediatric Emergency Care2000;16(1):1-4. [PMID: 10698133]">D'Agostino 2000</a>; <a href="./references#CD011786-bbs2-0007" title="FallahR , NakhaeiMH , BehdadS , MoghaddamRN , ShamszadehA . Oral chloral hydrate vs. intranasal midazolam for sedation during computerized tomography. Indian Pediatrics2013;50(2):233-5. [PMID: 23024102]">Fallah 2013</a>; <a href="./references#CD011786-bbs2-0008" title="GumusH , BayramAK , PoyrazogluHG , CanpolatDG , PerH , CanpolatM , et al. Comparison of effects of different dexmedetomidine and chloral hydrate doses used in sedation on electroencephalography in pediatric patients. Journal of Child Neurology2015;30(8):983-8. [DOI: 10.1177/0883073814549582] [PMID: 25246305]">Gumus 2015</a>; <a href="./references#CD011786-bbs2-0011" title="MalviyaS , Voepel-LewisT , TaitAR , ReynoldsPI , GujarSK , GebarskiSS , et al. Pentobarbital vs chloral hydrate for sedation of children undergoing MRI: efficacy and recovery characteristics. Paediatric Anaesthesia2004;14(7):589-95. [PMID: 15200658]">Malviya 2004</a>; <a href="./references#CD011786-bbs2-0013" title="RaziehF , SharamJ , MotahharehG , SedighahAK , Mohammad-HoseinJ . Efficacy of chloral hydrate and promethazine for sedation during electroencephalography in children: a randomised clinical trial. Iranian Journal of Pediatrics2013;23(1):27-31. [PMID: 23550099]">Razieh 2013</a>; <a href="./references#CD011786-bbs2-0014" title="SezerT , AlehanF . Chloral hydrate versus hydroxyzine HCL for sedation prior to pediatric sleep EEG recording. International Journal of Neuroscience2013;123(10):719-23. [DOI: 10.3109/00207454.2013.796310] [PMID: 23594140]">Sezer 2013</a>). Apart from <a href="./references#CD011786-bbs2-0011" title="MalviyaS , Voepel-LewisT , TaitAR , ReynoldsPI , GujarSK , GebarskiSS , et al. Pentobarbital vs chloral hydrate for sedation of children undergoing MRI: efficacy and recovery characteristics. Paediatric Anaesthesia2004;14(7):589-95. [PMID: 15200658]">Malviya 2004</a> and <a href="./references#CD011786-bbs2-0004" title="AzizkhaniR , KananiS , SharifiA , GolshaniK , MasoumiB , AhmadiO . Oral chloral hydrate compare with rectal thiopental in pediatric procedural sedation and analgesia; a randomized clinical trial. Emergency (Tehran, Iran)2014;2(2):85-9. [PMID: 26495353]">Azizkhani 2014</a>, all of the studies that included older children showed oral chloral hydrate to be just as effective as or more effective than the comparator sedative agent (<a href="./references#CD011786-bbs2-0002" title="AshrafiMR , Azizi MalamiriR , ZamaniGR , MohammadiM , HosseiniF . Sleep inducing for EEG recording in children: a comparison between oral midazolam and chloral hydrate. Iranian Journal of Child Neurology2013;7(1):15-9. [PMID: 24665284]">Ashrafi 2013</a>; <a href="./references#CD011786-bbs2-0003" title="AshrafiMR , MohebbiH , MohamadiM , AziziE , ZamaniGR , TavasoliA , et al. Clonidine versus chloral hydrate for recording sleep EEG in children. Iranian Journal of Child Neurology2020;14(1):85-92. [PMID: 32021632]">Ashrafi 2020</a>; <a href="./references#CD011786-bbs2-0005" title="BektasO , AricaB , TeberS , YilmazA , ZeybekH , KaymakS , et al. Chloral hydrate and/or hydroxyzine for sedation in pediatric EEG recording. Brain &amp; Development2014;36(2):130-6. [DOI: 10.1016/j.braindev.2013.03.002] [PMID: 23582501]">Bektas 2014</a>; <a href="./references#CD011786-bbs2-0006" title="D'AgostinoJ , TerndrupTE . Chloral hydrate versus midazolam for sedation of children for neuroimaging: a randomized clinical trial. Pediatric Emergency Care2000;16(1):1-4. [PMID: 10698133]">D'Agostino 2000</a>; <a href="./references#CD011786-bbs2-0007" title="FallahR , NakhaeiMH , BehdadS , MoghaddamRN , ShamszadehA . Oral chloral hydrate vs. intranasal midazolam for sedation during computerized tomography. Indian Pediatrics2013;50(2):233-5. [PMID: 23024102]">Fallah 2013</a>; <a href="./references#CD011786-bbs2-0008" title="GumusH , BayramAK , PoyrazogluHG , CanpolatDG , PerH , CanpolatM , et al. Comparison of effects of different dexmedetomidine and chloral hydrate doses used in sedation on electroencephalography in pediatric patients. Journal of Child Neurology2015;30(8):983-8. [DOI: 10.1177/0883073814549582] [PMID: 25246305]">Gumus 2015</a>; <a href="./references#CD011786-bbs2-0013" title="RaziehF , SharamJ , MotahharehG , SedighahAK , Mohammad-HoseinJ . Efficacy of chloral hydrate and promethazine for sedation during electroencephalography in children: a randomised clinical trial. Iranian Journal of Pediatrics2013;23(1):27-31. [PMID: 23550099]">Razieh 2013</a>; <a href="./references#CD011786-bbs2-0014" title="SezerT , AlehanF . Chloral hydrate versus hydroxyzine HCL for sedation prior to pediatric sleep EEG recording. International Journal of Neuroscience2013;123(10):719-23. [DOI: 10.3109/00207454.2013.796310] [PMID: 23594140]">Sezer 2013</a>). Apart from <a href="./references#CD011786-bbs2-0004" title="AzizkhaniR , KananiS , SharifiA , GolshaniK , MasoumiB , AhmadiO . Oral chloral hydrate compare with rectal thiopental in pediatric procedural sedation and analgesia; a randomized clinical trial. Emergency (Tehran, Iran)2014;2(2):85-9. [PMID: 26495353]">Azizkhani 2014</a> and <a href="./references#CD011786-bbs2-0067" title="YuenCL , CherkWW , FungTH , HoCS , ChanKK , YuYW . Melatonin versus chloral hydrate as the sedating agent in performing electroencephalogram in paediatric patients. International Journal of Epilepsy2017;4:51-4. ">Yuen 2017b</a>, no other studies showed oral chloral hydrate to have a higher rate of adverse effects. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD011786-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD011786-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/full#CD011786-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011786-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/full#CD011786-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011786-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/full#CD011786-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Chloral hydrate oral (50 mg/kg or 100 mg/kg) versus dexmedetomidine oral (2 µg/kg or 3 µg/kg), Outcome 1: EEG time onset for adequate sedation (minutes)" data-id="CD011786-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Chloral hydrate oral (50 mg/kg or 100 mg/kg) versus dexmedetomidine oral (2 µg/kg or 3 µg/kg), Outcome 1: EEG time onset for adequate sedation (minutes) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Chloral hydrate oral (50 mg/kg or 100 mg/kg) versus dexmedetomidine oral (2 µg/kg or 3 µg/kg), Outcome 2: EEG sedation failure" data-id="CD011786-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Chloral hydrate oral (50 mg/kg or 100 mg/kg) versus dexmedetomidine oral (2 µg/kg or 3 µg/kg), Outcome 2: EEG sedation failure </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Chloral hydrate oral (50 mg/kg or 100 mg/kg) versus dexmedetomidine oral (2 µg/kg or 3 µg/kg), Outcome 3: EEG sedation / sleep duration (minutes)" data-id="CD011786-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Chloral hydrate oral (50 mg/kg or 100 mg/kg) versus dexmedetomidine oral (2 µg/kg or 3 µg/kg), Outcome 3: EEG sedation / sleep duration (minutes) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Chloral hydrate oral (50 mg/kg or 100 mg/kg) versus dexmedetomidine oral (2 µg/kg or 3 µg/kg), Outcome 4: EEG sedation adverse event: total" data-id="CD011786-fig-0007" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Chloral hydrate oral (50 mg/kg or 100 mg/kg) versus dexmedetomidine oral (2 µg/kg or 3 µg/kg), Outcome 4: EEG sedation adverse event: total </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Chloral hydrate oral (50 mg/kg or 100 mg/kg) versus dexmedetomidine oral (2 µg/kg or 3 µg/kg), Outcome 5: EEG sedation adverse event: hypotension" data-id="CD011786-fig-0008" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Chloral hydrate oral (50 mg/kg or 100 mg/kg) versus dexmedetomidine oral (2 µg/kg or 3 µg/kg), Outcome 5: EEG sedation adverse event: hypotension </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Chloral hydrate oral (50 mg/kg or 100 mg/kg) versus dexmedetomidine oral (2 µg/kg or 3 µg/kg), Outcome 6: EEG sedation adverse event: bradycardia" data-id="CD011786-fig-0009" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Chloral hydrate oral (50 mg/kg or 100 mg/kg) versus dexmedetomidine oral (2 µg/kg or 3 µg/kg), Outcome 6: EEG sedation adverse event: bradycardia </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Chloral hydrate oral (50 mg/kg or 100 mg/kg) versus dexmedetomidine oral (2 µg/kg or 3 µg/kg), Outcome 7: EEG sedation adverse event: behavioural change" data-id="CD011786-fig-0010" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: Chloral hydrate oral (50 mg/kg or 100 mg/kg) versus dexmedetomidine oral (2 µg/kg or 3 µg/kg), Outcome 7: EEG sedation adverse event: behavioural change </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Chloral hydrate oral (50 mg/kg or 100 mg/kg) versus dexmedetomidine oral (2 µg/kg or 3 µg/kg), Outcome 8: EEG sedation adverse event: nausea or vomiting" data-id="CD011786-fig-0011" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: Chloral hydrate oral (50 mg/kg or 100 mg/kg) versus dexmedetomidine oral (2 µg/kg or 3 µg/kg), Outcome 8: EEG sedation adverse event: nausea or vomiting </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-001.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Chloral hydrate oral (50 mg/kg or 100 mg/kg) versus dexmedetomidine oral (2 µg/kg or 3 µg/kg), Outcome 9: EEG sedation adverse event: oxygen desaturation" data-id="CD011786-fig-0012" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-001.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-001.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1: Chloral hydrate oral (50 mg/kg or 100 mg/kg) versus dexmedetomidine oral (2 µg/kg or 3 µg/kg), Outcome 9: EEG sedation adverse event: oxygen desaturation </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-001.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Chloral hydrate oral (75 mg/kg) versus pentobarbital intravenous (5 mg/kg), Outcome 1: Neuroimaging time onset for adequate sedation (minutes)" data-id="CD011786-fig-0013" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Chloral hydrate oral (75 mg/kg) versus pentobarbital intravenous (5 mg/kg), Outcome 1: Neuroimaging time onset for adequate sedation (minutes) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Chloral hydrate oral (75 mg/kg) versus pentobarbital intravenous (5 mg/kg), Outcome 2: Neuroimaging sedation failure after 2 administrations of sedative agent (same or different)" data-id="CD011786-fig-0014" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Chloral hydrate oral (75 mg/kg) versus pentobarbital intravenous (5 mg/kg), Outcome 2: Neuroimaging sedation failure after 2 administrations of sedative agent (same or different) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Chloral hydrate oral (75 mg/kg) versus pentobarbital intravenous (5 mg/kg), Outcome 3: Neuroimaging sedation failure after 1 administration of sedative agent" data-id="CD011786-fig-0015" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Chloral hydrate oral (75 mg/kg) versus pentobarbital intravenous (5 mg/kg), Outcome 3: Neuroimaging sedation failure after 1 administration of sedative agent </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Chloral hydrate oral (75 mg/kg) versus pentobarbital intravenous (5 mg/kg), Outcome 4: Neuroimaging uninterpretable" data-id="CD011786-fig-0016" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: Chloral hydrate oral (75 mg/kg) versus pentobarbital intravenous (5 mg/kg), Outcome 4: Neuroimaging uninterpretable </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Chloral hydrate oral (75 mg/kg) versus pentobarbital intravenous (5 mg/kg), Outcome 5: Neuroimaging sedation adverse event: oxygen desaturation" data-id="CD011786-fig-0017" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: Chloral hydrate oral (75 mg/kg) versus pentobarbital intravenous (5 mg/kg), Outcome 5: Neuroimaging sedation adverse event: oxygen desaturation </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-002.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Chloral hydrate oral (75 mg/kg) versus pentobarbital intravenous (5 mg/kg), Outcome 6: Neuroimaging sedation adverse event: nausea or vomiting" data-id="CD011786-fig-0018" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-002.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-002.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2: Chloral hydrate oral (75 mg/kg) versus pentobarbital intravenous (5 mg/kg), Outcome 6: Neuroimaging sedation adverse event: nausea or vomiting </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-002.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-002.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Chloral hydrate oral (75 mg/kg) versus pentobarbital intravenous (5 mg/kg), Outcome 7: Neuroimaging sedation adverse event: paradoxical reaction" data-id="CD011786-fig-0019" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-002.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-002.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2: Chloral hydrate oral (75 mg/kg) versus pentobarbital intravenous (5 mg/kg), Outcome 7: Neuroimaging sedation adverse event: paradoxical reaction </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-002.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-002.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Chloral hydrate oral (75 mg/kg) versus pentobarbital intravenous (5 mg/kg), Outcome 8: Neuroimaging sedation adverse event: return to baseline activity postdischarge" data-id="CD011786-fig-0020" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-002.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-002.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2: Chloral hydrate oral (75 mg/kg) versus pentobarbital intravenous (5 mg/kg), Outcome 8: Neuroimaging sedation adverse event: return to baseline activity postdischarge </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-002.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Chloral hydrate oral (100 mg/kg or 75 mg/kg) versus midazolam (intranasal 0.2 mg/kg or oral 0.5 mg/kg), Outcome 1: Neuroimaging time onset for adequate sedation (minutes)" data-id="CD011786-fig-0021" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: Chloral hydrate oral (100 mg/kg or 75 mg/kg) versus midazolam (intranasal 0.2 mg/kg or oral 0.5 mg/kg), Outcome 1: Neuroimaging time onset for adequate sedation (minutes) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Chloral hydrate oral (100 mg/kg or 75 mg/kg) versus midazolam (intranasal 0.2 mg/kg or oral 0.5 mg/kg), Outcome 2: Neuroimaging inadequate level of sedation achieved (Ramsay score 4)" data-id="CD011786-fig-0022" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: Chloral hydrate oral (100 mg/kg or 75 mg/kg) versus midazolam (intranasal 0.2 mg/kg or oral 0.5 mg/kg), Outcome 2: Neuroimaging inadequate level of sedation achieved (Ramsay score 4) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Chloral hydrate oral (100 mg/kg or 75 mg/kg) versus midazolam (intranasal 0.2 mg/kg or oral 0.5 mg/kg), Outcome 3: Neuroimaging sedation failure after 1 administration of sedative agent" data-id="CD011786-fig-0023" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: Chloral hydrate oral (100 mg/kg or 75 mg/kg) versus midazolam (intranasal 0.2 mg/kg or oral 0.5 mg/kg), Outcome 3: Neuroimaging sedation failure after 1 administration of sedative agent </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-003.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Chloral hydrate oral (100 mg/kg or 75 mg/kg) versus midazolam (intranasal 0.2 mg/kg or oral 0.5 mg/kg), Outcome 4: Neuroimaging sedation / sleep duration (minutes)" data-id="CD011786-fig-0024" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-003.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-003.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3: Chloral hydrate oral (100 mg/kg or 75 mg/kg) versus midazolam (intranasal 0.2 mg/kg or oral 0.5 mg/kg), Outcome 4: Neuroimaging sedation / sleep duration (minutes) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-003.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-003.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Chloral hydrate oral (100 mg/kg or 75 mg/kg) versus midazolam (intranasal 0.2 mg/kg or oral 0.5 mg/kg), Outcome 5: EEG sedative‐induced artefact" data-id="CD011786-fig-0025" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-003.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-003.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3: Chloral hydrate oral (100 mg/kg or 75 mg/kg) versus midazolam (intranasal 0.2 mg/kg or oral 0.5 mg/kg), Outcome 5: EEG sedative‐induced artefact </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-003.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-003.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Chloral hydrate oral (100 mg/kg or 75 mg/kg) versus midazolam (intranasal 0.2 mg/kg or oral 0.5 mg/kg), Outcome 6: EEG sedation adverse event: total" data-id="CD011786-fig-0026" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-003.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-003.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3: Chloral hydrate oral (100 mg/kg or 75 mg/kg) versus midazolam (intranasal 0.2 mg/kg or oral 0.5 mg/kg), Outcome 6: EEG sedation adverse event: total </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-003.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-003.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Chloral hydrate oral (100 mg/kg or 75 mg/kg) versus midazolam (intranasal 0.2 mg/kg or oral 0.5 mg/kg), Outcome 7: Neuroimaging adverse event: behavioural change" data-id="CD011786-fig-0027" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-003.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-003.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3: Chloral hydrate oral (100 mg/kg or 75 mg/kg) versus midazolam (intranasal 0.2 mg/kg or oral 0.5 mg/kg), Outcome 7: Neuroimaging adverse event: behavioural change </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-003.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-003.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Chloral hydrate oral (100 mg/kg or 75 mg/kg) versus midazolam (intranasal 0.2 mg/kg or oral 0.5 mg/kg), Outcome 8: Neuroimaging adverse event: vomiting" data-id="CD011786-fig-0028" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-003.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-003.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3: Chloral hydrate oral (100 mg/kg or 75 mg/kg) versus midazolam (intranasal 0.2 mg/kg or oral 0.5 mg/kg), Outcome 8: Neuroimaging adverse event: vomiting </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-003.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-003.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Chloral hydrate oral (100 mg/kg or 75 mg/kg) versus midazolam (intranasal 0.2 mg/kg or oral 0.5 mg/kg), Outcome 9: Neuroimaging sedation failure with intranasal midazolam" data-id="CD011786-fig-0029" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-003.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-003.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.9</div> <div class="figure-caption"> <p>Comparison 3: Chloral hydrate oral (100 mg/kg or 75 mg/kg) versus midazolam (intranasal 0.2 mg/kg or oral 0.5 mg/kg), Outcome 9: Neuroimaging sedation failure with intranasal midazolam </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-003.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-003.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Chloral hydrate oral (100 mg/kg or 75 mg/kg) versus midazolam (intranasal 0.2 mg/kg or oral 0.5 mg/kg), Outcome 10: Neuroimaging sedation failure with oral midazolam" data-id="CD011786-fig-0030" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-003.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-003.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.10</div> <div class="figure-caption"> <p>Comparison 3: Chloral hydrate oral (100 mg/kg or 75 mg/kg) versus midazolam (intranasal 0.2 mg/kg or oral 0.5 mg/kg), Outcome 10: Neuroimaging sedation failure with oral midazolam </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-003.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Chloral hydrate oral (50 mg/kg) versus melatonin oral, Outcome 1: EEG sedative‐induced artefact" data-id="CD011786-fig-0031" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: Chloral hydrate oral (50 mg/kg) versus melatonin oral, Outcome 1: EEG sedative‐induced artefact </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-004.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Chloral hydrate oral (50 mg/kg) versus melatonin oral, Outcome 2: EEG sedation adverse event: total" data-id="CD011786-fig-0032" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-004.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-004.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4: Chloral hydrate oral (50 mg/kg) versus melatonin oral, Outcome 2: EEG sedation adverse event: total </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-004.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-005.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Chloral hydrate oral (50 mg/kg + 50 mg/kg) versus hydroxyzine hydrochloride oral (1 mg/kg + 1 mg/kg), Outcome 1: EEG time onset for adequate sedation (minutes)" data-id="CD011786-fig-0033" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-005.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-005.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5: Chloral hydrate oral (50 mg/kg + 50 mg/kg) versus hydroxyzine hydrochloride oral (1 mg/kg + 1 mg/kg), Outcome 1: EEG time onset for adequate sedation (minutes) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-005.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-005.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Chloral hydrate oral (50 mg/kg + 50 mg/kg) versus hydroxyzine hydrochloride oral (1 mg/kg + 1 mg/kg), Outcome 2: EEG sedation failure" data-id="CD011786-fig-0034" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-005.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-005.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5: Chloral hydrate oral (50 mg/kg + 50 mg/kg) versus hydroxyzine hydrochloride oral (1 mg/kg + 1 mg/kg), Outcome 2: EEG sedation failure </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-005.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-005.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Chloral hydrate oral (50 mg/kg + 50 mg/kg) versus hydroxyzine hydrochloride oral (1 mg/kg + 1 mg/kg), Outcome 3: EEG sedation / sleep duration (minutes)" data-id="CD011786-fig-0035" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-005.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-005.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5: Chloral hydrate oral (50 mg/kg + 50 mg/kg) versus hydroxyzine hydrochloride oral (1 mg/kg + 1 mg/kg), Outcome 3: EEG sedation / sleep duration (minutes) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-005.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-005.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Chloral hydrate oral (50 mg/kg + 50 mg/kg) versus hydroxyzine hydrochloride oral (1 mg/kg + 1 mg/kg), Outcome 4: EEG sedative‐induced artefact" data-id="CD011786-fig-0036" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-005.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-005.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5: Chloral hydrate oral (50 mg/kg + 50 mg/kg) versus hydroxyzine hydrochloride oral (1 mg/kg + 1 mg/kg), Outcome 4: EEG sedative‐induced artefact </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-005.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-005.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Chloral hydrate oral (50 mg/kg + 50 mg/kg) versus hydroxyzine hydrochloride oral (1 mg/kg + 1 mg/kg), Outcome 5: EEG sedation adverse event: behavioural change" data-id="CD011786-fig-0037" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-005.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-005.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5: Chloral hydrate oral (50 mg/kg + 50 mg/kg) versus hydroxyzine hydrochloride oral (1 mg/kg + 1 mg/kg), Outcome 5: EEG sedation adverse event: behavioural change </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-005.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-005.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Chloral hydrate oral (50 mg/kg + 50 mg/kg) versus hydroxyzine hydrochloride oral (1 mg/kg + 1 mg/kg), Outcome 6: EEG sedation adverse event: nausea or vomiting" data-id="CD011786-fig-0038" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-005.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-005.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5: Chloral hydrate oral (50 mg/kg + 50 mg/kg) versus hydroxyzine hydrochloride oral (1 mg/kg + 1 mg/kg), Outcome 6: EEG sedation adverse event: nausea or vomiting </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-005.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-005.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Chloral hydrate oral (50 mg/kg + 50 mg/kg) versus hydroxyzine hydrochloride oral (1 mg/kg + 1 mg/kg), Outcome 7: EEG failure after 1 administration of sedative agent" data-id="CD011786-fig-0039" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-005.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-005.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.7</div> <div class="figure-caption"> <p>Comparison 5: Chloral hydrate oral (50 mg/kg + 50 mg/kg) versus hydroxyzine hydrochloride oral (1 mg/kg + 1 mg/kg), Outcome 7: EEG failure after 1 administration of sedative agent </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-005.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-006.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Chloral hydrate oral (70 mg/kg) versus promethazine oral (1 mg/kg), Outcome 1: EEG time for adequate sedation (minutes)" data-id="CD011786-fig-0040" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-006.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-006.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6: Chloral hydrate oral (70 mg/kg) versus promethazine oral (1 mg/kg), Outcome 1: EEG time for adequate sedation (minutes) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-006.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-006.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Chloral hydrate oral (70 mg/kg) versus promethazine oral (1 mg/kg), Outcome 2: EEG inadequate level of EEG sedation achieved (Ramsay score 4)" data-id="CD011786-fig-0041" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-006.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-006.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6: Chloral hydrate oral (70 mg/kg) versus promethazine oral (1 mg/kg), Outcome 2: EEG inadequate level of EEG sedation achieved (Ramsay score 4) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-006.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-006.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Chloral hydrate oral (70 mg/kg) versus promethazine oral (1 mg/kg), Outcome 3: EEG sedation failure" data-id="CD011786-fig-0042" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-006.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-006.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6: Chloral hydrate oral (70 mg/kg) versus promethazine oral (1 mg/kg), Outcome 3: EEG sedation failure </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-006.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-006.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Chloral hydrate oral (70 mg/kg) versus promethazine oral (1 mg/kg), Outcome 4: EEG sedation adverse event: behavioural change" data-id="CD011786-fig-0043" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-006.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-006.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6: Chloral hydrate oral (70 mg/kg) versus promethazine oral (1 mg/kg), Outcome 4: EEG sedation adverse event: behavioural change </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-006.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-006.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Chloral hydrate oral (70 mg/kg) versus promethazine oral (1 mg/kg), Outcome 5: EEG sedation adverse event: vomiting or nausea" data-id="CD011786-fig-0044" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-006.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-006.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.5</div> <div class="figure-caption"> <p>Comparison 6: Chloral hydrate oral (70 mg/kg) versus promethazine oral (1 mg/kg), Outcome 5: EEG sedation adverse event: vomiting or nausea </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-006.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-006.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Chloral hydrate oral (70 mg/kg) versus promethazine oral (1 mg/kg), Outcome 6: EEG Ramsay Sedation Score after 1 administration of sedative agent" data-id="CD011786-fig-0045" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-006.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-006.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.6</div> <div class="figure-caption"> <p>Comparison 6: Chloral hydrate oral (70 mg/kg) versus promethazine oral (1 mg/kg), Outcome 6: EEG Ramsay Sedation Score after 1 administration of sedative agent </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-006.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-007.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Chloral hydrate oral (60 mg/kg) versus music therapy, Outcome 1: EEG time onset for adequate sedation (minutes)" data-id="CD011786-fig-0046" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-007.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-007.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7: Chloral hydrate oral (60 mg/kg) versus music therapy, Outcome 1: EEG time onset for adequate sedation (minutes) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-007.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-007.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Chloral hydrate oral (60 mg/kg) versus music therapy, Outcome 2: EEG sedation failure" data-id="CD011786-fig-0047" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-007.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-007.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7: Chloral hydrate oral (60 mg/kg) versus music therapy, Outcome 2: EEG sedation failure </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-007.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-007.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Chloral hydrate oral (60 mg/kg) versus music therapy, Outcome 3: EEG sedation / sleep duration (minutes)" data-id="CD011786-fig-0048" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-007.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-007.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7: Chloral hydrate oral (60 mg/kg) versus music therapy, Outcome 3: EEG sedation / sleep duration (minutes) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-007.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-008.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Chloral hydrate oral (50 mg/kg) versus midazolam rectal (1 mg/kg), Outcome 1: EEG time onset for adequate sedation (minutes)" data-id="CD011786-fig-0049" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-008.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-008.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8: Chloral hydrate oral (50 mg/kg) versus midazolam rectal (1 mg/kg), Outcome 1: EEG time onset for adequate sedation (minutes) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-008.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-008.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Chloral hydrate oral (50 mg/kg) versus midazolam rectal (1 mg/kg), Outcome 2: EEG sedation/ sleep duration (minutes)" data-id="CD011786-fig-0050" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-008.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-008.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8: Chloral hydrate oral (50 mg/kg) versus midazolam rectal (1 mg/kg), Outcome 2: EEG sedation/ sleep duration (minutes) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-008.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-008.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Chloral hydrate oral (50 mg/kg) versus midazolam rectal (1 mg/kg), Outcome 3: EEG sedative‐induced artefact" data-id="CD011786-fig-0051" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-008.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-008.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8: Chloral hydrate oral (50 mg/kg) versus midazolam rectal (1 mg/kg), Outcome 3: EEG sedative‐induced artefact </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-008.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-009.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Chloral hydrate oral high dose (100 mg/kg) versus chloral hydrate oral low dose (70 mg/kg), Outcome 1: Neuroimaging time onset for adequate sedation (minutes)" data-id="CD011786-fig-0052" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-009.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-009.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9: Chloral hydrate oral high dose (100 mg/kg) versus chloral hydrate oral low dose (70 mg/kg), Outcome 1: Neuroimaging time onset for adequate sedation (minutes) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-009.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-009.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Chloral hydrate oral high dose (100 mg/kg) versus chloral hydrate oral low dose (70 mg/kg), Outcome 2: Neuroimaging sedation failure after 1 administration of sedative agent" data-id="CD011786-fig-0053" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-009.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-009.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9: Chloral hydrate oral high dose (100 mg/kg) versus chloral hydrate oral low dose (70 mg/kg), Outcome 2: Neuroimaging sedation failure after 1 administration of sedative agent </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-009.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-009.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Chloral hydrate oral high dose (100 mg/kg) versus chloral hydrate oral low dose (70 mg/kg), Outcome 3: Neuroimaging sedation / sleep duration (minutes)" data-id="CD011786-fig-0054" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-009.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-009.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.3</div> <div class="figure-caption"> <p>Comparison 9: Chloral hydrate oral high dose (100 mg/kg) versus chloral hydrate oral low dose (70 mg/kg), Outcome 3: Neuroimaging sedation / sleep duration (minutes) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-009.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-009.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Chloral hydrate oral high dose (100 mg/kg) versus chloral hydrate oral low dose (70 mg/kg), Outcome 4: Neuroimaging sedation adverse event: total" data-id="CD011786-fig-0055" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-009.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-009.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.4</div> <div class="figure-caption"> <p>Comparison 9: Chloral hydrate oral high dose (100 mg/kg) versus chloral hydrate oral low dose (70 mg/kg), Outcome 4: Neuroimaging sedation adverse event: total </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-009.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-010.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: Chloral hydrate oral high dose (100 mg/kg) versus chloral hydrate oral low dose (50 mg/kg), Outcome 1: EEG time onset for adequate sedation (minutes)" data-id="CD011786-fig-0056" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-010.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-010.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10: Chloral hydrate oral high dose (100 mg/kg) versus chloral hydrate oral low dose (50 mg/kg), Outcome 1: EEG time onset for adequate sedation (minutes) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-010.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-010.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: Chloral hydrate oral high dose (100 mg/kg) versus chloral hydrate oral low dose (50 mg/kg), Outcome 2: EEG sedation failure" data-id="CD011786-fig-0057" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-010.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-010.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.2</div> <div class="figure-caption"> <p>Comparison 10: Chloral hydrate oral high dose (100 mg/kg) versus chloral hydrate oral low dose (50 mg/kg), Outcome 2: EEG sedation failure </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-010.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-010.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: Chloral hydrate oral high dose (100 mg/kg) versus chloral hydrate oral low dose (50 mg/kg), Outcome 3: EEG sedation/sleep duration (minutes)" data-id="CD011786-fig-0058" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-010.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-010.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.3</div> <div class="figure-caption"> <p>Comparison 10: Chloral hydrate oral high dose (100 mg/kg) versus chloral hydrate oral low dose (50 mg/kg), Outcome 3: EEG sedation/sleep duration (minutes) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-010.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-010.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: Chloral hydrate oral high dose (100 mg/kg) versus chloral hydrate oral low dose (50 mg/kg), Outcome 4: EEG sedation adverse event: total" data-id="CD011786-fig-0059" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-010.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-010.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.4</div> <div class="figure-caption"> <p>Comparison 10: Chloral hydrate oral high dose (100 mg/kg) versus chloral hydrate oral low dose (50 mg/kg), Outcome 4: EEG sedation adverse event: total </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-010.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-010.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: Chloral hydrate oral high dose (100 mg/kg) versus chloral hydrate oral low dose (50 mg/kg), Outcome 5: EEG sedation adverse event: behavioural change" data-id="CD011786-fig-0060" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-010.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-010.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.5</div> <div class="figure-caption"> <p>Comparison 10: Chloral hydrate oral high dose (100 mg/kg) versus chloral hydrate oral low dose (50 mg/kg), Outcome 5: EEG sedation adverse event: behavioural change </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-010.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-010.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: Chloral hydrate oral high dose (100 mg/kg) versus chloral hydrate oral low dose (50 mg/kg), Outcome 6: EEG sedation adverse event: nausea or vomiting" data-id="CD011786-fig-0061" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-010.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-010.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.6</div> <div class="figure-caption"> <p>Comparison 10: Chloral hydrate oral high dose (100 mg/kg) versus chloral hydrate oral low dose (50 mg/kg), Outcome 6: EEG sedation adverse event: nausea or vomiting </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-010.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-010.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: Chloral hydrate oral high dose (100 mg/kg) versus chloral hydrate oral low dose (50 mg/kg), Outcome 7: EEG sedation adverse event: oxygen desaturation" data-id="CD011786-fig-0062" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-010.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-010.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.7</div> <div class="figure-caption"> <p>Comparison 10: Chloral hydrate oral high dose (100 mg/kg) versus chloral hydrate oral low dose (50 mg/kg), Outcome 7: EEG sedation adverse event: oxygen desaturation </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-010.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-011.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 11: Chloral hydrate oral (50 mg/kg) versus sodium thiopental rectal (25 mg/kg), Outcome 1: Neuroimaging adequate sedation (Ramsay score 4)" data-id="CD011786-fig-0063" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-011.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-011.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.1</div> <div class="figure-caption"> <p>Comparison 11: Chloral hydrate oral (50 mg/kg) versus sodium thiopental rectal (25 mg/kg), Outcome 1: Neuroimaging adequate sedation (Ramsay score 4) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-011.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-011.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 11: Chloral hydrate oral (50 mg/kg) versus sodium thiopental rectal (25 mg/kg), Outcome 2: Neuroimaging onset sedation (minutes)" data-id="CD011786-fig-0064" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-011.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-011.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.2</div> <div class="figure-caption"> <p>Comparison 11: Chloral hydrate oral (50 mg/kg) versus sodium thiopental rectal (25 mg/kg), Outcome 2: Neuroimaging onset sedation (minutes) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-011.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-011.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 11: Chloral hydrate oral (50 mg/kg) versus sodium thiopental rectal (25 mg/kg), Outcome 3: Neuroimaging sedation failure after 1 administration of sedation agent" data-id="CD011786-fig-0065" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-011.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-011.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.3</div> <div class="figure-caption"> <p>Comparison 11: Chloral hydrate oral (50 mg/kg) versus sodium thiopental rectal (25 mg/kg), Outcome 3: Neuroimaging sedation failure after 1 administration of sedation agent </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-011.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-011.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 11: Chloral hydrate oral (50 mg/kg) versus sodium thiopental rectal (25 mg/kg), Outcome 4: Neuroimaging sedation duration (minutes)" data-id="CD011786-fig-0066" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-011.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-011.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.4</div> <div class="figure-caption"> <p>Comparison 11: Chloral hydrate oral (50 mg/kg) versus sodium thiopental rectal (25 mg/kg), Outcome 4: Neuroimaging sedation duration (minutes) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-011.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-011.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 11: Chloral hydrate oral (50 mg/kg) versus sodium thiopental rectal (25 mg/kg), Outcome 5: Neuroimaging adverse effect: desaturation" data-id="CD011786-fig-0067" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-011.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-011.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.5</div> <div class="figure-caption"> <p>Comparison 11: Chloral hydrate oral (50 mg/kg) versus sodium thiopental rectal (25 mg/kg), Outcome 5: Neuroimaging adverse effect: desaturation </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-011.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-011.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 11: Chloral hydrate oral (50 mg/kg) versus sodium thiopental rectal (25 mg/kg), Outcome 6: Neuroimaging adverse effect: diarrhoea" data-id="CD011786-fig-0068" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-011.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-011.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.6</div> <div class="figure-caption"> <p>Comparison 11: Chloral hydrate oral (50 mg/kg) versus sodium thiopental rectal (25 mg/kg), Outcome 6: Neuroimaging adverse effect: diarrhoea </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-011.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-011.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 11: Chloral hydrate oral (50 mg/kg) versus sodium thiopental rectal (25 mg/kg), Outcome 7: Mean diastolic blood pressure during procedure (mmHg)" data-id="CD011786-fig-0069" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-011.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-011.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.7</div> <div class="figure-caption"> <p>Comparison 11: Chloral hydrate oral (50 mg/kg) versus sodium thiopental rectal (25 mg/kg), Outcome 7: Mean diastolic blood pressure during procedure (mmHg) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-011.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-012.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 12: Chloral hydrate oral (50 mg/kg) versus clonidine oral (4 μg/kg), Outcome 1: EEG onset sedation (minutes)" data-id="CD011786-fig-0070" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-012.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-012.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.1</div> <div class="figure-caption"> <p>Comparison 12: Chloral hydrate oral (50 mg/kg) versus clonidine oral (4 μg/kg), Outcome 1: EEG onset sedation (minutes) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-012.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-012.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 12: Chloral hydrate oral (50 mg/kg) versus clonidine oral (4 μg/kg), Outcome 2: EEG sedation / sleep duration (minutes)" data-id="CD011786-fig-0071" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-012.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-012.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.2</div> <div class="figure-caption"> <p>Comparison 12: Chloral hydrate oral (50 mg/kg) versus clonidine oral (4 μg/kg), Outcome 2: EEG sedation / sleep duration (minutes) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-012.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-012.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 12: Chloral hydrate oral (50 mg/kg) versus clonidine oral (4 μg/kg), Outcome 3: EEG sedation adverse event: drowsiness" data-id="CD011786-fig-0072" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-012.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-012.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.3</div> <div class="figure-caption"> <p>Comparison 12: Chloral hydrate oral (50 mg/kg) versus clonidine oral (4 μg/kg), Outcome 3: EEG sedation adverse event: drowsiness </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-012.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-012.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 12: Chloral hydrate oral (50 mg/kg) versus clonidine oral (4 μg/kg), Outcome 4: EEG sedation adverse event: vertigo" data-id="CD011786-fig-0073" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-012.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-012.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.4</div> <div class="figure-caption"> <p>Comparison 12: Chloral hydrate oral (50 mg/kg) versus clonidine oral (4 μg/kg), Outcome 4: EEG sedation adverse event: vertigo </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-012.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0074"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-013.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 13: Chloral hydrate oral (50 mg/kg) versus dexmedetomidine intranasal (3 μg/kg), Outcome 1: Neuroimaging sedation onset (minutes)" data-id="CD011786-fig-0074" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-013.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-013.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.1</div> <div class="figure-caption"> <p>Comparison 13: Chloral hydrate oral (50 mg/kg) versus dexmedetomidine intranasal (3 μg/kg), Outcome 1: Neuroimaging sedation onset (minutes) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0074">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-013.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0075"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-013.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 13: Chloral hydrate oral (50 mg/kg) versus dexmedetomidine intranasal (3 μg/kg), Outcome 2: Neuroimaging adverse event: bradycardia" data-id="CD011786-fig-0075" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-013.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-013.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.2</div> <div class="figure-caption"> <p>Comparison 13: Chloral hydrate oral (50 mg/kg) versus dexmedetomidine intranasal (3 μg/kg), Outcome 2: Neuroimaging adverse event: bradycardia </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0075">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-013.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0076"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-013.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 13: Chloral hydrate oral (50 mg/kg) versus dexmedetomidine intranasal (3 μg/kg), Outcome 3: Neuroimaging adverse event: unsteadiness within 24 h after discharge" data-id="CD011786-fig-0076" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-013.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-013.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.3</div> <div class="figure-caption"> <p>Comparison 13: Chloral hydrate oral (50 mg/kg) versus dexmedetomidine intranasal (3 μg/kg), Outcome 3: Neuroimaging adverse event: unsteadiness within 24 h after discharge </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0076">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-013.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0077"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-013.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 13: Chloral hydrate oral (50 mg/kg) versus dexmedetomidine intranasal (3 μg/kg), Outcome 4: Neuroimaging adverse event: crying during administration of sedation" data-id="CD011786-fig-0077" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-013.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-013.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.4</div> <div class="figure-caption"> <p>Comparison 13: Chloral hydrate oral (50 mg/kg) versus dexmedetomidine intranasal (3 μg/kg), Outcome 4: Neuroimaging adverse event: crying during administration of sedation </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0077">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-013.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011786-fig-0078"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/urn:x-wiley:14651858:media:CD011786:CD011786-CMP-013.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 13: Chloral hydrate oral (50 mg/kg) versus dexmedetomidine intranasal (3 μg/kg), Outcome 5: Neuroimaging adverse event: vomiting" data-id="CD011786-fig-0078" src="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-013.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_t/tCD011786-CMP-013.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.5</div> <div class="figure-caption"> <p>Comparison 13: Chloral hydrate oral (50 mg/kg) versus dexmedetomidine intranasal (3 μg/kg), Outcome 5: Neuroimaging adverse event: vomiting </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-fig-0078">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/media/CDSR/CD011786/image_n/nCD011786-CMP-013.05.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD011786-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Chloral hydrate oral (50 mg/kg or 100 mg/kg) compared to dexmedetomidine oral (2 µg/kg or 3 µg/kg) as sedating agents for neurodiagnostic procedures in children</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Chloral hydrate oral (50 mg/kg or 100 mg/kg) compared to dexmedetomidine oral (2 µg/kg or 3 µg/kg) as sedating agents for neurodiagnostic procedures in children</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children undergoing neurodiagnostic procedures<br/><b>Setting:</b> paediatric hospital or outpatient<br/><b>Intervention:</b> chloral hydrate oral (50 mg/kg or 100 mg/kg)<br/><b>Comparison:</b> dexmedetomidine oral (2 µg/kg or 3 µg/kg) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with dexmedetomidine</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with chloral hydrate</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children who successfully completed neurodiagnostic procedure without interruption by the child awakening </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study in this comparison assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children who required a further dose of either the same sedative agent or the addition of a different sedative agent </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study in this comparison assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean EEG time onset for adequate sedation (minutes) was 35.2.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean EEG time onset for adequate sedation (minutes) in the intervention group was 3.86 minutes shorter (5.12 shorter to 2.6 shorter). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>160<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Proportion of children who had sedation failure or inadequate level of sedation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.14<br/>(0.51 to 2.53) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>160<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>119 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>136 per 1000<br/>(61 to 301) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sedation duration (minutes)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of sedation/sleep was 112.1 minutes.<sup>3</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean EEG sedation/sleep duration in the intervention group was 16.47 minutes longer (9.21 to 23.72 minutes longer). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>160<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of children with clinical adverse events (any)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 7.66<br/>(1.78 to 32.91) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>160<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>24 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>182 per 1000<br/>(42 to 784) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>EEG:</b> electroencephalogram; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>The 95% CI for this estimate ranges from 2.6 to 5.1 minutes of difference, which in terms of length of sedation is wide. Certainty of evidence downgraded one level due to risk of bias.<br/><sup>2</sup>The 95% CI for this estimate ranges from substantial benefits favouring chloral hydrate to substantial benefits favouring dexmedetomidine. Certainty of evidence downgraded one level due to imprecision.<br/><sup>3</sup>The mean was derived by averaging the mean values of the two subgroups of children receiving two different doses of oral dexmedetomidine (2 mg/kg and 3 mg/kg), each of which consisted of 40 children.<br/><sup>4</sup>The 95% CI for this estimate ranges from about 9 more minutes to 23 more minutes of sleep duration, which is too wide in the context of sedation for neurodiagnostic procedures. Certainty of evidence downgraded one level due to imprecision.<br/><sup>5</sup>The 95% CI for this estimate is very wide. Certainty of evidence downgraded two levels due to imprecision. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Chloral hydrate oral (50 mg/kg or 100 mg/kg) compared to dexmedetomidine oral (2 µg/kg or 3 µg/kg) as sedating agents for neurodiagnostic procedures in children</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/full#CD011786-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011786-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Chloral hydrate oral (75 mg/kg) compared to pentobarbital intravenous (5 mg/kg) as sedating agents for neurodiagnostic procedures in children</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Chloral hydrate oral (75 mg/kg) compared to pentobarbital intravenous (5 mg/kg) as sedating agents for neurodiagnostic procedures in children</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children undergoing neurodiagnostic procedures<br/><b>Setting:</b> paediatric hospital or outpatient<br/><b>Intervention:</b> chloral hydrate oral (75 mg/kg)<br/><b>Comparison:</b> pentobarbital intravenous (5 mg/kg) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p>Risk with <b>pentobarbital</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with chloral hydrate</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children who successfully completed neurodiagnostic procedure without interruption by the child awakening </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study in this comparison assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children who required a further dose of either the same sedative agent or the addition of a different sedative agent </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study in this comparison assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean time to adequate sedation was 9 minutes.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean time to adequate sedation in the intervention group was 19 minutes longer (16.61 to 21.39 minutes longer). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Proportion of children who had sedation failure after 1 dose of sedative agent</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 4.33<br/>(1.35 to 13.89) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>70<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>86 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>371 per 1000<br/>(116 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Proportion of children who had sedation failure after 2 doses of sedative agent (same or different) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 3.00<br/>(0.33 to 27.46) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>70<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>29 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>86 per 1000<br/>(9 to 785) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Non‐interpretable neuroimaging finding</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.23<br/>(0.03 to 1.94) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>54<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>154 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>35 per 1000<br/>(5 to 298) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of children with clinical adverse event: oxygen desaturation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.67<br/>(0.21 to 2.16) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>70<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>171 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>115 per 1000<br/>(36 to 370) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>The single included study had unclear risk of bias for allocation concealment and blinding of outcome assessor and high risk of bias for blinding of participants and personnel. Certainty of evidence downgraded one level due to risk of bias.<br/><sup>2</sup>Although both ends of the 95% CI clearly indicate a longer onset of adequate sedation for the chloral hydrate group, the range of 95% CI for this estimate was too wide to permit a confident estimate on the time difference. Certainty of evidence downgraded one level due to imprecision.<br/><sup>3</sup>The 95% CI for this estimate ranges from slightly higher risk of sedation failure for chloral hydrate group to substantially higher risk of sedation failure for chloral hydrate group. Certainty of evidence downgraded two levels due to imprecision.<br/><sup>4</sup>The 95% CI for this estimate ranges from substantially favouring chloral hydrate group to substantially favouring pentobarbital group. Certainty of evidence downgraded two levels due to imprecision.<br/><sup>5</sup>The 95% CI for this estimate ranges from substantially lower risk of sedation failure for chloral hydrate group to substantially higher risk of sedation failure for chloral hydrate group. Certainty of evidence downgraded two levels due to imprecision. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Chloral hydrate oral (75 mg/kg) compared to pentobarbital intravenous (5 mg/kg) as sedating agents for neurodiagnostic procedures in children</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/full#CD011786-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011786-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Chloral hydrate oral (100 mg/kg or 75 mg/kg) compared to midazolam (intranasal 0.2 mg/kg or oral 0.5 mg/kg) as sedating agents for neurodiagnostic procedures in children</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Chloral hydrate oral (100 mg/kg or 75 mg/kg) compared to midazolam (intranasal 0.2 mg/kg or oral 0.5 mg/kg) as sedating agents for neurodiagnostic procedures in children</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children undergoing neurodiagnostic procedures<br/><b>Setting:</b> paediatric hospital or outpatient<br/><b>Intervention:</b> chloral hydrate oral (100 mg/kg or 75 mg/kg)<br/><b>Comparison:</b> midazolam (intranasal 0.2 mg/kg or oral 0.5 mg/kg) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with midazolam</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with chloral hydrate</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children who successfully completed neurodiagnostic procedure without interruption by the child awakening </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study in this comparison assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children who required a further dose of either the same sedative agent or the addition of a different sedative agent </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study in this comparison assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean time to adequate sedation was 10.92 minutes (intranasal midazolam).</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean time to adequate sedation in the intervention group was 12.83 minutes longer (7.22 to 18.44 minutes longer). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Proportion of children with inadequate level of sedation (Ramsay score below 4)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.11<br/>(0.03 to 0.44) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>60<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>600 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>66 per 1000<br/>(18 to 264) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Proportion of children who had sedation failure after 1 dose of sedative agent</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.17<br/>(0.02 to 1.12) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>33<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>545 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>93 per 1000<br/>(11 to 611) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sedation duration (minutes)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of sedation or sleep was 76 minutes (oral midazolam).</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of sedation or sleep in the intervention group was 19 minutes longer (3.4 minutes shorter to 41.4 minutes longer). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>EEG sedative‐induced artefact</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.58<br/>(0.44 to 0.76) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>198<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/>HIGH </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>700 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>406 per 1000</p> <p>(308 to 532)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of children with clinical adverse events (any)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.20<br/>(0.01 to 4.20) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>198<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>20 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4 per 1000<br/>(0 to 84) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>EEG:</b> electroencephalogram; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>The 95% CI for this estimate is wide, although both ends are on the same direction of effect. Certainty of evidence downgraded one level due to imprecision.<br/><sup>2</sup>The 95% CI for this estimate ranges from substantially lower risk to higher risk for chloral hydrate group. Certainty of evidence downgraded two levels due to imprecision.<br/><sup>3</sup>The 95% CI for this estimate ranges from slightly shorter to substantially higher for chloral hydrate group. Certainty of evidence downgraded two levels due to imprecision. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Chloral hydrate oral (100 mg/kg or 75 mg/kg) compared to midazolam (intranasal 0.2 mg/kg or oral 0.5 mg/kg) as sedating agents for neurodiagnostic procedures in children</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/full#CD011786-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011786-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Chloral hydrate oral (50 mg/kg) compared to melatonin oral as sedating agents for neurodiagnostic procedures in children</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Chloral hydrate oral (50 mg/kg) compared to melatonin oral as sedating agents for neurodiagnostic procedures in children</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children undergoing neurodiagnostic procedures<br/><b>Setting:</b> paediatric hospital or outpatient<br/><b>Intervention:</b> chloral hydrate oral (50 mg/kg)<br/><b>Comparison:</b> melatonin oral </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with melatonin</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with chloral hydrate</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children who successfully completed neurodiagnostic procedure without interruption by the child awakening </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study in this comparison assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children who required a further dose of either the same sedative agent or the addition of a different sedative agent </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study in this comparison assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study in this comparison assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children who had sedation failure or inadequate level of sedation</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study in this comparison assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>EEG sedative‐induced artefact</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.33<br/>(0.14 to 0.82) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>348<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>103 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>34 per 1000<br/>(14 to 85) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of children with clinical adverse events (any)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.00<br/>(0.25 to 3.93) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>348<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>23 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>23 per 1000<br/>(6 to 90) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>EEG:</b> electroencephalogram; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>The single included study was at unclear risk of bias for random sequence generation, allocation concealment, and blinding of outcome assessors, and high risk of bias for blinding of participants and personnel. Certainty of evidence downgraded one level due to risk of bias.<br/><sup>2</sup>The 95% CIs were too wide to permit a confident estimate of the effect sizes. Certainty of evidence downgraded one level due to imprecision. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Chloral hydrate oral (50 mg/kg) compared to melatonin oral as sedating agents for neurodiagnostic procedures in children</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/full#CD011786-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011786-tbl-0005"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Chloral hydrate oral (50 mg/kg + 50 mg/kg) compared to hydroxyzine hydrochloride oral (1 mg/kg + 1 mg/kg) as sedating agents for neurodiagnostic procedures in children</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Chloral hydrate oral (50 mg/kg + 50 mg/kg) compared to hydroxyzine hydrochloride oral (1 mg/kg + 1 mg/kg) as sedating agents for neurodiagnostic procedures in children</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children undergoing neurodiagnostic procedures<br/><b>Setting:</b> paediatric hospital or outpatient<br/><b>Intervention:</b> chloral hydrate oral (50 mg/kg + 50 mg/kg)<br/><b>Comparison:</b> hydroxyzine hydrochloride oral (1 mg/kg + 1 mg/kg) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with hydroxyzine hydrochloride</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with chloral hydrate</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children who successfully completed neurodiagnostic procedure without interruption by the child awakening </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study in this comparison assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children who required a further dose of either the same sedative agent or the addition of a different sedative agent </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study in this comparison assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TIme to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The time onset to adequate sedation was 23.7 minutes.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean time to adequate sedation in the intervention group was 7.5 minutes shorter (7.85 to 7.15 minutes shorter). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>282<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Proportion of children who had sedation failure or inadequate level of sedation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.33<br/>(0.11 to 1.01) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>282<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>85 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>28 per 1000<br/>(9 to 86) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sedation duration (minutes)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of sedation or sleep was 85.1 minutes.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of sedation or sleep in the intervention group was 3.1 minutes longer (2.23 to 3.97 minutes longer). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>282<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of children with clinical adverse event: behavioural change</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.17<br/>(0.40 to 3.38) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>282<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>43 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>50 per 1000<br/>(17 to 144) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of children with clinical adverse event: nausea or vomiting</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.25<br/>(0.34 to 4.56) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>282<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>28 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>35 per 1000<br/>(10 to 129) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>The single included study was at unclear risk of bias for random sequence generation, allocation concealment, blinding of participants and personnel, and blinding of outcome assessors. Certainty of evidence downgraded one level due to risk of bias.<br/><sup>2</sup>The 95% CI for this estimate ranges from substantially lower risk to marginally to moderately higher risk of sedation failure for the chloral hydrate group. Certainty of evidence downgraded one level due to imprecision. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Chloral hydrate oral (50 mg/kg + 50 mg/kg) compared to hydroxyzine hydrochloride oral (1 mg/kg + 1 mg/kg) as sedating agents for neurodiagnostic procedures in children</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/full#CD011786-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011786-tbl-0006"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Chloral hydrate oral (70 mg/kg) compared to promethazine oral (1 mg/kg) as sedating agents for neurodiagnostic procedures in children</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Chloral hydrate oral (70 mg/kg) compared to promethazine oral (1 mg/kg) as sedating agents for neurodiagnostic procedures in children</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children undergoing neurodiagnostic procedures<br/><b>Setting:</b> paediatric hospital or outpatient<br/><b>Intervention:</b> chloral hydrate oral (70 mg/kg)<br/><b>Comparison:</b> promethazine oral (1 mg/kg) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with promethazine</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with chloral hydrate</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children who successfully completed neurodiagnostic procedure without interruption by the child awakening </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study in this comparison assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children who required a further dose of either the same sedative agent or the addition of a different sedative agent </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study in this comparison assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean time to adequate sedation was 33.84 minutes.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean time to adequate sedation in the intervention group was 12.11 minutes shorter (18.48 to 5.74 minutes shorter). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Proportion of children with inadequate level of sedation (Ramsay score below 4)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.03<br/>(0.00 to 0.45) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>60<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>567 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>17 per 1000<br/>(0 to 255) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Proportion of children who had sedation failure or inadequate level of sedation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.11<br/>(0.01 to 0.82) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>60<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>300 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>33 per 1000<br/>(3 to 246) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of children with clinical adverse event: behavioural change</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.20<br/>(0.01 to 4.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>60<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>67 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>13 per 1000<br/>(1 to 267) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of children with clinical adverse event: vomiting or nausea</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 13.00<br/>(0.76 to 220.96) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>60<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/>(0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>The 95% CI for this estimate is wide but falls on the same direction of effect. Certainty of evidence downgraded one level due to imprecision.<br/><sup>2</sup>The 95% CI for this estimate is very wide, especially if the data are inverted. Certainty of evidence downgraded two levels due to serious imprecision.<br/><sup>3</sup>The 95% CI for this estimate is very wide. Certainty of evidence downgraded two levels due to imprecision. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Chloral hydrate oral (70 mg/kg) compared to promethazine oral (1 mg/kg) as sedating agents for neurodiagnostic procedures in children</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/full#CD011786-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011786-tbl-0007"> <div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Chloral hydrate oral (60 mg/kg) compared to music therapy as sedating agents for neurodiagnostic procedures in children</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Chloral hydrate oral (60 mg/kg) compared to music therapy as sedating agents for neurodiagnostic procedures in children</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children undergoing neurodiagnostic procedures<br/><b>Setting:</b> paediatric inpatient or outpatient<br/><b>Intervention:</b> chloral hydrate oral (60 mg/kg)<br/><b>Comparison:</b> music therapy </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with music therapy</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with chloral hydrate</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children who successfully completed neurodiagnostic procedure without interruption by the child awakening </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study in this comparison assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children who required a further dose of either the same sedative agent or the addition of a different sedative agent </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study in this comparison assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean EEG time onset for adequate sedation was 23 minutes.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean EEG time onset for adequate sedation in the intervention group was 9 minutes more (2.15 fewer to 20.15 more). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Proportion of children who had sedation failure or inadequate level of sedation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 17.00<br/>(2.37 to 122.14) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>58<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>29 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>500 per 1000<br/>(70 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sedation duration (minutes)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean EEG sedation/sleep duration was 66 minutes.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean EEG sedation/sleep duration in the intervention group was 160 minutes more (121.07 more to 198.93 more). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of children with clinical adverse events (any)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study in this comparison assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>EEG:</b> electroencephalogram; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Very serious concerns regarding the trial methodology led to a judgement of high risk of selection bias (using alternation rather than true randomisation), performance and detection biases (non‐blinding of participants and care personnel as well as outcome assessors), and reporting bias. Certainty of evidence downgraded two levels due to risk of bias.<br/><sup>2</sup>The 95% CI was wide. Certainty of evidence downgraded one level due to imprecision.<br/><sup>3</sup>The 95% CI was very wide. Certainty of evidence downgraded two levels due to imprecision. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Chloral hydrate oral (60 mg/kg) compared to music therapy as sedating agents for neurodiagnostic procedures in children</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/full#CD011786-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011786-tbl-0008"> <div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Chloral hydrate oral (50 mg/kg) compared to sodium thiopental rectal (25 mg/kg) for neurodiagnostic procedures in children</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Chloral hydrate oral (50 mg/kg) compared to sodium thiopental rectal (25 mg/kg) for neurodiagnostic procedures in children</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> neurodiagnostic procedures in children<br/><b>Setting:</b> paediatric hospital or outpatient<br/><b>Intervention:</b> chloral hydrate (50 mg/kg) oral<br/><b>Comparison:</b> sodium thiopental rectal (25 mg/kg) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with sodium thiopental</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with chloral hydrate</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Proportion of children who successfully completed neurodiagnostic procedure without interruption by the child awakening </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.95<br/>(0.83 to 1.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>140<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>1</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>871 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>828 per 1000<br/>(723 to 950) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean onset sedation (minutes) was 28.7 minutes.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 4.2 minutes lower<br/>(6.08 lower to 2.32 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>140<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Proportion of children who had sedation failure or inadequate level of sedation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.33<br/>(0.60 to 2.96) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>140<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>129 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>171 per 1000<br/>(77 to 381) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sedation duration (minutes</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean sedation duration (minutes) was 13.7 minutes.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.8 minutes lower<br/>(1.7 lower to 0.1 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>140<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>4</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of children with clinical adverse event: desaturation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 5.00<br/>(0.24 to 102.30) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>140<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>5</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/>(0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of children with clinical adverse event: diarrhoea</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.04<br/>(0.00 to 0.72) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>140<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>6</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>157 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>6 per 1000<br/>(0 to 113) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean diastolic blood pressure during procedure (mmHg)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean diastolic blood pressure during procedure (mmHg) was 53 mmHg.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 7.4 mmHg higher<br/>(5.11 higher to 9.69 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>140<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>7</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>The 95% confidence interval ranges from a moderate reduction to a slight increase in risk in a single‐study analysis with a small sample.<br/><sup>2</sup>The 95% confidence interval ranges from a marked decrease to a modest decrease in a single‐study analysis with a small sample.<br/><sup>3</sup>The 95% confidence interval ranges from a marked decrease to a marked increase in risk in a single‐study analysis with a small sample.<br/><sup>4</sup>The 95% confidence interval ranges from a marked reduction to a slight increase in a single‐study analysis with a small sample.<br/><sup>5</sup>The small number of events in the single‐study analysis resulted in very wide 95% confidence interval; certainty of evidence downgraded two levels.<br/><sup>6</sup>The 95% confidence interval ranges from a marked reduction to a moderate reduction in the risk of diarrhoea in a single study with a small sample.<br/><sup>7</sup>Whilst the mean diastolic blood pressure was reported as representing the possible adverse effect of hypotension, the reported measure here does not provide a direct indication of the risk of hypotension, which is usually reported as the number of participants with hypotension. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Chloral hydrate oral (50 mg/kg) compared to sodium thiopental rectal (25 mg/kg) for neurodiagnostic procedures in children</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/full#CD011786-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011786-tbl-0009"> <div class="table-heading"><span class="table-label">Summary of findings 9.</span> <span class="table-title">Chloral hydrate oral (50 mg/kg) compared to clonidine oral (4 μg/kg) for neurodiagnostic procedures in children</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Chloral hydrate oral (50 mg/kg) compared to clonidine oral (4 μg/kg) for neurodiagnostic procedures in children</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> neurodiagnostic procedures in children<br/><b>Setting:</b> hospital or outpatient<br/><b>Intervention:</b> chloral hydrate oral (50 mg/kg)<br/><b>Comparison:</b> clonidine oral (4 μg/kg) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with clonidine</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with chloral hydrate</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) (minutes) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean onset sedation (minutes) was 86.28 minutes.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 37.48 minutes lower<br/>(55.97 lower to 18.99 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>198<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sedation duration (minutes)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean sedation duration (minutes) was 74.2 minutes.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 6.07 minutes lower<br/>(15.32 lower to 3.18 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>198<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of children with clinical adverse event: drowsiness</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.44<br/>(0.30 to 0.64) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>198<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>1</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>580 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>255 per 1000<br/>(174 to 371) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of children with clinical adverse event: vertigo</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.15<br/>(0.01 to 2.79) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>198<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>1</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>30 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5 per 1000<br/>(0 to 84) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>EEG:</b> electroencephalogram; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>The single included study had a high risk of selection bias.<br/><sup>2</sup>Wide 95% confidence interval that ranges from a major reduction to a modest reduction in the time taken for onset of sedation.<br/><sup>3</sup>Wide 95% confidence interval that ranges from a moderate reduction to a slight increase in sleep duration. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 9.</span> <span class="table-title">Chloral hydrate oral (50 mg/kg) compared to clonidine oral (4 μg/kg) for neurodiagnostic procedures in children</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/full#CD011786-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011786-tbl-0010"> <div class="table-heading"><span class="table-label">Summary of findings 10.</span> <span class="table-title">Chloral hydrate oral (50 mg/kg) compared to dexmedetomidine intranasal (3 μg/kg) for neurodiagnostic procedures in children</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Chloral hydrate oral (50 mg/kg) compared to dexmedetomidine intranasal (3 μg/kg) for neurodiagnostic procedures in children</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> neurodiagnostic procedures in children<br/><b>Setting:</b> hospital or outpatient<br/><b>Intervention:</b> chloral hydrate oral (50 mg/kg)<br/><b>Comparison:</b> dexmedetomidine intranasal (3 μg/kg) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with dexmedetomidine</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with chloral hydrate</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) (minutes) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean sedation onset (minutes) was 19.6 minutes.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 2.8 minutes higher<br/>(0.77 higher to 4.83 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>194<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>1</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of children with clinical adverse event: bradycardia</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.17<br/>(0.05 to 0.59) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>194<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/>HIGH </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>161 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>27 per 1000<br/>(8 to 95) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of children with clinical adverse event: unsteadiness within 24 h after discharge</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 10.21<br/>(0.58 to 178.52) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>173<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/>(0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of children with clinical adverse event: crying during administration of sedation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.39<br/>(1.08 to 1.80) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>194<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>483 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>671 per 1000<br/>(521 to 869) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of children with clinical adverse event: vomiting</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 10.59<br/>(0.61 to 185.45) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>194<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/>(0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>The 95% confidence interval ranges from a slight increase to a moderate increase in duration of sedation in a single included study.<br/><sup>2</sup>Low event rate in a single included study resulted in a very wide 95% confidence interval.<br/><sup>3</sup>95% confidence interval ranges from 8% to 80% increase in the risk of crying during administration of medication. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 10.</span> <span class="table-title">Chloral hydrate oral (50 mg/kg) compared to dexmedetomidine intranasal (3 μg/kg) for neurodiagnostic procedures in children</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/full#CD011786-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011786-tbl-0011"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Outcomes with skewed data as reported by individual studies</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Comparison</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Outcome</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Effect estimate</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>P value</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Chloral hydrate versus melatonin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sleep onset latency</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011786-bbs2-0001" title="AshrafiMR , MohammadiM , TafarrojiJ , ShabanianR , SalamatiP , ZamaniGR . Melatonin versus chloral hydrate for recording sleep EEG. European Journal of Paediatric Neurology2010;14(3):235-8. [DOI: 10.1016/j.ejpn.2009.06.010] [PMID: 19616978]">Ashrafi 2010</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Median (range) in minutes</b> </p> <p>Chloral hydrate group (35 (10 to 150)), melatonin group (45 (5 to 210))</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.113</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sleep duration</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011786-bbs2-0001" title="AshrafiMR , MohammadiM , TafarrojiJ , ShabanianR , SalamatiP , ZamaniGR . Melatonin versus chloral hydrate for recording sleep EEG. European Journal of Paediatric Neurology2010;14(3):235-8. [DOI: 10.1016/j.ejpn.2009.06.010] [PMID: 19616978]">Ashrafi 2010</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Median (range) in minutes</b> </p> <p>Chloral hydrate group (60 (15 to 240)), melatonin group (30 (15 to 240))</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.001</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Drowsiness time</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011786-bbs2-0001" title="AshrafiMR , MohammadiM , TafarrojiJ , ShabanianR , SalamatiP , ZamaniGR . Melatonin versus chloral hydrate for recording sleep EEG. European Journal of Paediatric Neurology2010;14(3):235-8. [DOI: 10.1016/j.ejpn.2009.06.010] [PMID: 19616978]">Ashrafi 2010</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Median (range) in minutes</b> </p> <p>Chloral hydrate group (60 (0 to 300)), melatonin group (20 (0 to 300))</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.001</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Chloral hydrate versus midazolam</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sleep onset latency</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011786-bbs2-0002" title="AshrafiMR , Azizi MalamiriR , ZamaniGR , MohammadiM , HosseiniF . Sleep inducing for EEG recording in children: a comparison between oral midazolam and chloral hydrate. Iranian Journal of Child Neurology2013;7(1):15-9. [PMID: 24665284]">Ashrafi 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Median (range) in minutes</b> </p> <p>Chloral hydrate group (32 (20 to 95)), midazolam group (20 (0 to 300))</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.001</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sleep duration</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011786-bbs2-0002" title="AshrafiMR , Azizi MalamiriR , ZamaniGR , MohammadiM , HosseiniF . Sleep inducing for EEG recording in children: a comparison between oral midazolam and chloral hydrate. Iranian Journal of Child Neurology2013;7(1):15-9. [PMID: 24665284]">Ashrafi 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Median (range) in minutes</b> </p> <p>Chloral hydrate group (66.5 (56 to 98)), midazolam group (25.5 (12 to 38))</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.001</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Drowsiness time</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011786-bbs2-0002" title="AshrafiMR , Azizi MalamiriR , ZamaniGR , MohammadiM , HosseiniF . Sleep inducing for EEG recording in children: a comparison between oral midazolam and chloral hydrate. Iranian Journal of Child Neurology2013;7(1):15-9. [PMID: 24665284]">Ashrafi 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Median (range) in minutes</b> </p> <p>Chloral hydrate group (32 (21 to 36)), midazolam group (6 (2 to 9))</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.001</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Chloral hydrate versus hydroxyzine</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time of sleep</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011786-bbs2-0005" title="BektasO , AricaB , TeberS , YilmazA , ZeybekH , KaymakS , et al. Chloral hydrate and/or hydroxyzine for sedation in pediatric EEG recording. Brain &amp; Development2014;36(2):130-6. [DOI: 10.1016/j.braindev.2013.03.002] [PMID: 23582501]">Bektas 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Median (range) in minutes</b> </p> <p>Chloral hydrate group (20 (5 to 120)), hydroxyzine group (30 (5 to 240))</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.309</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excessive fast activity</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011786-bbs2-0005" title="BektasO , AricaB , TeberS , YilmazA , ZeybekH , KaymakS , et al. Chloral hydrate and/or hydroxyzine for sedation in pediatric EEG recording. Brain &amp; Development2014;36(2):130-6. [DOI: 10.1016/j.braindev.2013.03.002] [PMID: 23582501]">Bektas 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Percentage</b> </p> <p>Chloral hydrate (24.5%) vs hydroxyzine (11.6%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.02</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Success in falling asleep</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011786-bbs2-0005" title="BektasO , AricaB , TeberS , YilmazA , ZeybekH , KaymakS , et al. Chloral hydrate and/or hydroxyzine for sedation in pediatric EEG recording. Brain &amp; Development2014;36(2):130-6. [DOI: 10.1016/j.braindev.2013.03.002] [PMID: 23582501]">Bektas 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Percentage</b> </p> <p>Chloral hydrate (90.7%) vs hydroxyzine (89.6%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.841</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Chloral hydrate versus intramuscular AMPS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to sedation</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011786-bbs2-0015" title="ThompsonJR , SchneiderS , AshwalS . The choice of sedation for computed tomography in children. A prospective evaluation. Radiology1982;143(2):475-9. [PMID: 7071350]">Thompson 1982</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean (minutes)</b> </p> <p>Chloral hydrate (55) vs AMPS (53)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Imaging failure</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011786-bbs2-0015" title="ThompsonJR , SchneiderS , AshwalS . The choice of sedation for computed tomography in children. A prospective evaluation. Radiology1982;143(2):475-9. [PMID: 7071350]">Thompson 1982</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Percentage</b> </p> <p>Chloral hydrate (15%) vs AMPS (12%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>AMPS: atropine/meperidine/promethazine/secobarbital<br/>N/A: not applicable </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Outcomes with skewed data as reported by individual studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/full#CD011786-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011786-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Chloral hydrate oral (50 mg/kg or 100 mg/kg) versus dexmedetomidine oral (2 µg/kg or 3 µg/kg)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 EEG time onset for adequate sedation (minutes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.86 [‐5.12, ‐2.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 high dose (100 mg/kg chloral hydrate vs 3 µg/kg dexmedetomidine)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.60 [‐7.33, ‐3.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.2 low dose (50 mg/kg chloral hydrate vs 2 µg/kg dexmedetomidine)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.90 [‐3.74, ‐0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 EEG sedation failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.51, 2.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.1 high dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.12, 3.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.2 low dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [0.54, 3.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 EEG sedation / sleep duration (minutes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>16.47 [9.21, 23.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.1 high dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>21.70 [11.76, 31.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.2 low dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.50 [‐0.11, 21.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 EEG sedation adverse event: total <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.66 [1.78, 32.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.1 high dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.50 [1.41, 78.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.2 low dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.67 [0.55, 39.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 EEG sedation adverse event: hypotension <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.01, 8.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.1 high dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.01, 8.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.2 low dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 EEG sedation adverse event: bradycardia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.02, 9.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.1 high dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.2 low dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.02, 9.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 EEG sedation adverse event: behavioural change <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.24 [0.26, 105.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.1 high dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.24 [0.26, 105.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.2 low dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 EEG sedation adverse event: nausea or vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>12.04 [1.58, 91.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.1 high dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>15.73 [0.93, 266.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.2 low dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.14 [0.43, 152.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.9 EEG sedation adverse event: oxygen desaturation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.31 [0.35, 31.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.1 high dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.15 [0.13, 75.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.2 low dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.49 [0.15, 83.03]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Chloral hydrate oral (50 mg/kg or 100 mg/kg) versus dexmedetomidine oral (2 µg/kg or 3 µg/kg)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011786-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Chloral hydrate oral (75 mg/kg) versus pentobarbital intravenous (5 mg/kg)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Neuroimaging time onset for adequate sedation (minutes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>19.00 [16.61, 21.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Neuroimaging sedation failure after 2 administrations of sedative agent (same or different) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.00 [0.33, 27.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Neuroimaging sedation failure after 1 administration of sedative agent <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.33 [1.35, 13.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Neuroimaging uninterpretable <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.23 [0.03, 1.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 Neuroimaging sedation adverse event: oxygen desaturation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.21, 2.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.6 Neuroimaging sedation adverse event: nausea or vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.00 [0.76, 47.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.7 Neuroimaging sedation adverse event: paradoxical reaction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.01, 1.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.8 Neuroimaging sedation adverse event: return to baseline activity postdischarge <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.00 [‐11.43, ‐0.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Chloral hydrate oral (75 mg/kg) versus pentobarbital intravenous (5 mg/kg)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011786-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Chloral hydrate oral (100 mg/kg or 75 mg/kg) versus midazolam (intranasal 0.2 mg/kg or oral 0.5 mg/kg)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Neuroimaging time onset for adequate sedation (minutes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>12.83 [7.22, 18.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Neuroimaging inadequate level of sedation achieved (Ramsay score 4) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [0.03, 0.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 Neuroimaging sedation failure after 1 administration of sedative agent <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.02, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.4 Neuroimaging sedation / sleep duration (minutes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>19.00 [‐3.40, 41.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.5 EEG sedative‐induced artefact <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.44, 0.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.6 EEG sedation adverse event: total <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.01, 4.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.7 Neuroimaging adverse event: behavioural change <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.8 Neuroimaging adverse event: vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.29 [0.84, 33.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.9 Neuroimaging sedation failure with intranasal midazolam <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.19, 0.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.10 Neuroimaging sedation failure with oral midazolam <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [0.01, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Chloral hydrate oral (100 mg/kg or 75 mg/kg) versus midazolam (intranasal 0.2 mg/kg or oral 0.5 mg/kg)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011786-tbl-0015"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Chloral hydrate oral (50 mg/kg) versus melatonin oral</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 EEG sedative‐induced artefact <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>348</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.14, 0.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.2 EEG sedation adverse event: total <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>348</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.25, 3.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Chloral hydrate oral (50 mg/kg) versus melatonin oral</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011786-tbl-0016"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Chloral hydrate oral (50 mg/kg + 50 mg/kg) versus hydroxyzine hydrochloride oral (1 mg/kg + 1 mg/kg)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.1 EEG time onset for adequate sedation (minutes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>282</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.50 [‐7.85, ‐7.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.2 EEG sedation failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>282</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.11, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.3 EEG sedation / sleep duration (minutes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>282</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.10 [2.23, 3.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.4 EEG sedative‐induced artefact <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>282</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [0.47, 3.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.5 EEG sedation adverse event: behavioural change <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>282</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.40, 3.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.6 EEG sedation adverse event: nausea or vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>282</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.34, 4.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.7 EEG failure after 1 administration of sedative agent <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>282</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.18, 1.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Chloral hydrate oral (50 mg/kg + 50 mg/kg) versus hydroxyzine hydrochloride oral (1 mg/kg + 1 mg/kg)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-tbl-0016">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011786-tbl-0017"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Chloral hydrate oral (70 mg/kg) versus promethazine oral (1 mg/kg)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.1 EEG time for adequate sedation (minutes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐12.11 [‐18.48, ‐5.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.2 EEG inadequate level of EEG sedation achieved (Ramsay score 4) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [0.00, 0.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.3 EEG sedation failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [0.01, 0.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.4 EEG sedation adverse event: behavioural change <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.01, 4.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.5 EEG sedation adverse event: vomiting or nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>13.00 [0.76, 220.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.6 EEG Ramsay Sedation Score after 1 administration of sedative agent <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.53 [1.00, 2.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Chloral hydrate oral (70 mg/kg) versus promethazine oral (1 mg/kg)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-tbl-0017">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011786-tbl-0018"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Chloral hydrate oral (60 mg/kg) versus music therapy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.1 EEG time onset for adequate sedation (minutes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.00 [‐2.15, 20.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.2 EEG sedation failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>17.00 [2.37, 122.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.3 EEG sedation / sleep duration (minutes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>160.00 [121.07, 198.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Chloral hydrate oral (60 mg/kg) versus music therapy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-tbl-0018">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011786-tbl-0019"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Chloral hydrate oral (50 mg/kg) versus midazolam rectal (1 mg/kg)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.1 EEG time onset for adequate sedation (minutes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐95.70 [‐114.51, ‐76.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.2 EEG sedation/ sleep duration (minutes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>15.10 [3.35, 26.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.3 EEG sedative‐induced artefact <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.73, 2.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Chloral hydrate oral (50 mg/kg) versus midazolam rectal (1 mg/kg)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-tbl-0019">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011786-tbl-0020"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Chloral hydrate oral high dose (100 mg/kg) versus chloral hydrate oral low dose (70 mg/kg)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.1 Neuroimaging time onset for adequate sedation (minutes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.00 [‐7.62, ‐6.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.2 Neuroimaging sedation failure after 1 administration of sedative agent <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.19, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.3 Neuroimaging sedation / sleep duration (minutes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.00 [5.81, 10.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.4 Neuroimaging sedation adverse event: total <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.49, 2.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Chloral hydrate oral high dose (100 mg/kg) versus chloral hydrate oral low dose (70 mg/kg)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-tbl-0020">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011786-tbl-0021"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Chloral hydrate oral high dose (100 mg/kg) versus chloral hydrate oral low dose (50 mg/kg)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.1 EEG time onset for adequate sedation (minutes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.10 [‐7.05, ‐3.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.2 EEG sedation failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.05, 0.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.3 EEG sedation/sleep duration (minutes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>17.80 [8.50, 27.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.4 EEG sedation adverse event: total <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.25 [0.77, 6.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.5 EEG sedation adverse event: behavioural change <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.51 [0.22, 90.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.6 EEG sedation adverse event: nausea or vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.10 [0.59, 7.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.7 EEG sedation adverse event: oxygen desaturation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.06, 13.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Chloral hydrate oral high dose (100 mg/kg) versus chloral hydrate oral low dose (50 mg/kg)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-tbl-0021">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011786-tbl-0022"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Chloral hydrate oral (50 mg/kg) versus sodium thiopental rectal (25 mg/kg)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11.1 Neuroimaging adequate sedation (Ramsay score 4) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.83, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11.2 Neuroimaging onset sedation (minutes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.20 [‐6.08, ‐2.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11.3 Neuroimaging sedation failure after 1 administration of sedation agent <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [0.60, 2.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11.4 Neuroimaging sedation duration (minutes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.80 [‐1.70, 0.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11.5 Neuroimaging adverse effect: desaturation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.00 [0.24, 102.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11.6 Neuroimaging adverse effect: diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [0.00, 0.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11.7 Mean diastolic blood pressure during procedure (mmHg) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.40 [5.11, 9.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Chloral hydrate oral (50 mg/kg) versus sodium thiopental rectal (25 mg/kg)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-tbl-0022">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011786-tbl-0023"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">Chloral hydrate oral (50 mg/kg) versus clonidine oral (4 μg/kg)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12.1 EEG onset sedation (minutes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐37.48 [‐55.97, ‐18.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12.2 EEG sedation / sleep duration (minutes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.07 [‐15.32, 3.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12.3 EEG sedation adverse event: drowsiness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.30, 0.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12.4 EEG sedation adverse event: vertigo <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.15 [0.01, 2.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">Chloral hydrate oral (50 mg/kg) versus clonidine oral (4 μg/kg)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-tbl-0023">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011786-tbl-0024"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">Chloral hydrate oral (50 mg/kg) versus dexmedetomidine intranasal (3 μg/kg)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13.1 Neuroimaging sedation onset (minutes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>194</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.80 [0.77, 4.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13.2 Neuroimaging adverse event: bradycardia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>194</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.05, 0.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13.3 Neuroimaging adverse event: unsteadiness within 24 h after discharge <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>173</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.21 [0.58, 178.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13.4 Neuroimaging adverse event: crying during administration of sedation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>194</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.39 [1.08, 1.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13.5 Neuroimaging adverse event: vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>194</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.59 [0.61, 185.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">Chloral hydrate oral (50 mg/kg) versus dexmedetomidine intranasal (3 μg/kg)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011786.pub3/references#CD011786-tbl-0024">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD011786.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD011786-note-0023">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD011786-note-0021">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD011786-note-0022">Français</a> </li> <li class="section-language"> <a class="" href="ko#CD011786-note-0018">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD011786-note-0020">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD011786-note-0017">Русский</a> </li> <li class="section-language"> <a class="" href="th#CD011786-note-0019">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD011786-note-0016">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011786\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011786\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011786\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011786\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011786\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011786\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011786\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011786\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011786\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011786\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011786\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011786\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011786\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011786\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011786\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011786\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011786\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011786\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jxlIh5Me&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011786.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011786.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD011786.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD011786.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011786.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740729709607"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011786.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740729709611"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011786.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ee3855ddc9377',t:'MTc0MDcyOTcxMC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 